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Abstract: Effects of varying dosages (0.6 to 4.8 μg/egg) of vitamin D 3 (D3) and
25-hydroxycholecalciferol (25OHD3), administrated by in ovo (amniotic) injection, on
various embryonic and post-hatch physiological variables in Ross 708 broilers were
investigated. The in ovo injection of 1.2 to 4.8 μg of both D3 and 25OHD3 increased
serum 25OHD3 concentrations in broiler embryos in comparison to non-injected and
diluent-injected control groups. Furthermore, the effects of 2.4 μg of D3 and 25OHD3
alone and in combination on the performance, meat yield and quality, small intestine
morphology, and immunity of the broilers fed a diet restricted in calcium and
phosphorous (ReCaP) content by 20% throughout grow out, period were investigated. In
comparison to the in ovo injection of diluent or the combination of D3 and 25OHD3, the
in ovo injection of 2.4 μg of 25OHD3 increased breast meat yield at 14 and 40 days of age
(doa). In addition, Serum IgM increased in response to the in ovo injection of 25OHD3 at
14 doa. Furthermore, increases in villus length VL to crypt depth ratio (RVC) at both 14
and 40 doa in response to the injection of 25OHD3 alone were observed. The

improvements in these observed factors may be due to an improvement in small intestine
morphology in response to the in ovo injection of 25OHD3 alone. Lastly, the effects of
2.4 μg of D3 and 25OHD3 alone or in combination on the performance, meat yield and
quality, small intestine morphology, and immunity of Ross 708 broilers after being
subjected to a coccidiosis challenge at 14 doa were investigated. The in ovo injection of
25OHD3 alone increased broiler BW gain from 29 to 41 doa in comparison to those
injected with diluent or D3 alone. Furthermore, the RVC of birds increased before and 2
weeks after a coccidiosis challenge when in ovo-injected with 25OHD3 alone in
comparison to being injected with diluent or D3 alone. These results indicate that
25OHD3 alone may improve small intestine morphology, growth performance, and
increase meat yield and antibody production of broilers subjected to a coccidiosis
infection.
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CHAPTER I
INTRODUCTION
Over the past 50 years, intensive genetic selection in poultry has resulted in great
progress in increasing the functional characteristics of layers and broilers. Currently,
laying hens lay more than 320 eggs during their 52-week laying cycle. Additionally, from
1957 to 2005, the body weight (BW) of broilers increased by over 400% at 42 days of
age (Zuidhof et al., 2014). Zuidhof et al. (2014) found that the annual rate of increase in
the BW of broiler chicks is 3.30%. Moreover, the birds reach a higher BW over a shorter
period of time while consuming less feed per kg of BW gain (BWG). The feed
conversion ratio (FCR) has decreased every year on average by 2.55%. In 1957, broilers
consumed about 2.85 g of feed for 1 g of BW, while in 2005 they needed only about 1.67
g. These results indicate that intense genetic selection in the poultry industry has
increased broiler performance while contributing to their growth efficiency. However, the
rapid growth and development of birds have caused a number of adverse metabolic
complications, including ascites, skeletal abnormalities, impaired immunity and increased
susceptibility to infectious diseases (Havenstein et al., 2003; Emmerson, 1997). These
negative impacts on growth and development may occur during both the embryogenic
and post-hatch periods (Buzala et al., 2015). Improvements in chicken embryo immune
status in response to the in ovo injection of various nutrients, including amino acids,
carbohydrates, vitamins, stimulants (caffeine and theophylline) and hormones, can
1

promote embryonic development as well as post-hatch performance of poultry under
intensive production conditions (Peebles, 2018).
Vitamin D3 and its metabolites are multi-functional nutrients that are involved in
both physiological and metabolic pathways. Vitamin D3 is crucial to calcium and
phosphorus metabolism and the prevention of skeleton developmental problems in birds
(Fritts and Waldroup, 2003; Sun et al., 2013). Vitamin D3 is involved in calcium
homeostasis, intestinal absorption of calcium and phosphorus, and bone resorption
(Soares et al., 1995; Atencio et al., 2005; Rama-Rao et al., 2006; 2009). In addition,
vitamin D3 has a wide range of metabolic effects including increased bone mineralization
and mobilization (Fritts and Waldroup, 2003; Sun et al., 2013), immune function (Morris
et al., 2014), and muscle development in broiler chickens (Vignale et al., 2015).
Therefore, the aim of the current research was to explore the mechanisms and effects of
two vitamin D3 sources administered by in ovo injection on broiler chicken development,
performance, meat yield, immunity, and small intestine morphology.

2

CHAPTER II
LITRATURE REVIEW
2.1

AVIAN EMBRYO DEVELOPMENT
Chickens are oviparous animals, in that they lay eggs in which their offspring

develop. The fertilization of a chicken ovum occurs in the infundibulum, which
subsequently leads to the formation of a zygote. Embryo development begins after
fertilization by sequential mitotic divisions (Romanoff, 1960). Cellular division takes
place in the blastodisc, known as the germinal disc (Patten, 1920). The blastoderm is a
result of the cluster of cells comprising a single layer formed during cellular division.
Further development of the blastoderm ultimately leads to the full formation of the
chicken embryo. The success of avian embryo development is dependent upon the
provision of optimum incubational conditions, which are 37.5 ± 0.5 dry bulb and 28.9 ±
0.5 ° C wet bulb temperatures, respectively (Peebles and Brake, 1987; Bruzual et al.,
2000; Pulikanti et al., 2012). As incubation proceeds, the primitive streak, which includes
the ectoderm, endoderm, and mesoderm, becomes visible in the posterior end of the
embryo (Smith, 2002). The nervous system, sensory organs, feathers, claws, and glands
differentiate from the ectoderm layer (Patten, 1920). The endoderm layer differentiates
into the digestive and respiratory organs, and finally, the mesoderm differentiates into the
body cavities, and circulatory and lymphatic organs. The daily anatomical and
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developmental activities of an embryo from Day 1 to 21 (at hatch) of incubation are
presented in Table 2.1 (Parkhurst and Mountney, 1988).
In the first 3 days of embryonic development, the yolk and albumen serve as
primary nutritional sources, while the allantois and amnion, as well as the yolk sac, serve
as residual sources of nutrition for the remaining incubation period (Smith, 2002). The 3
week incubation period is categorized into the early, mid, and late developmental phases.
The development of several organs including the digestive tract and heart occur during
early embryonic development, which extends from 0 to 7 days of incubation (doi; Smith,
2002). From 8 to 14 doi, which is referred to as the middle period of embryonic
development, the development of the allantois, amnion, and yolk sac are completed and
the kidneys are functionally active. Additionally, maximum development of the amnion
occurs at 12 doi (Patten, 1920). From 15 doi to hatch, the late stages of embryonic
development begin and the amniotic sac begins to regress. Also, the yolk sac is the main
reservoir of nutrients for the developing embryo until it migrates into the embryo`s body
cavity by 19 doi. The activity of metabolic enzymes, including lipase and alpha amylase
in the embryonic pancreas (Rinaudo et al, 1979), 25-hydroxylase in the embryonic liver,
and 1α-hydroxylase in the embryonic kidney, can be detected at very low levels at 19 doi
(Moriuchi and Deluca, 1974). In addition, the development of immune-related tissues
such as the spleen, bursa of Fabricius, and thymus occur by 19 doi. In chickens,
antibodies (immunoglobulins; Ig) are formed by B-cells in the bursa of Fabricius, and by
T-cells in the thymus (Erf, 1997). Chickens have three classes of immunoglobulins,
which are IgM, IgY (corresponding to lgG in mammals), and IgA. Small intestine
development begins early in embryo development and it continues through the first week
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of post-hatch life (Uni et al., 1998a,b; Applegate et al., 1999; Geyra et al., 2001a).
However, changes in small intestine morphology during the last few days of incubation
have been shown to have a large impact on post-hatch broiler performance as well as
nutrient absorption. For instance, the in ovo injection of a leucine metabolite, with the
goal of accelerating the process of intestinal growth and development in chicks, has been
shown to promote posthatch intestinal carbohydrate absorption (Uni et al., 2005; Foye et
al., 2006), increased brush border carbohydrase activity at hatch and increased BW
through 10 d posthatch (Tako et al., 2004), increased villus surface area at hatch and
through 3 d posthatch (Smirnov et al., 2006), and increased expression of selected brush
border transporters (Tako et al., 2005).
2.2

IN OVO INJECTION
Broilers are often raised in environments that make them susceptible to infectious

agents as well as environmental, zootechnical and nutritional fluctuations. Therefore,
successful poultry production requires the maintenance of poultry health by
implementing intervention strategies against infectious pathogens such as High
Pathogenic Avian Influenza (HPAI), Newcastle Disease (ND), Marek's Disease (MD),
Infectious Bursal Disease (IBD) and Infectious Bronchitis (IB; Lister, 2000). Currently,
vaccination is the common method to control infectious diseases in intensive modern
poultry operations. However, all birds in a flock should be vaccinated to implement an
effective vaccination program. Also, several days are usually required for optimum levels
of humoral and cellular immune responses to become complete (Negash et al., 2004). In
ovo vaccination is, therefore, used to stimulate an early immune response in young
broilers (Sharma and Burmester, 1982).
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In ovo vaccination is an alternative approach to the post-hatch vaccination of
chickens, particularly in broilers. In ovo vaccination is used to deliver a particular vaccine
between 17.5 and 19.25 doi into the amniotic sac surrounding the broiler embryo
(Williams, 2007 and 2011). In ovo-injection is widely used in the U.S. commercial
broiler industry and has allowed for the direct administration of particular nutrients or
vaccines to embryos. It is less labor intensive, and is relatively stress-free for the embryo
(Williams, 2007). In ovo injection also uniformly delivers vaccines with limited
contamination for the initiation of an early immune response in broilers (Williams, 2007).
The poultry industry commercially uses in ovo injection against Marek`s disease
(Williams, 2007).
In addition to vaccines, in ovo injection has been used to successfully deliver
various nutrients such as vitamins, minerals, carbohydrates, and amino acids into broiler
embryos (Peebles, 2018). In ovo injection of carbohydrate mixtures containing maltose,
sucrose, and dextrin at 17.5 doi into the amnion results in an increase in hatchling BW,
10 d-old chick BW, and villus surface area in the intestines of Ross 708 broilers (Tako et
al., 2004). Furthermore, the in ovo injection of 20 μg of selenium into the amnion of Ross
708 broilers at 18 doi increased BW when challenged with Eimeria maxima and
Clostridium perfringens (Lee et al., 2014). The in ovo injection of selenium also
increased the inflammatory response as well as serum antibody levels of broilers against
Clostridium perfringens α-toxin and NetB toxin (Lee et al., 2014), and the in ovo
injection of vitamin C increased the antioxidant capacity as well as performance of
broiler chickens (Zhang et al., 2019). Furthermore, the in ovo injection of glycine and
proline, or lysine, methionine, and cysteine amino acid mixtures at 14 doi resulted in an
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increase in feed intake and cell-mediated and humoral immunity, and a decrease in the
FCR of broilers (Bhanja and Mandal, 2005). The in ovo injection of several types of
nutrients is, therefore, proposed to stimulate the performance, small intestine
morphology, immunity, and antioxidant activity of broilers.
2.3

VITAMIN D
Vitamin D is a secosteroid which has a similar structure to steroid hormones such

as estradiol and cortisols (Norman, 2008). Vitamin D is largely involved in bone
development and preservation through its maintenance of plasma calcium (Ca) and
phosphorus homeostasis (Soares et al., 1995; Khan et al., 2010). Additionally, vitamin D
plays vital roles in broiler performance (Fritts and Waldroup, 2003), eggshell formation
(Khan and Mukhtar, 2013), reproduction (Saunders-Blades and Korver, 2015), and
immunity (Chou et al., 2009). Thus, vitamin D is not only a fat-soluble vitamin (Abawi
and Sullivan, 1989), but it is also considered as a prohormone (Norman, 2008), and an
immunomodulatory nutrient (Correale et al., 2009).
2.3.1

VITAMIN D METABOLISM
Vitamin D3 (D3) can be synthesized by the conversion of 7-dehydrocholesterol

(7DHC), in skin via ultraviolet radiation exposure (Edwards, 2003) or it can be
supplemented in the diet. Chicken skin is mainly covered with feathers that reduce the
amount of D3 production from their skin, but they produce high amounts of 7DHC in
their legs and feet (or nonfeathered skin areas), which contribute to D3 synthesis (Tian et
al., 1994). The endogenous synthesis of D3 has been shown to increase in birds managed

in free-range systems in comparison to those managed indoors and supplemented with
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same levels of D3 (Kühn et al., 2014). Moreover, most commercial poultry facilities
allow limited or no exposure to direct sunlight; thus, endogenous production of D 3 is low,
and its dietary supplementation is required (Holick, 1995; Soares et al., 1995). Dietary D 3
and its metabolites are categorized as lipophilic feed constituents and absorption of
vitamin D3 sources is facilitated by bile salts in the upper small intestine (Garrett and
Young, 1975). Vitamin D3 must undergo two sequential hydroxylation steps to become
active. The first hydroxylation occurs through 25-hydroxylase activity in liver
microsomes and mitochondria. This first hydroxylation produces 25hydroxycholecalciferol (25OHD3). Also, conversion of D3 to 25OHD3 takes place in the
intestine or kidney but at a lower rate (Norman, 1987). Then, 25OHD3 is transported via
vitamin D binding protein to the kidneys, where 25OHD3 is hydroxylated to 1,25dihydroxyvitamin D3 (1,25(OH)2 D3) by 1α-hydroxylase (Henry, 1980). The second
hydroxylation is highly regulated by parathyroid hormone, Ca serum level, 1,25-(OH)2
D3 itself, estrogens, prolactin, and growth hormone (De Matos, 2008; Rosol et al., 2000;
Taylor and Dacke, 1984). The expression of 1α-hydroxylase has been reported in innate
and adaptive immune cells the digestive tract, skeletal muscle fibers, pancreatic cells,
parathyroid glands, and skin in mammals and birds (Zhang et al., 2002; Correale et al.,
2009; Shanmugasundaram and Selvaraj, 2012; Morris et al., 2014; Shojadoost et al.,
2015).
Vitamin D3 level in birds is best assessed by an evaluation of the concentration of
25OHD3 in the blood, since 25OHD3 has a longer half-life, which is approximately 15 d
(Jones et al., 2015), in contrast to D3 which has a half-life of 15 h (Mawer et al., 1969).
Additionally, dietary 25OHD3 significantly increases circulating 25OHD3 concentrations
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as compared to vitamin D3 at the same level of activity in both broilers (Vignale et al.,
2015) and laying hens (Käppeli et al., 2011). A longer half-life of 25OHD3 allows this
metabolite to stay longer in the blood and it may be subsequently converted to active
form of vitamin D when Ca serum level or serum 25OHD3 are low (Rosol et al., 2000;
Taylor and Dacke, 1984). A longer half-life of 25OHD3 can be beneficial in the newly
hatched chick due to impaired absorption of D3. During the first two weeks of life, the
absorption of D3 by the chick is low due to immaturity of the digestive tract and low
activity of enzymes involved in lipid absorption (Noy and Sklan, 1995). In a more recent
study in broiler chickens, plasma 25OHD3 level decreased from 0 to 6 d of age (doa) and
it remains low until 10 doa when D3 was supplemented at the recommended level in the
diet (Saunders-Blades and Korver, 2014). This indicates that birds are not able to absorb
D3 from the diet properly in first 10 day of posthatch.
The intestinal absorption of 25OHD3 was greater (83.6%) in comparison to D3
(66.5%) at the same level of inclusion (50 μg/kg; Bar et al., 1980). This could be due to
greater polarity of 25OHD3 than D3. The more polar molecules are less dependent on bile
salts for absorption (Compston et al., 1981; Borel, 2003). An increase in absorption of
25OHD3 can be associated with increased serum 25OHD3 level as compared to D3 at the
same level of activity (Yarger et al 1995); however, the conversion of 25OHD3 to the
active hormone is highly regulated (Rosol et al., 2000; Taylor and Dacke, 1984).
Additionally, serum 1,25-(OH)2 D3 concentrations did not change with dietary levels of
either source of D3 (Yarger et al., 1995). The serum 25OHD3 level is mostly converted to
1,25-(OH)2D3 when serum Ca level is low, but if the serum Ca level is high or at the
normal level it is converted to 24, 25-dihydroxylcholecalciferol [24,25-(OH)2D3] which
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is the excretory form of vitamin D. These results indicate that increased serum 25OHD3
would not be the possible reason for the increased potency of 25OHD3. Both D3 sources
can be stored in several tissues such as adipose tissue, liver, and white and red muscles
(Burild et al., 2016). Dietary 25OHD3 at low levels of inclusion (5 μg) is mainly stored in
white and red muscle rather than in adipose tissue. However, D3 is mainly stored in
adipose tissue with only small amounts stored in the liver or muscle tissues (Burild et al.,
2016).
In chickens, vitamin D affects the morphological and functional development of
the intestinal mucosa by mediating putrescine secretion (Shinki et al., 1991). The active
form of vitamin D, 1,25(OH)2 D3, contributes to small intestine development by
stimulating both ornithine decarboxylase and spermidine N-acetyltransferase activity
(Shinki et al., 1981, 1985, 1991). Ornithine decarboxylase and spermidine Nacetyltransferase are rate-limiting enzymes in the biosynthesis of polyamines. These
enzymes are involved in the conversion of the higher polyamines (spermidine and
spermine) into putrescine (Tabor and Tabor, 1976) subsequently, leading to enhanced cell
proliferation and growth (Tabor and Tabor, 1984). Increased duodenal putrescine level
has been observed in vitamin D-deficient broilers in response to the single injection of
1,25(OH)2 D3 (Shinki et al., 1985). Therefore, the influence of vitamin D3 on intestinal
development is mediated likely through the production of putrescine in response to
1α,25-(OH)2-D3.
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2.3.2
2.3.2.1

VITAMIN D3 AND 25OHD3 IN POULTRY DIETS
BROILER PERFORMANCE
Several studies have reported the effects of vitamin D3 sources on broiler

performance. When compared to NRC (1994)-recommended dietary level (250 IU/kg),
dietary D3 from 1,000 to 4,000 IU/kg increased the BW of broilers (Fritts and Waldroup,
2003). However, only 500 IU/kg of dietary 25OHD3 was sufficient to increase broiler
BW (Fritts and Waldroup, 2003). In comparison to D3 at the same level of inclusion,
supplemental dietary 25OHD3 from 50 to 69 μg/kg increased broiler BW, BW gain
(BWG), and feed intake, and to reduce FCR (Bar et al., 2003; Yarger et al., 1995),
particularly when included throughout the growing period (Yarger et al., 1995). In
addition, broiler performance was not affected by either D3 or 25OHD3 when both were
supplemented at between 4,000 and 5,520 IU/kg (Fritts and Waldroup, 2003; Yarger et
al., 1995; Vazquez et al., 2018).
2.3.2.2

BREAST MEAT YIELD AND MUSCLE DEVELOPMENT
Several studies have reported the effects of various vitamin D3 sources on breast

meat yield (Yarger et al., 1995; Michalczuk et al., 2010; Vignale et al 2015). Dietary
25OHD3 at high levels of inclusion (2,760 or 5,520 IU/kg) exhibited a greater potency for
breast meat yield when compared to D3, particularly when it is supplemented throughout
the grow-out period (Yarger et al., 1995; Vignale et al 2015). However, the combination
of dietary D3 and 25OHD3 or 25OHD3 alone at 5,520 IU/kg for 21 days had no effect on
breast or leg meat yield at 42 days of age (Michalczuk et al., 2010; Vignale et al 2015).
Based on genomic analysis, the molecular mechanisms by which 25OHD3 affects chicken
muscle proliferation and development involve the mTOR-S6K pathway (Vignale et al
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2015). The authors also reported that expression of the vitamin D receptor (VDR) was
increased in response to 25OHD3 alone in the muscle tissue of broilers. An increase in the
expression of VDR is directly associated with increased levels of circulating 1,25(OH)2
D3 (Shojadoost et al., 2015), which can be subsequently linked to increased breast meat
yield in chickens (Vignale et al 2015). Another positive effect of 25OHD3 on breast meat
yield in broilers involves an increase in the D3 status of the organism and its stimulation
of skeletal muscle satellite cell activity in the pectoralis major muscle (Hutton et al.,
2014). Satellite cells are present in post-hatch broiler skeletal muscle and an increase in
satellite cells is associated with hypertrophic skeletal muscle growth (Moss, 1968).
Therefore, an increase in the number and size of satellite cells can result in an increase in
meat yield in broilers
2.3.2.3

SMALL INTESTINE MORPHOLOGY
An improvement in small intestine morphology is associated with increased breast

meat yield and enhanced broiler performance (Wang et al., 2019). An increase in villus
height or the ratio of villus height to crypt depth is associated with greater nutrient
absorption (Onderci et al., 2006), which can subsequently result in increased BW and
breast meat yield (Wang et al., 2019). Furthermore, a shallower crypt depth is associated
with less frequent epithelial cell turnover, leading to a lower energy requirement in the
gut (Yang et al., 2008). The influence of D3 sources on small intestine morphology has
been previously reported in broiler embryos and chickens. Maternal dietary 25OHD3
increased the villus height of broiler embryos at 19 doi and broiler chickens at 1 and 2
doa (Ding et al., 2011). In addition, as compared to D3 at the same level of dietary
inclusion, 25OHD3 at 2,760 IU/kg increased broiler intestine villus height and villus
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height to crypt depth ratio, and reduced crypt depth at 28 and 35 doa (Chou et al., 2009).
These results indicate that dietary 25OHD3 at 2,760 IU/kg is sufficient to promote the
small intestine morphology of broilers when compared to D3 at the same level of
inclusion.
2.3.2.4

IMMUNITY
Supplemental dietary 25OHD3 has shown an inconsistent pattern of effects on the

humoral immunity of birds when compared to D3. Vazquez et al. (2018) reported that
supplementing 2,760 IU/kg of 25OHD3 in diets already containing 200 or 5,000 IU/kg of
D3 resulted in increased IgA and antibody titers against NDV, as compared to those
supplemented with D3 at the same level of inclusion. However, in a separate study by
Chou et al. (2009), total serum IgA levels were found to be lower in birds fed 25OHD3 at
2,760 IU/kg relative to those fed D3 at the same level of inclusion. On the other hand,
dietary 25OHD3 increased humoral immunity when birds are challenged with a pathogen.
For example, serum IgG increased in broilers fed 25OHD3 at 69 μg/ kg relative to those
fed vitamin D3 at the same level of inclusion when challenged with Salmonella
Typhimurium E29 (Chou et al., 2009). It appears that the immunomodulatory effect of the
vitamin D3 source is related more to cellular immunity. In comparison with D3, dietary
supplementation of 25OHD3 at 69 μg/ kg has a greater effect on cellular immunity by
decreasing the number of CD3+CD4+ T-cells in unchallenged birds (Vazquez et al.,
2018) and increasing the percentage of CD4+CD25+ T-cells in birds challenged with
coccidiosis (Morris et al., 2015). As compared to D3, the greater effect of 25OHD3 on Tcell activity could be due to a lack of expression of 25-hydroxylase in those cells that is
needed to convert vitamin D3 to 25OHD3 (Correale et al., 2009). It is well documented
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that macrophages express both 25-hydroxylase and 1α-hydroxylase (Gottfried et al.,
2006) for the production of 1,25(OH)2 D3, whereas only the final metabolic step can be
performed in T-cells (Correale et al., 2009; Shanmugasundaram and Selvaraj, 2012).
Forty-eight hours after a lipopolysaccharide (LPS) challenge, a chicken macrophage line
(HD11) cells treated with 200 nM of 25OHD3 resulted in an increase in nitric oxide
(NO), IL-1β, IL-10, 1α-hydroxylase, and 24-hydroxylase levels (Morris and Selvaraj,
2014). However, D3 at 200 nM did not affect the expression of NO, IL-1β, IL-10, 1αhydroxylase or 24-hydroxylase 48 hours post-LPS challenge. In addition, in the absence
of LPS, 200 nM of 25OHD3 decreased the expression of both 1α-hydroxylase and 24hydroxylase in comparison to D3 at the same level of inclusion. Dietary 25OHD3 has
shown greater immunomudulatory effects compared to D3 in infected chickens. For
example, as compared to D3 at the same level of inclusion, dietary 25OHD3 enhanced
broiler performance during a coccidiosis challenge (Morris et al., 2014). This
improvement could be due to a reduced pro-inflammatory response (IL-1 β) and
increased anti-inflammatory response (IL-10) in birds fed 25OHD3 (Morris et al., 2014).
These results indicate that 25OHD3 has greater immunomodulatory potency than D3 when
used at higher levels of inclusion during an Emeria infection. In conclusion, the first
metabolite of vitamin D3 (25OHD3) is more effective in maximizing breast meat yield,
small intestine morphology, and immunity as compared to D3, when continuously
supplemented in broiler diets at 2,760/kg throughout the rearing period.
2.3.3

IN OVO INJECTION OF VITAMIN D3 SOURCES
A number of studies have clearly demonstrated the importance and requirement of

D3 for chicken embryonic development. The presence of vitamin D3 in eggs is very
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important to support embryo Ca metabolism during incubation (Landauer, 1967).
Therefore, a deficiency of this vitamin can lead to reduced hatchability, which can be
specifically related to late embryo mortality (Stevens et al., 1984). The in ovo injection of
vitamin D3 (0.2 μg) in the amniotic fluid at 12 doi increased the concentrations of Ca and
P in the yolk and of embryos at 17 doi. Ross 708 broiler embryos receiving 100 μl of
diluent containing 0.6 μg of pure crystalline 25OHD3 into their amnion experienced a
higher hatchability of fertile eggs (HI) as compared to those that only received
commercial diluent (Bello et al., 2013). However, the in ovo injection of various levels
(0.625, 1.250, and 1.875 μg) of water soluble 25OHD3 (Rovimix HY-Dâ 1.25%) into the
egg air cell did not affect HI of Cobb 500 broiler embryos in comparison to the noninjected control group (Mansour et al., 2017). It is worth mentioning that in response to
various ranges of in ovo-injected 25OHD3, HI was increased in Ross 708 broiler
embryos, but not in Cobb 500 broiler embryos. Additionally, the water-soluble form of
25OHD3 was injected into the air cells of the Cobb 500 broiler hatchling eggs rather than
the amniotic fluid. Regardless of the site of injection, both authors reported an increase in
serum 25OHD3 levels. Furthermore, broiler performance was also not affected by either
form of 25OHD3 (Bello et al., 2014 a,c; Gonzales et al., 2013). However, Gonzales et al
(2013) reported that in ovo injection of 1.875 μg of the water-soluble form of 25OHD3
resulted in lower hatchling body weight at hatch as compared to those embryos that
received 25OHD3 from 0 to 1.25 μg. Also, the higher dose of in ovo injection of 25OHD3
had faster body weight recovery from 0 to 10 doa in comparison to those that did not
receive 25OHD3. Bello et al. (2014b) reported that in comparison to a diluent-injected
control group, male broiler bone breaking strength at 28 doa was increased when they
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received an in ovo injection of 0.6 μg of 25OHD3. Also, an in ovo injection of 0.8 μg of
25OHD3 increased the bone quality of broilers at 10 and 42 doa when 25OHD3 was
administrated in a 500 μl volume of diluent at 18 doi (Abbasi et al., 2017). The
biopotency of the various vitamin D3 sources are still debatable, because D3 and 25OHD3
have been administrated at different time periods (12 doi for D3 and 17 and 18 doi for
25OHD3). Additionally, HI, hatchling quality, and broiler performance have not been
determined after an in ovo injection of D3. Few studies have shown effects of the in ovo
injection of various vitamin D3 sources on broiler immunity. Abbasi et al. (2017) reported
that 0.4 μg of 25OHD3 in combination with 6 μg of menadione (K3; a nutritional
supplement because of its vitamin K activity) increased Newcastle disease virus antibody
titers and antibody production against sheep red blood cells. These results demonstrate
the successful administration of these vitamin D3 sources. However, effects of the in ovo
administration of D3 and 25OHD3 alone or in combination on birds raised under
commercial conditions have not been reported in the literature. The possible mechanism
involved in in ovo injection of vitamin D3 sources can be linked to an increase demand of
Ca in the last phase of incubation. Calcium absorption through vitelline or gut cells is
facilitated by a calcium-binding-protein expressed by 1,25(OH)2 D3 renal metabolite
(Hurwitz, 1992). In the renal cells 1,25(OH)2 D3 is produced by the hydrolysis of
25OHD3 which is available in the yolk or it can be obtained from D3 metabolism in the
hepatic cells (Hurwitz, 1992). At 20 doi, the abdominal internalization of yolk sac occurs
and the only source of nutrient including Ca for embryo is the yolk remaining in the gut
(Noy and Sklan, 2001). Therefore, the greater demand of vitamin D3 during the last stage
of incubation may increase if the level of 25OHD3 is insufficient or limited mobilization
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of D3 and 25OHD3 due to immature liver and kidney of the embryos. In addition, vitamin
D3 sources can be stored in several organs including white and red muscle, liver, and
adipose tissues (Burild et al., 2016). The delay in access feed in 24-h of post-hatch can
result in decreased in finisher performance at 42 doa (Gonzales et al., 2003, 2008ab).
However, the storage of vitamin D3 sources in mentioned tissues can be used to achieve
the best performance of broiler chicks selected for high grown rate in the very early phase
of life.
2.4

PATHOGENIC AGENTS

2.4.1

REUSED LITTER

Recycled litter used for bedding material contains feathers, feed, and microbiota.
Recycled litter from previous flocks is commonly used in modern poultry production
(Torok et al., 2009; Coufal et al., 2006) due to the reduced cost of litter removal and
disposal, and costs associated with the purchase of new litter (Coufal et al., 2006). The
majority of microbiota in poultry litter is gram positive and can surpass 1010 cells per g of
litter (Bolan et al., 2010). Poultry litter contains microbes which allow for the earlier
establishment of a more stable gut microflora in young broiler chickens (Torok et al.,
2009; Cressman et al., 2010). In addition, the microbiota in used poultry litter can
function as a competitive exclusion culture for newly-placed chickens, allowing
beneficial bacteria to colonize the gastro-intestinal tract, thereby providing the gut
protection from enteric pathogens (Nurmi and Rantala, 1973; Nakamura et al., 2002;
Zhang et al., 2007).
In spite of these potential advantages, reused litter may also contain several species of
pathogenic bacteria, including Salmonella spp., Campylobacter spp., Escherichia coli,
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Clostridium perfringens, and Staphylococcus aureus (Lu et al., 2003; Cressman et al.,
2010; Roll et al., 2011). With those accumulated pathogens, there is a health concern for
flocks raised on reused litter. Additionally, gut microbial populations change qualitatively
and quantitatively when chickens are raised on reused litter (Lee et al., 2011; Cressman et
al., 2010). It is well documented that in comparison to fresh litter, reused litter results in
the colonization of more pathogenic bacteria in the small intestine of broilers. For
example, environmental bacteria (Lactobacillus) are the predominant microbes in the
small intestine of birds reared on fresh litter, but bacteria of intestinal origin
(Clostridiales) are predominant in birds reared on reused litter (Cressman et al., 2010; Lu
et al., 2003). The pathogenic environment caused by reused litter, however, can
negatively affect immunity, small intestine morphology, and bone quality of broiler
chickens. Pro-inflammatory response indicators increase in birds raised in reused letter
rather than fresh litter (Shanmugasundaram et al., 2012). Additionally, villus height was
decreased and crypt depth was increased in birds reared on reused litter in comparison to
those reared on fresh litter (Fatemi, 2016). In comparison to fresh litter, reused litter also
results in reduced bone quality in broiler chickens (Fatemi, 2016). Therefore, although
reused litter is cost efficient, it may also contain pathogens that can decrease the
performance and immunity of chickens.
2.4.2

COCCIDIOSIS
Coccidiosis in poultry is considered as one of the main diseases affecting their

performance when reared under intensive production systems (Dalloul and Lillehoj,
2006). The life cycle of coccidiosis is very short, being only about 4 to 6 d (Reid and
Long, 1979; Parry et al., 1992). There are both sexual and asexual stages in the life cycle
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of Eimeria (Hammond, 1973; Fayer, 1980). In the asexual stage, oocyst walls are crushed
by the gizzard and 4 sporocysts are released from each oocyst. Sporocysts move to the
small intestine and they are exposed to chymotrypsin and bile salts, resulting in the
release of 8 sporozoites per sporocyst. Sporozoites enter intestinal epithelial cells where 2
to 4 generations of asexual development, including schizogony or merogony, occur
(Hammond, 1973). The sexual stage includes the formation of a zygote by fusion of
micro- and macro-gametes. Motile microgametes seek out macrogametes and
subsequently produce an oocyst or zygote (Hammond, 1973). Sporulated oocysts are
shed on the litter if birds are raised in poultry houses (Fayer, 1980). Annual economic
losses to the commercial poultry industry due to coccidiosis are estimated at $800 million
worldwide, and $127 million in the United States (Chapman, 2009). It is also estimated
that preventive medication costs for coccidiosis are approximately $3 billion USD in the
USA (Williams, 1999; Dalloul and Lillehoj, 2006) although the worldwide economic
impact is unclear. According to the European Commission in 2006 (report COM
2008/233 of Regulation 1831/2003), approximately 84% of broilers in Europe avoided a
coccidiosis infection when treated with a coccidiostat and 12% avoided infection after
receiving a vaccination against coccidiosis. Furthermore, the cost of uncontrolled
coccidiosis is estimated approximately €0.21 per bird and the cost of intervention
(treatment and prevention of coccidiosis) is estimated approximately €0.17 per bird
(Jones et al., 2018), which can reduce BW gain and increase FCR and mortality
(Abdelrahman et al. 2014; Ritzi et al., 2014). Györke et al. (2016) reported that the total
economic loss due to coccidiosis in Romania is approximately €3,162.4 per flock (18,000
chicks per flock) as a result of mortality (34.8%) and increased feed conversion (65.2%).
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In another European study, four infectious species of Eimeria were most often identified:
E. acervulina (91%), E. tenella (61%), E. maxima (22%) and E. praecox (13%). Infection
by a single species (E. acervulina) was detected in 6 (26%) infected flocks that originated
from large farms. Mixed infections were found in 15 (65%) flocks, and the most
prevalent infection was due to a combination of E. acervulina and E. tenella (35%;
Györke et al., 2013). A coccidiosis infection has been shown to result in an increase in
oxidative stress (Georgieva et al., 2006), which can lead to a reduction in fat-soluble
vitamin status, including vitamin D (Lee, 2018). Furthermore, the small intestine
morphology of broilers has been shown to decline during a coccidiosis infection. Wang et
al. (2019) reported that villus height to crypt depth ratio was decreased in birds that were
challenged with coccidiosis. The authors also reported that a reduction in villus height to
crypt depth ratio was associated with a reduction in the breast meat yield as well as the
BW of infected broilers. Broiler immunity is negatively influenced in response to severe
coccidiosis infections. In broilers, the expression of pro-inflammatory response genes,
such as IL-1β increased, and the expression of anti-inflammatory response genes
including IL-10 decreased during a coccidiosis infection (Morris et al., 2015).
Additionally, CD8+ cell percentages in cecal tonsils increase in birds challenged with
coccidial oocysts, which indicates that cell mediated immunity is stimulated during a
coccidiosis challenge. Inclusion of 25OHD3 at 100 μg/kg feed in broiler diets during a
coccidiosis challenge has been shown to increase their BW gain and anti-inflammatory
response, and to decrease their pro-inflammatory response (Morris and Selvaraj, 2014;
Morris et al., 2015). Additionally, dietary 25OHD3 at 100 μg/kg increases CD4+CD25+
cells and deceases CD8+CD25+ cells in coccidial-infected broilers (Morris et al., 2015)
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and turkeys (Shanmugasundaram et al., 2019). These results indicate that dietary
25OHD3 at 100 μg/kg increases the anti-inflammatory response of broilers leading to
inflammation during a coccidiosis infection. Therefore, dietary 25OHD3 has the potential
to overcome the negative effects of coccidiosis in broilers.
2.5

WOODY BREAST MYOPATHY
Woody breast myopathy (WBM) is an abnormality in breast fillets that results in

hard and thick breast meat. The occurrence of WBM is due to lymphocyte and
macrophage infiltration, fibrosis (inflammation or necrosis in connective tissue), and
lipidosis in muscle fibers (Kuttappan et al., 2013; Sihvo et al., 2014). The increased
incidence of WBM is one of the recent major concerns in the poultry industry. An
increase in severity of WBM is associated with an increase in broiler age (Bodle et al.,
2018). It is also more frequently reported in male broilers than female (Kuttappan et al.,
2013). Furthermore, WBM was more reported in broilers supplemented with high protein
and energy diets (Kuttappan et al., 2012; Bodle et al., 2018). It is well documented that
the genetic correlations between breast muscle myopathies and BW, processing BW, and
breast yield are low (0.132-0.248) (Bailey et al., 2015). In addition, the heritabilities (h2)
of BW and of processing BW and breast yield ranged from 0.271to 0.418. For WBM, h2
was less than 0.1. These data indicate that WBM is mainly correlated to environmental
and/or management factors that contribute 90% of the variance of the incidence of WBM
in broiler chickens (Bailey et al., 2015). It is well documented that the rate of protein
synthesis is reduced, resulting in an increase in the fat content of the breast fillets of
broilers exhibiting WBM (Kuttappan et al., 2013; Trocino et al., 2015). Furthermore,
RNA sequencing results in WBM breast fillets has revealed that there is a greater
21

expression of genes involved in oxidative stress, and that there are higher levels of
intracellular Ca as well as an increase in the inflammatory response in fast-growing
broilers (Mutryn et al., 2015). An increase in the amount of Ca in the sarcoplasmic
reticula in skeletal muscle can stimulate enzymatic activity in association with protein
denaturation (Sandercock and Mitchell, 2003; Whitehead et al., 2006). It is well
documented that vitamins, such as vitamins C and E, may reduce WBM due to enhanced
antioxidant capacity. Vitamin E, selenium, and sulfur are involved in antioxidant activity
through the operation of several enzymes including glutathione peroxidase, catalase, and
superoxide dismutase. These enzymes prevent the propagation of free radicals (Herrera
and Barbas, 2001). It was hypothesized that increased plasma vitamin E concentrations in
response to dietary vitamin E (50 mg/kg) are mildly associated with a reduction in muscle
fiber damage (Guetchom et al., 2012). Additionally, vitamin C at 94.4 mg /kg feed has
been shown to reduce the severity of WBM. However, vitamin C at 188.8 mg /kg feed
had no effect on WBM (Bodle et al., 2018). The influence of vitamin D3 sources on
WBM has not been previously reported, but they have the potential to exert
immunomodulatory effects. One of the major physiological characteristics of WBM is
fibrosis and inflammation in breast fillets (Mutryn et al., 2015). Vitamin D 3 sources,
particularly 25OHD3, have been shown to reduce the expression of genes involved in
inflammation and oxidative stress in breast tissue (Fatemi, 2016). Therefore, vitamin D3
sources may be used to reduce the incidence of WBM through a reduction in the
incidence of inflammation in WBM breast fillets.
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2.6

OBJECTIVES AND HYPOTHESES

It was hypothesized that the in ovo injection of various vitamin D3 sources would
increase embryonic serum 25OHD3 concentration, as well as subsequently inreasing the
hatchability and hatch quality of broiler hatchling. This hypothesis was addressed in
Chapter 3, in which the objectives of the study were to examine the effects of the in ovo
injection of D3 and 25OHD3 on Ross 708 broiler hatchability, somatic characteristics, and
embryonic serum 25OHD3 concentrations.
It was further hypothesized that the in ovo injection of various vitamin D3 sources
would decrease eggshell temperature as well as improve early posthatch broiler
performance. This hypothesis was addressed in Chapter 4, in which the objectives of the
study were to determine the effects of D3 and 25OHD3 on eggshell temperature, which is
directly correlated with embryonic heat production, and the post-hatch performance of
Ross 708 broiler chickens.
It was also hypothesized that the in ovo injection of various vitamin D3 sources would
increase the performance, meat yield, and reduce the incidence of woody breast
myopathy of broilers. Additionally, it was hypothesized that severe reductions in dietary
calcium and available phosphorus levels would inhibit the immunity and small intestine
function of broilers. This hypothesis was addressed in Chapter 5, in which the objectives
of the study were to determine the effects of the in ovo injection of D3 and 25OHD3 on
the performance, breast meat yield, and incidence of woody breast myopathy in Ross 708
broilers fed either normal commercial diets or commercial diets restricted in calcium and
available phosphorous content by 20%.
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It was likewise hypothesized that the in ovo injection of various vitamin D3 sources
would increase antibody production, decrease indicators of an acute phase inflammatory
response, and enhance small intestine morphology in broilers. Additionally, it was
hypothesized that severe reductions in dietary calcium and available phosphorus would
reduce immune and small intestine functions of broilers. These hypotheses were
addressed in Chapter 6, in which the objectives of the study were to determine the effects
of D3 and 25OHD3 on the immunity and small intestine morphology of Ross 708 broilers
fed either normal commercial diets or commercial diets restricted in calcium and
available phosphorous content by 20%.
Additionally, it was hypothesized that the in ovo injection of various vitamin D3
sources would increase the meat yield and performance, and reduce coccidiosis lesion
severity in broilers during a coccidiosis challenge. This hypothesis was addressed in
Chapter 7, in which the objective of this study was to determine the effects of the in ovo
injection of D3 and 25OHD3 on the performance, breast meat yield, and severity of
coccidiosis lesions in Ross 708 broilers challenged with a coccidiosis vaccine.
It was lastly hypothesized that the in ovo injection of various vitamin D3 sources
would improve the small intestine morphology and decrease the inflammatory response
of broilers during a coccidiosis challenge. This hypothesis was addressed in Chapter 8, in
which the objective of this study was to determine the effects of the in ovo injection of D3
and 25OHD3 on the small intestine morphology and inflammatory response of Ross 708
broilers after a coccidial vaccine challenge.

24

Table 2.1
Days
1
2
3
4
5-6

Daily developmental stages of an embryo (Parkhurst and Mountney, 1988)
Daily embryonic development features

Formation of area pellucida and area opaca on the blastoderm, and appearance of
the primitive streak, neural groove and primordial sex cells.
Development of brain, eyes, ear pits, heart, and tail bud. Slight appearance of
blood.
Formation of limb buds and esophagus, and rapid incremental development of the
circulatory system.
Presence of all body organs and vivid evidence of vascular system.
Embryo differentiation and rapid development. Embryo already has bird-like
shape, and main division of wings and legs. Beak and egg tooth in place.

7

Development of abdominal viscera and digits. Evidence of rapid body movement.

8

Appearance of feather tracts and prominence of the eyes.

9

Embryo, amnion, and yolk almost entirely surrounded by allantois.

10

Complete separation of wings and digits on the feet. Hardening of beak begins.

11

Appearance of abdominal wall and intestines.

12

Down feathers start appearing on embryo.

13

Covering of the body with down feathers and appearance of scales and nails.

14

Embryo turning to the normal hatching position; lying parallel to long axis.

15

Small intestine pulled into the abdomen.

16
17
18
19
20
21

Albumen almost totally absorbed and developing embryo increasingly dependent
on the yolk for nutrients.
Regression of amniotic fluid, and embryo begins preparation for hatch by
positioning itself correctly.
Amniotic fluid regression and yolk sac prepared for absorption by embryo.
Absorption of yolk sac by the embryo and beak of the embryo penetrates the air
cell to initiate pulmonary respiration.
Beginning of pulmonary respiration and external pipping and cessation of chorioallantoic respiration and circulation.
Changes in the posture of the head, completion of pipping, and subsequent
normal hatching.
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CHAPTER III
EFFECTS OF SOURCE AND LEVEL OF IN OVO-INJECTED VITAMIN D3 ON THE
HATCHABILITY AND SERUM 25- HYDROXYCHOLECALCIFEROL
CONCENTRATIONS OF ROSS 708 BROILERS
3.1

ABSTRACT
Effects of in ovo-injection of vitamin D3 (D3) and 25-hydroxycholecalciferol

(25OHD3) on broiler hatchability, somatic characteristics and embryo serum 25OHD3
concentrations were determined. Eggs from a 35 wk-old commercial Ross 708 broiler
breeder flock were set in a single stage incubator with 11 treatments represented on each
of 8 incubator tray levels (blocks). Each treatment group on each tray level contained 30
eggs. Control treatments were: non-injected and diluent-injected. Commercial diluent
containing vitamin treatments were: 0.6 μg D 3, 0.6 μg 25OHD3, 0.6 μg D3 + 0.6 μg
25OHD3, 1.2 μg D3, 1.2 μg 25OHD3, 1.2 μg D3 + 1.2 μg 25OHD3, 2.4 μg D3, 2.4 μg
25OHD3, and 2.4 μg D3 + 2.4 μg 25OHD3. At 432 h of incubation (hoi), 50 μL solution
volumes were injected. Blood samples were collected at 462 hoi for serum 25OHD3
analysis, and hatchability was determined at 492 and 516 hoi. At 516 hoi, hatchling yolkfree BW, and weights of the liver and yolk sac were determined. Percentage yolk
moisture (PYM), and dry mater (PYDM) were calculated. Hatchability did not differ
between treatments at 492 and 516 hoi. Embryos that received 1.2 μg or more of either
vitamin D3 source alone or in combination had higher serum 25OHD3 concentrations
compared to those that were injected with diluent alone or diluent containing 0.6 μg of
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D3. Hatchlings that received 1.2 or 2.4 μg of 25OHD 3 had higher PYDM or lower PYM
levels than non-injected controls and those that received D3 at any level. These results
indicate that the in ovo injection of 1.2 μg or higher of either vitamin D source did not
negatively affect broiler hatchability or chick quality. In addition, the in ovo injection of
either vitamin D source at levels equal to or higher than 1.2 μg resulted in serum 25OHD3
concentrations that were higher than that of non-injected controls.
Key words: in ovo injection, vitamin D3 source, serum 25OHD3, percentage yolk
dry matter, broiler.
3.2

INTRODUCTION
In ovo vaccination is used to deliver a particular vaccine between 17.5 and 19.25

d of incubation (doi) into the amniotic sac surrounding the broiler embryo (Williams,
2011). In ovo-injection is widely used in the U.S. commercial broiler industry and has
allowed for the direct administration of particular nutrients or vaccines to embryos. It is
less labor intensive, and is relatively stress-free for the embryo. It also uniformly delivers
vaccines with limited contamination for the initiation of an early immune response in
broilers (Williams, 2007). The poultry industry commercially uses in ovo injection
against Marek`s disease. Additionally, several laboratories have conducted research to
determine effects of the in ovo injection of various nutrients including glucose and Lascorbic acid, in order to increase the hatchability and BW, and reduce the FCR of
broilers (Salmanzadeh, 2012; Zhang et al., 2018; Peebles, 2018).
Vitamin D3 (D3) and 25-hydroxycholecalciferol (25OHD3) are both involved in
calcium and phosphorous absorption and bone mineralization, and have regulatory
functions for the immune system and in the development of muscle in broiler chickens
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(Rama-Rao et al., 2006; Morris et al., 2014; Vignale et al., 2015). Dietary D3 is absorbed
in the upper portion of the small intestine and is then hydroxylated to 25OHD3 by 25
hydroxylase in the liver before being converted to the biologically active form of D3 (1,
25-dihydroxycholecalciferol [1,25 (OH)2 D3]) by 1 α-hydroxylase in the kidney (Henry,
1980). An increase in broiler hatchability is associated with increased serum 25OHD3
levels (Bello et al., 2013). In comparison to D3, the inclusion of 25OHD3 in the drinking
water of broiler breeders elevated their serum 25OHD3 levels and subsequently decreased
the embryo mortality (Saunders-Blades and Korver, 2014). The breast meat yield and
performance of broilers were increased when their serum 25OHD3 levels are increased in
response to dietary supplementation with 25OHD3. This same response is not observed
when supplemental dietary D3 is used at the same level of inclusion (Yarger et al., 1995).
This response to 25OHD3 has been attributed to its longer half-life (Norman, 1987) and
its higher rate of absorption in the intestine (Bar et al., 1980) in comparison to D 3.
The in ovo injection of 0.60 μg of 25OHD3 has likewise been shown to influence
the hatchability and yolk characteristics of broilers (Bello et al., 2013; Bello et al., 2015).
Embryos that received an in ovo injection of 0.60 μg of 25OHD3 exhibited higher
hatchability and serum 25OHD3 levels in comparison to embryos from non-injected and
diluent-injected control groups (Bello et al., 2013). The in ovo injection of 20 ng of
vitamin D3 at 12 doi increased blood calcium levels of chicken embryos (Mansour et al.,
2017). However, the effects of D3 and 25OHD3 alone or in combination on broiler
hatchability and chick quality have not been well delineated in previous research.
Therefore, the objective of this study was to investigate the effects of the in ovo injection

37

of vitamin D3 and 25OHD3 across a broad dosage range, alone or in combination, on
broiler hatchability and chick quality.
3.3
3.3.1

MATERIAL AND METHODS
GENERAL
Both preliminary and main experiment protocols of this study were approved by

the Institutional Animal Care and Use Committee of Mississippi State University. Eggs
were collected from 35 wk-old commercial Ross 708 broiler breeder hens and stored
under commercial conditions for one d prior to being set as described by Sokale et al.
(2017). In both trials, pre-specified concentrations of D3 (ROVIMIX® D3 500; DSM
Nutritional Products Inc., Parsippany, NJ) or 25OHD3 (ROVIMIX® Hy-D® 1.25%;
DSM Nutritional Products Inc., Parsippany, NJ) were dissolved in distilled water. Diluent
(commercial MD vaccine diluent, Merial Co., Athen, GA) in each injector infusion bag
(400 mL total volume) was removed and replaced with15.3 mL of D3 or 3.8 mL of
25OHD3 in sterile water. On 18 doi, 50 μL volumes of the in ovo injection treatments
were applied to those eggs that were pre-assigned to a specific treatment.
3.3.2

PRELIMINARY EXPERIMENT DESIGN, SAMPLING AND DATA
COLLECTION
A total of 270 Ross × Ross 708 broiler hatching eggs from 35 wk-old broiler

breeder hens were randomly set in a single stage NMC2000 NatureForm Incubator
(NatureForm Incubator Co., Jacksonville, FL). The eggs were incubated at 37.5 °C (dry
bulb) and 28.9 °C (wet bulb) temperatures. Thirty eggs were assigned to each of 3
treatment groups that were randomly represented on each of 3 incubator tray levels. Each
tray level served as a replicate unit (block) for each treatment. All eggs were candled at
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288 and 430 h of incubation (hoi) to remove infertile eggs and early-dead embryos. The 3
treatments were applied by hand injection at 432 hoi , and included a diluent-injected
control or commercial diluent containing either 1.2 μg D3 or 1.2 μg 25OHD3. At 462 hoi,
blood samples were collected from the chorio-allantoic vasculature of 4 eggs within each
treatment group on each of the 3 tray levels. Serum from each of the 4 eggs was extracted
and pooled (Peebles et al. 1996). The 25OHD3 concentrations of the 3 pooled serum
samples in each treatment were subsequently assayed by RIA using the method described
by Hollis et al. (1993). At hatch (504 hoi), hatchling BW and hatchability of injected live
embryonated eggs were also determined.
3.3.3

MAIN EXPERIMENT DESIGN, SAMPLING AND DATA
COLLECTION
A total of 2,640 Ross × Ross 708 broiler hatchling eggs from 35 wk-old broiler

breeder hens were randomly set in a Chick Master Incubator (Chick Master Incubator
Company, Medina, Ohio, USA). The eggs were incubated at 37.2 °C (dry bulb) and 28.8
°C (wet bulb) temperatures in a multi-stage profile Chick Master Incubator according to
procedure recommended by the company. Thirty eggs were assigned to each of 11
treatment groups that were randomly assigned to each of 8 incubator tray levels. Each
tray level served as a replicate unit (block) for each treatment. Incubator air temperature
and relative humidity were recorded every 15 min using HOBO ZW Series wireless data
loggers (Onset Computer Corporation, Bourne, MA) during the 21 doi period. Eggs were
candled at 288 and 430 hoi in order to remove infertile eggs and dead embryo. Control
treatments were: non-injected and diluent-injected. Vitamin treatments in diluent were:
0.6 μg D3, 0.6 μg 25OHD3, 0.6 μg D3 + 0.6 μg 25OHD3, 1.2 μg D3, 1.2 μg 25OHD3, 1.2
μg D3 + 1.2 μg 25OHD3, 2.4 μg D3, 2.4 μg 25OHD3, and 2.4 μg D3 + 2.4 μg 25OHD3. At
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432 hoi, the prespecified in ovo-injected treatments were applied using a Zoetis Inovoject
M (Zoetis, Parsippany, NJ) multi-egg injection machine. At the same time, one egg from
each of the 11 treatment groups on each of the 8 incubator tray levels (88 total eggs) were
injected with coomassie brilliant blue G-250 (colloidal) dye for embryo staging analysis.
At 462 hoi, blood samples were collected from the chorio-allantoic vasculature of
4 eggs from in each of the 11 treatment groups on each of the 8 incubator tray levels (352
total eggs) and serum was extracted as described by Peebles et al. (1996). Blood samples
from live embryonated eggs within each replicate group randomly selected and pooled
and 3 replicate serum samples were prepared and sent to DSM Nutritional Products
laboratory for RIA analysis of serum 25OHD3 concentrations as described by Hollis et al.
(1993). Hatchability of injected live embryonated eggs (HI) was determined at 492 and
516 hoi, and at 516, hatch residue analysis was conducted as described by Ernst et al.
(2004) for determination of post-injection embryonic mortality. Hatchling BW, yolk free
BW (YFBW), relative liver weight (RLW), and relative yolk sac weight (RYW) were
determined for one chick from each of the 11 treatment groups on each of the 8
incubator tray levels (88 total chicks) at 516 hoi. Yolk sac samples were collected and
stored at -20 oC in sealed containers for subsequent yolk moisture analysis. Percentages
of yolk moisture (PYM) and dry matter (PYDM) was determined by drying yolk samples
at 37.7 ᵒC for 4 d. The samples were cooled for 2 h at room temperature before being
weighed.
3.3.4

STATISTICAL ANALYSIS
The experimental design was a randomized complete block in both the

preliminary and the main studies, and incubator level was the blocking factor with all
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treatments randomly represented on each of 8 levels. All variables were analyzed by Oneway ANOVA using the MIXED procedure of SAS 9.4© (SAS Institute, 2013). Means
separations were performed by Fisher`s protected least significant difference (Steel and
Torrie, 1980). Pairwise differences between means were significant considered at P ≤
0.05. The following model was used for analysis of the data:
Yij= μ + Bi + Tj + + Eij

(3.1)

Where μ was the population mean; Bi was incubator tray level (i= 1 to 8); Tj was
treatment (j= 1 to 11); and Eij was the residual error.
In the main study, hatch and sample data were further tested by contrast analysis
using the MIXED procedure of SAS 9.4© (SAS Institute, 2013). The effects of injection
dosage across vitamin D3 source (0.6, 1.2, 2.4, and 4.8 μg) and vitamin D3 source (D3,
25OHD3, and D3 + 25OHD3) across dosage of injection were tested (Table 3.1). Pairwise
differences between means for contrast analysis were significant considered at P ≤ 0.1, P
≤ 0.05, and P ≤ 0.001.
3.4
3.4.1

RESULTS and DISSCUSSION
3.4.1 PRELIMINARY EXPERIMENT
In the preliminary trial, it was observed that the injection of 1.2 μg of either D3 or

25OHD3 significantly increased serum levels of 25OHD3 in the embryos at 19.25 doi
(Figure 1). These results indicate that the in ovo injection of 1.2 μg of either D3 or
25OHD3 is capable of increasing the circulating levels of 25OHD3 in broiler embryos. No
significant differences were observed for HI (90.6 % ± 5.16, diluent; 77.3 % ± 5.16, D3;
and 90.3 % ± 5.16, 25OHD3) and hatchling BW (40.2 g ± 0.75, diluent; 42.3 g ± 0.79,
D3; and 42.0 g ± 0.69, 25OHD3) between treatments. The low hatchability numbers in the
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preliminary trial were likely a result the small number of replicates, which resulted in the
low hatch rate in one replicate of the D3-injected treatment having a large effect on the
treatment mean. Consequently, a non-significant increase in HI and its corresponding
SEM were noted. A larger scale study with more replicated per treatment may be
required to reveal actual differences between the D3-injected treatment groups in
comparison to the other treatment groups. This was addressed in the main study.
3.4.2

MAIN EXPERIMENT
The site of injection in the main study were confirmed to be 2.27, 93.18, and

4.55% in the air cell, amnion, and embryo, respectively. Embryonic serum 25OHD3
concentrations were lower in embryos in the 0.6 μg of D3 treatment, diluent-injected, and
non-injected control groups in comparison to all other treatments (Table 3.2). Across D 3
dosage, serum 25OHD3 concentrations were greater in embryos that received 25OHD3
alone or in combination with D3 compared to those that received D3 alone (Table 3.3).
Additionally, across source of vitamin D3, serum 25OHD3 concentrations were greater in
embryos that were injected at dosages equal at or greater than 1.2 μg when compared to
those that were injected with a 0.6 μg dosage (Table 3.3). There were no significant
treatment effects for BW, YFBW, RLW, or RYW at 516 hoi or for HI at 492 and 516 hoi
(Table 3.4).
Across vitamin D3 source, HI at 492 hoi was greater for chicks that received 2.4
or 4.8 μg dosages in comparison to those received the 0.6 μg dosage (Table 3.3).
Additionally, the 25OHD3 and D3 combination resulted in a higher HI at 492 hoi in
comparison to the injection of D3 alone across dosage level. Across vitamin D3 source,
birds that received the 4.8 μg dosage had a significantly greater RLW in comparison to
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those that received the 2.4 μg dosage and birds that received the 4.8 μg dosage tended to
have a greater RLW in comparison to those that received the 1.2 μg dosage (Table 3.3).
Across injection dose, the in ovo injection of 25OHD3 alone resulted in a higher PYDM
and a lower PYM as compared to those receiving D3 alone in the broiler chicks at hatch
(Table 3.3). Across vitamin D3 source, the 4.8 μg dose resulted in a lower PYDM and a
higher PYM in comparison to the 2.4 μg dose (Table 3.3). Chicks in the non-injected
control group had a lower PYDM and higher PYM as compared to those in any other
treatment groups. In addition, those that received D3 alone had a significantly lower
PYDM and higher PYM relative to those that received 1.2 μg of 25OHD3 or a
combination of D3+ 25OHD3 at 2.4 μg (Table 3.4). There were no significant treatment
effects for any of the hatch residue variables, but embryo mortalities in eggs that received
a 2.4 μg dosage of either D3 or 25OHD3 tended to have fewer (P=0.099) late deads in
comparison to those that received 1.2 μg of either D3 or 25OHD3 (Table 3.5).
The objective of the main study was to investigate the effects of the in ovo
injection of various levels of 2 vitamin D3 sources on broiler hatchability and chick
quality. A number of studies have clearly demonstrated the importance and requirement
of vitamin D3 for chick embryonic development. The presence of vitamin D3 in eggs is
very important in the support of embryo calcium metabolism during incubation (Narbaitz,
1987). A deficiency in vitamin D reduced hatchability and increased late embryo
mortality (Stevens et al., 1984). During the last stage of embryo growth, calcium is
mainly absorbed from the yolk, as only small amounts of calcium is absorbed directly
from the eggshell (Noy and Sklan, 2001). Vitamin D increased yolk calcium mobilization
by increasing the level of vitamin D-dependent calcium-binding protein and calbindin in
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the yolk sac (Tuan and Suyama, 1996). The maximum activity of 1-α hydroxylase during
embryogenesis is observed at 17 doi and dramatically decreases from 19 doi to hatch
(Turner et al., 1987). Also, the activity of 25-hydroxylase is low during the 10-d-posthatch, which resulted in no effect on serum 25OHD3 when D3 was supplemented at 3,000
IU/kg feed in early post-hatch broilers (Saunders-Blades and Korver, 2014). In
comparison to D3, 25OHD3 has a longer half-life. The half-life of 25OHD3 is
approximately 2 weeks (Jones et al., 2015), whereas the half-life of D3 is 15 h (Mawer et
al., 1969). Also, as compared to dietary D3, 25OHD3 is mainly stored in the liver as well
as white and red muscles at the same level of inclusion (Burild et al., 2016). These results
indicate that 25OHD3 persists for longer in the blood in order to being subsequently
converted to the active form vitamin D or being stored for later usage.
Effects of the in ovo injection of 25OHD3 alone at various levels on the
hatchability, hatching chick quality, and the posthatch production and performance of
broilers have been investigated (Gonzales et al., 2013; Bello et al., 2013; Bello et al.,
2014a,b; Bello et al., 2015; Mansour et al., 2017). However, those effects on the broiler
embryo have not been investigated when vitamin D3 is administrated by amniotic in ovo
injection alone or in combination with 25OHD3 at 18 doi. It is well documented that the
dietary or in ovo use of 25OHD3 increases serum 25OHD3 concentrations in broiler
embryos and hatchlings (Bello et al., 2013; Saunders-Blades and Korver, 2014). Similar
to that of previous studies, various levels of injected 25OHD3 alone or in combination
with vitamin D3 increased serum 25OHD3 concentrations in broiler embryos. However,
1.2 μg or greater D3 was required to cause this increase in serum 25OHD3 concentration
in comparison to non-injected or diluent-injected control groups.
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In agreement with the current results, Gonzales et al. (2013) similarly reported
that the in ovo injection of 25OHD3 did not affect HI. Conversely, Bello et al. (2013),
observed that the in ovo injection of 25OHD3 increased HI at 20 and 21 doi as compared
to diluent-injected controls. The difference in 25OHD3 sources and volume of injection
used in the present study and in the study by Bello et al. (2013) may be the basis for the
inconsistencies in their results. The crystalline form of 25OHD3 in ovo injected at 100 μl
in the study performed by Bello et al. (2013),whereas water-soluble forms of both
vitamin D3 in ovo injected at 50 μl in the current study. Another reason may be related to
the very different HI percentages observed in the diluent-injected control groups of the 2
studies. The diluent-injected treatment group in this study had an 83% HI in comparison
to 90% HI in 25OHD3 injected treatment groups in the study of Bello et al. (2013),
whereas HI was 94% for diluent-injected control groups in the present study which was
in the same range as vitamin D3 sources-in ovo injected treatments (Table 3.4). The
practice of in ovo injection of 25OHD3 or D3 alone or in combination has not been
examined in the past. However, the dietary combination of D3 with 25OHD3 increased
BW, Ca and P content of the bone (Papešová et al., 2008), and increased bone
mineralization (Fritts and Waldroup, 2003), protein synthesis, and satellite cell activity
and size in broiler chickens (Hutton et al., 2014). The novel observation in this study was
that across level of injection, a combination of D3 and 25OHD3 increased HI at 492 h in
comparison to D3 alone. In ovo injection of the D3 and 25OHD3 combination could be
more effective in increasing HI in comparison to D3 alone. The reason for this increment
in HI at 492 hoi in response to in ovo injection of the combination of D3 and 25OHD3 as
compared to D3-injected embryos is not clear and further study is required to determine
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the possible synergic effects between these in ovo-injected vitamin D3 sources on
neonatal performance of broilers.
Broilers are resistant to high levels of dietary D3 (50,000 IU per kg), with no
apparent negative effects on bone mineralization and growth (Baker et al., 1998).
However, hypervitaminosis of vitamin D3 was reported when broilers were fed D3 at 2.5
mg/kg BW, equivalent to 100,000 IU (Baker et al., 1998). Vitamin D3 toxicity in chicken
leads to deposition of calcium in soft tissues, resulting in renal tubular calcification,
reduced performance, and reduced egg production (NRC, 1987; Terry et al., 1999). It has
been established that elevated levels of 1,25(OH)2D3 can retard mineral deposition, and
can reduce cell survival and liver function (Pande et al., 2015). In an in vitro study, 2.4
and 24 mM dosages of 1,25(OH)2D3 resulted in decreased cell proliferation and mineral
deposition in chicken bone marrow-derived mesenchymal stem cells(Pande et al., 2015).
However, in this study, the in ovo injection of a combination of D3 and 25OHD3 at a high
dosage (4.8 μg) resulted in no negative effects on HI and chick quality as compared to
diluent and non-injected control group. However, effects of the in ovo injection of
vitamin D3 sources at levels higher than 4.8 μg have not been tested to determine their
possible effects on post-hatch performance. Bello et al. (2013) reported that the in ovo
injection of 5.4 μg of 25OHD3 resulted in higher PYM and lower PYDM values as
compared to treatment levels that ranged between 0.3 and 1.2 μg. Similarly, the 2 vitamin
D3 sources used together at higher doses of injection in the present study resulted in a
higher PYM and a lower PYDM in comparison to that in response to the 0.60 and 1.20
μg levels. A higher PYM may indicate that the in ovo injection of D3 or 25OHD3 alone or
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in combination at 4.8 μg or higher may negatively affect chick quality at hatch as well as
post-hatch performance.
In conclusion, these findings showed that when in ovo-injected, D3 and 25OHD3
at dosages between 0.60 to 4.8 μg alone or in combination increased the serum 25OHD3
concentrations of broiler embryos in comparison to those in both non-injected and
diluent-injected control groups. Nevertheless, they did not affect the HI and hatchling
BW of the broilers. The increased circulating levels of 25OHD3 may have the potential to
improve broiler performance. However, the combination of the D3 and 25OHD3 at the 4.8
μg level resulted in an increased RLW and PYM, and reduced PYDM, which may lead to
a subsequent reduction in posthatch chick performance. Further research is needed to
determine the effects of vitamin D3 sources alone or in combination on post-hatch broiler
performance and meat yield.
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Table 3.1

Contrast type and treatment means compared in the main study. Eggs
injected with vitamin D3 (D3) or 25-hydroxyvitamin D3 (25OHD3) alone at
0.6, 1.2, and 2.4 μg at 18 d of incubation (doi) or in combination at 1.2, 2.4,
and 4.8 μg at 18 doi.

Contrast type
1

Treatment means compared
2

Vitamin D3 compared with 25OHD3
D3 vs 25OHD3
Vitamin D3 compared with 25OHD3 and the
D3 vs D3 + 25OHD3
Combination of vitamin D33 and 25OHD3
25OHD3 compared with vitamin D3 and the
25OHD3 vs D3 + 25OHD3
combination of vitamin D3 and 25OHD3
Vitamin D3 sources4 at 0.6 compared with vitamin D3
0.6 vs 1.2
source at 1.2
Vitamin D3 sources at 0.6 compared with vitamin D3
0.6 vs 2.4
source at 2.4
Vitamin D3 sources at 0.6 compared with vitamin D3
0.6 vs 4.8
source at 4.8
Vitamin D3 sources at 01.2 compared with vitamin D3
1.2 vs 2.4
source at 2.4
Vitamin D3 sources at 1.2 compared with vitamin D3
1.2 vs 4.8
source at 4.8
Vitamin D3 sources at 2.4 compared with vitamin D3
2.4 vs 4.8
source at 14.8
1
Vitamin D3 across the level of injection
2
25-hydroxyvitamin D3 across the level of injection
3
Combination of vitamin D3 and 25-hydroxyvitamin D3 across the level of injection
4
Vitamin D3 and 25-hydroxyvitamin D3

48

Table 3.2

Serum 25-hydroxycholecalciferol (25OHD3) concentrations of embryos at
456 of incubation
Serum 25OHD31
(ng/ml)

Treatment

8.61b
9.74b

Non-injected
Diluent2
Vitamin D33
0.6
1.2
2.4

8.83b
11.24a
11.60a

0.6

10.95a

1.2

12.10a

25OHD34

2.4
Vitamin D3 + 25OHD3

12.29a
5

1.2

11.41a

2.4

10.96a

4.8

12.20a

Source of variation
Pooled SEM
P-value

0.301
0.001

a,b

Treatment means within the same column within effect with no common superscripts are
significantly different (P < 0.05).
1

Serum concentration of 25OHD3 was determined at 456 h of incubation.
Eggs injected with 50 μl commercial diluent at 18 d of incubation.
3
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 0.6, 1.2, and 2.4 μg at
18 d of incubation.
4
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 0.6, 1.2, and 2.4 μg at 18
d of incubation.
5
Eggs injected with 50 μl commercial diluent containing combination of D3 and 25OHD3 at
1.2, 2.4, and 4.8 μg at 18 d of incubation.
2
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Table 3.3

Three contrasts across the level of injection between vitamin D3 (D3) and 25-hydroxyvitamin D3 (25OHD3; D3
vs 25OHD3), between D3 and combination of D3 and 25OHD3 (D3 vs D3 + 25OHD3), and between 25OHD3 and
combination of D3 and 25OHD3 (25OHD3 vs D3 + 25OHD3). Six contrasts across vitamin D3 sources injection
between 0.6 and 1.2 μg/ egg (0.6 vs 1.2), between 0.6 and 2.4 μg/ egg (0.6 vs 2.4), between 0.6 and 4.8 μg/ egg
(0.6 vs 4.8), between 1.2 and 2.4 μg/ egg (1.2 vs 2.4), between 1.2 and 4.8 μg/ egg (1.2 vs 4.8), between 2.4 and
4.8 μg/ egg (2.4 vs 4.8) in Serum 25OHD3 concentration and parameters were observed at hatch.
Serum
2
1 BW
25OHD3

YFBW3

D3 vs 25OHD3

***

ns

D3 vs D3 + 25OHD3

***

25OHD3 vs D3 + 25OHD3

RLW4

RYW5

PYM6 PYDM7

H-4928

H-5169

ns

ns

ns

**

**

ns

ns

ns

ns

ns

ns

ns

ns

†

ns

ns

ns

ns

ns

ns

ns

ns

ns

ns

0.6 vs 1.2

***

ns

ns

ns

ns

ns

ns

ns

ns

0.6 vs 2.4

***

ns

ns

ns

ns

ns

ns

*

ns

0.6 vs 4.8

***

ns

ns

ns

ns

†

†

*

ns

1.2 vs 2.4

ns

ns

ns

ns

ns

ns

ns

ns

ns

1.2 vs 4.8

ns

ns

ns

†

ns

*

*

ns

ns

Contrasts
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Table 3.3 (continued)
2.4 vs 4.8

ns

ns

ns

**

ns

ns

ns

ns

ns

ns= not significant
†
Treatment means within the same column within effect with no common superscripts are significantly different (P <0.1).
*Treatment means within the same column within effect with no common superscripts are significantly different (P <0.05).
**Treatment means within the same column within effect with no common superscripts are significantly different (P ≤ 0.01).
***Treatment means within the same column within effect with no common superscripts are significantly different (P ≤ 0.001).
1
Serum concentration of 25OHD3 was determined at 456 hour of incubation.
2
Hatchling BW at 516 hour of incubation.
3
Yolk free BW at 516 hour of incubation.
4
Relative liver weight at 516 h of incubation.
5
Relative yolk sac weight at 516 h of incubation.
6
Percentage of yolk moisture at 516 h of incubation.
7
Percentage of yolk dry matter at 516 h of incubation.
8
Hatchability of injected live embryonated eggs at 492 h of incubation.
9
Hatchability of injected live embryonated eggs at 516 h of incubation.
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Table 3.4

Body weight, yolk-free BW (YFBW), relative liver weight (RLW), relative yolk sac weight (RYW), percentage
of yolk moisture (PYM), percentage of yolk dry matter (PYDM), hatchability of injected live embryonated at
492 h of incubation (hoi) (H-492), and hatchability of injected live embryonated eggs at 516 hoi (H-516) in noninjected and diluent-injected (50 μL) control groups, and eggs injected diluent containing 0.6, 1.2, 2.4, and 4.8
μg of vitamin D3 (D3) or 25-hydroxycholecalciferol (25OHD3) alone or in combination.
BW
YFBW
--------g---------

Treatment
Non-injected

41.74

9

Diluent

D3

40.73

RLW
RYW
PYM
PYDM
H-4927 H-5168
---------------------------------%----------------------------------11.34

2.49

46.60a

53.40c

90.35

97.55

ab

ab

42.75

41.93

11.84

2.191

41.58

58.42

83.35

94.19

0.6

42.46

41.61

12.49

2.28

43.55a

56.46b

75.96

96.76

1.2

41.18

40.45

12.75

2.351

43.35a

56.65b

84.45

94.81

a

b

90.01

95.29

10

25OHD3

2.4

44.65

42.28

12.45

2.471

42.69

57.31

0.6

42.18

40.80

10.18

2.212

31.93ab

68.07ab

83.50

94.71

2.142

c

a

86.82

96.8

ab

92.20

94.81

11

1.2

42.50

41.73

12.2

31.26

ab

68.74

2.4

41.23

41.21

12.56

2.431

37.34

62.66

1.2

42.15

41.21

11.56

2.251

41.55ab

58.46ab

89.50

97.51

b

a

D3 + 25OHD312

Source of variation
Pooled SEM

2.4

41.58

39.75

12.28

2.361

33.00

66.00

87.80

94.11

4.8

43.21

41.44

12.5

1.97

40.04ab

59.95ab

93.94

95.7

1.039

1.127

11.34

0.144

3.669

3.669

5.236

1.324
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Table 3.4 (continued)
P-value

0.499

0.938

0.679

0.320

0.030

0.030

0.391

a,c

Treatment means within the same column within effect with no common superscripts are significantly different (P < 0.05).
Eggs injected with 50 μl commercial diluent at 432 hoi.

1

Eggs injected with 50 μl commercial diluent containing vitamin D3 (D3) at 0.6, 1.2, and 2.4 μg/egg at 432 hoi.

2

Eggs injected with 50 μl commercial diluent containing 25-hydroxyvitamin D3 (25OHD3) at 0.6, 1.2, and 2.4 μg/egg at 432 hoi.

3

Eggs injected with 50 μl commercial diluent containing combination of D3 and 25OHD3 at 1.2, 2.4, and 4.8 μg/egg at 432 hoi.

4
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0.495

Table 3.5

Effects of non-injected and diluent-injected (50 μL) controls, and eggs
injected with 0.6, 1.2, 2.4, and 4.8 μg/ egg of vitamin D3 (D3) and 25hydroxyvitamin D3 (25OHD3) in 50 μL of diluent in hatch residue at

Pipped dead1
(%)
Treatment
Non-injected
Diluent1
D32

0.34
1.35

Pipped
alive2
(%)

Late
dead3 (%)

Dead
chick
(%)

0
0

3.44
3.83

0
1.02

0.6
1.2
2.4

0.35
0.34
1.80

0.36
0
1.03

3.90
5.40
2.16

0.37
0.38
0.34

0.6
1.2
2.4

0.74
0.35
1.03

0.66
0.36
0.68

4.17
5.48
1.71

1.03
0.36
1.03

1.2
2.4
4.8

0
0.69
1.06

0
0
0

4.48
6.48
3.17

0
0.35
1.39

0.149
0.322

1.114
0.099

0.424
0.473

25OHD33

D3 + 25OHD34

Source of variation
Pooled SEM
P-value

0.529
0.404

1

External pip dead (chick pipped shell and was dead) at 502 h of
incubation (hoi).
2
External pip alive (chick pipped shell and was alive) at 502 hoi.
3
Dead embryos that had not externally pipped at 502 hoi.
4
Dead chicks that were found at 502 hoi.
5
Eggs injected with 50 μl commercial diluent at 432 hoi.
6
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 0.6, 1.2, and 2.4 μg/egg at 432
hoi.
7
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 0.6, 1.2, and 2.4 μg/egg at 432 hoi.
8
Eggs injected with 50 μl commercial diluent containing combination of D3 and 25OHD3 at 1.2, 2.4, and
4.8 μg/egg at 432 hoi.
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ng/ml

Figure 3.1

Serum 25-hydroxylvitamin D3 (25OHD3) concentrations at 19.25 h of
incubation in embryos received that in ovo-injected diluent, 1.2 μg vitamin
D3 (D3), or 1.2 μg 25OHD3.

20.0
18.0
16.0
14.0
12.0
10.0
8.0
6.0
4.0
2.0
0.0

a
a
b
Diluent
D3
D3
25OHD3
25OHD3

Diluent

a,b

D3
25OHD3
25OHD3
D3
Treatment

means with no common superscripts differ significantly.
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CHAPTER IV
THE EFFECTS OF IN OVO-INJECTED VITAMIN D3 SOURCES ON THE
EGGSHELL TEMPERATURE AND EARLY POST-HATCH
PERFORMANCE OF ROSS 708 BROILERS
4.1

ABSTRACT
The effects of in ovo injected-vitamin D3 source on eggshell temperature (ET) and

broiler performance through 14 d of age (doa) were investigated. Eggs from a 35 wk-old
commercial Ross 708 broiler breeder flock were set in a single-stage incubator with 4
treatments represented on each of 12 incubator tray levels (blocks). At 432 h of
incubation (hoi), control treatments were: non-injected and diluent-injected (50 μL).
Vitamin treatments in commercial diluent were: 2.4 μg of vitamin D 3 (D3) or 25hydroxylcholecalciferol (25OHD3). After injection, ET readings were recorded (435, 441,
453, 459, and 465 hoi) using infrared thermometry. Hatchability, hatchling BW, and
percentage of male and female hatchlings were determined at 502 hoi. Equal numbers of
male and female chicks were placed in each of 48 pens (12 replicates per treatment) and
grown out for 14 doa. On a pen basis, BW was recorded post-hatch at d 7 and 14 doa and
BW gain, average daily BW gain, feed intake (FI), and feed conversion ratio (FCR) were
calculated between 0 to 14 doa. The ET of eggs significantly fluctuated during the postinjection time period; however, the type of vitamin D3 source injected did not affect ET.
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Nevertheless, the injection of 25OHD3 resulted in a lower late embryo mortality as
compared to the diluent and D3-injection treatments. Additionally, birds that received
25OHD3 had a lower FI and FCR as compared to birds in all other treatments. In
conclusion, the in ovo injection of 25OHD3 has the potential to increase early post-hatch
broiler performance without affecting ET.
Key words: Eggshell temperature, broiler performance, in ovo injection, 25hydroxylcholecalciferol
4.2

INTRODUCTION
Vitamin D3 (D3) is a pre-hormone and is involved in biological and metabolic

processes, including calcium homeostasis, intestinal absorption of calcium and
phosphorus, muscle development, regulation of the immune response, and bone
formation in chickens (Soares et al., 1995; Rama-Rao et al., 2006; 2009; Morris et al.,
2014; Vignale et al., 2015). After intestinal absorption, D3 requires two metabolic steps to
become the biologically active form (Soares et al., 1995). In hepatic cells, D3 is converted
to 25-hydroxylcholecalciferol (25OHD3) by 25-hydroxylase (Atencio et al., 2005), and is
later hydroxylated to 1, 25-dihydroxylcholecalciferol [1,25-(OH)2D3] by 1 α-hydroxylase
in renal cells (Shanmugasundaram and Selvaraj, 2012). Vitamin D is deposited in the
form of 25OHD3 into the yolk because it is more stable, and unlike D3, it bypasses liver
hydroxylation (Rovegno et al., 2012). In the serum, 25OHD3 is also less toxic at higher
levels in comparison to 1,25-(OH)2D3 (Zanuzzi et al., 2012). Furthermore, injection of 2
μg of 25OHD3 to vitamin D deficient embryos at 14 d of incubation (doi) increased
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hatchability, muscle weight, and bone mineralization in broiler embryos (Narbaitz and
Tsang 1989).
Factors that are required for proper incubation include temperature, humidity,
ventilation, and turning. Of those, temperature is the most critical factor for optimal
embryonic development and successful incubation (Romanoff, 1960). Eggshell
temperature (ET) is highly correlated with embryo heat production (Lourens et al., 2006).
Additionally, an increase in ET above standard levels (ET between 38.9 to 40.0° C) is
associated with decreases in relative embryo weight and yolk-free BW (Ipek et al., 2014).
Additionally, a lower ET is associated with increased hatchling BW as well as chick
quality (Zhai et al., 2011). However, the influence of ET on early-post hatch broilers is
not well understood. Various vitamin D3 sources can modulate metabolism and have a
potential to subsequently affect ET, which may positively affect broiler performance.
Therefore, the objective of the current study was to determine the effects of D3 and
25OHD3 on ET and the post-hatch performance of Ross 708 broiler chickens.
4.3
4.3.1

MATERIAL AND METHODS
TREATMENT LAYOUT AND SOLUTION PREPARATION
The trial protocol was approved by the Institutional Animal Care and Use

Committee of Mississippi State University. Fertile eggs were collected from 35 wk-old
commercial Ross 708 broiler breeder hens and stored at 18 oC for one d prior to set. A
total of 30 eggs were randomly set in each of 4 pre-assigned treatment groups on each of
6 incubator tray levels (blocks) in a Jamesway model PS 500 setter unit (Jamesway
Incubator Company Inc., Cambridge, Ontario, Canada) set at 37.5 °C dry bulb and 29 °C
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wet bulb temperatures. Treatment group placement was randomized on each level to
avoid positional effects in the incubator. Incubator air temperature and relative humidity
were monitored in 3 locations within the incubator every 15 min using HOBO ZW Series
wireless data loggers (Onset Computer Corporation, Bourne, MA). At 18 doi, 50 μL
solution volumes of pre-specified treatments were injected using a Zoetis Inovoject m
(Zoetis, US) in ovo injection machine. Previous findings in our laboratory revealed that
2.4 μg of vitamin D3 sources were sufficient to result in a positive effect on hatching
chick quality with no negative impact on hatchability of injected live embryonated eggs
and hatchling BW (Chapter 3). Therefore, at 432 h of incubation (hoi), eggs were
subjected to one of the following treatments: 1) non-injected; 2) diluent-injected
(control; 50 μL of commercial diluent); 3) D3-injected (50 μL of commercial diluent
containing 2.4 μg D3 / egg), and 4) 25OHD3-injected (50 μL of commercial diluent
containing 2.4 μg 25OHD3/ egg). The pre-specified concentrations of D3 (ROVIMIX®
D3 500; DSM Nutritional Products Inc., Parsippany, NJ) or 25OHD3 (ROVIMIX® HyD® 1.25%; DSM Nutritional Products Inc., Parsippany, NJ) were initially dissolved in
distilled water. For treatment application, diluent (commercial MD vaccine diluent,
Merial Co., Duluth, GA) in each injector infusion bag (400 mL total volume) equal to
that of distilled water containing D3 or 25OHD3 the distilled water mixture. The D3 and
25OHD3 distilled water volume were 15.3 mL and 3.8 mL respectively.
4.3.2

EXPERIMENTAL DESIGN AND DATA COLLECTION
Mean set egg weight for each replicate tray was obtained, and all eggs were

candled at 288 and 432 hoi. Before injection, from 357 to 429 hoi, the ET of 5 eggs in
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each treatment group on each replicate tray was obtained twice daily using an infrared
thermometer (Thermoscan® Braun, Inc. Kronberg, Germany) according to the procedure
described by Olojede et al. (2016). The ET was recorded at the egg equator by a single
observer positioned in the incubator with the door closed. The ET recordings were made
after the incubation temperature became stable, which was approximately 10 min after
entrance into the incubator. The ET readings of 5 eggs in each treatment group on each
replicate tray were recorded at 435, 441, 453, 459, and 465 hoi, which were time periods
after injection until the first egg was externally pipped. Furthermore, percentage egg
weight loss (PEWL) between 0 to 432 hoi was determined on a batch tray weight basis.
At 432 hoi, 48 eggs were injected with coomassie brilliant blue G-250 (colloidal) dye for
embryo staging analysis as described by Sokale et al (2017). At that time, the remaining
eggs were not injected with dye but were injected with their pre-specified treatment.
After injection, the remaining eggs were transferred to hatchling basket sections within a
separate hatcher unit (Jamesway Incubator Company Inc., Cambridge, Ontario, Canada)
that corresponded with their positioning in the setter. All chicks were pulled from the
hatcher at 502 hoi (hatch). At hatch, all chicks were feather-sexed and the percentage of
male and female hatchlings in each treatment group was determined. In addition, for each
replicate treatment group, hatchability of fertile eggs, mean hatchling BW, and hatch
residue analysis was determined according to the procedures specified by Ernst et al.
(2004). For post-hatch evaluation, 9 male and 9 female chicks were placed in each of 48
floor pens (12 replicate pens per treatment). Floor pens contained used litter, top-dressed
with fresh wood shavings and were 1.22 m × 0.914 m (1.12 m2), which allowed for a
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0.062 m2/bird stocking density. Throughout 14 d post-hatch, birds were allowed ad
libitum access to water and feed and were provided a Mississippi State University basal
corn-soybean starter diet (Table 4.1) and were brooded and fed according to Ross 708
guidelines (Aviagen, 2015). At d 7 and 14, mean chick BW and feed intake (FI) were
determined for each pen and, average daily BW gain (ADG), feed conversion ratio
(FCR), and mortality were determined from 0 to 14 d.
4.3.3

STATISTICAL ANALYSES
A randomized complete block design was applied for the entire incubation and 2

wk post-hatch periods, and a repeated measures ANOVA was used to analyze all data. A
4 treatment x 4 observation times factorial arrangement was employed for the preinjection ET data, and a 4 treatment x 5 observation times factorial arrangement was
employed for the post-injection ET data. Incubator tray level was the blocking factor,
with all in ovo injection treatments randomly represented on each of 6 levels (blocks).
The Jamesway trays were experimental units, and time period and treatment were fixed
effects and block was considered a random effect using the procedure for linear mixed
models (PROC MIXED) of SAS 9.4© (SAS Institute Inc., Cary, NC) by the following
mixed-effects model was used for ET data:
Yijk= μ + Bi + Tj + Hk + (TH)jk + Eijk

(4.1)

Where μ was the population mean; Bi was incubator levels (i= 1 to 6); Tj was
treatment (j= 1 to 4); Hk time and date of eggshell temperature observations (k=1 to 4 for
pre-injection and 5 for post-injection); and Eijk was the residual error.
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For analysis at hatch, egg weight was included as covariate for hatchling BW. The
hatch data was analyzed as one-way ANOVA using the procedure for linear mixed
models by the following mixed-effects model was used for hatch data:
Yi= μ + Ii + Ti + Ei

(4.2)

Where μ was the population mean; Ii was incubator level (block) (i= 1 to 6); Ti
was treatment (i= 1 to 4); and Ei was the residual error.
For broiler performance analysis, the experimental unit was the individual pen
and a group of 4 treatments were represented in each block. Block was the blocking
factor that in ovo injection treatments being randomly represented in each of 12 blocks.
The performance data was analyzed as one-way ANOVA using the procedure for linear
mixed models (PROC MIXED) of SAS 9.4. Pairwise differences between means were
significant considered at P ≤ 0.05.
Yi= μ + Bi + Ti + Ei

(4.3)

Where μ was the population mean; Bi was block (i= 1 to 6); Ti was treatment (i= 1
to 4); and Ei was the residual error.
4.4
4.4.1

RESULTS AND DISCUSSION
EGGSHELL TEMPERATURE
There was no significant main or interactive effect due to treatment for ET from

15 to 18 doi (data not shown). There was also no significant main or interactive effect
due to treatment for ET from time of injection until hatch. Nevertheless, there was a
significant (P<0.0001) effect due to time on ET (Table 4.2). Eggshell temperature was
highest at 441 hoi in comparison to all other time periods and was lowest at 453 hoi as
66

compared to all other time periods. Also, ET was higher at 465, 459, and 435 hoi in
comparison to that at 453 hoi.
Eggshell temperature is influenced by embryonic heat production and changes in
ET have been shown to be associated with changes in hatchling quality and post-hatch
broiler performance (Molenaar et al., 2011; Ipek et al., 2015). Hamidu et al. (2018)
reported that decreased ET from 37 to 36° C resulted in delay in both Ross 708 and 308
broilers. Additionally, increases in ET above standard levels (ET between 38.9 to 40.0°
C) during the second half of incubation resulted in decreased hatchability and hatchling
weight, and increased residual yolk sac weight in early post-hatch broilers (Ipek et al.,
2015). At the same time period of incubation, ET at 38.9° C or greater also resulted in a
higher FCR in 6 wk-old broiler chickens, and has led to increases in the incidences of
metabolic diseases such as ascites (Molenaar et al., 2011). These results indicate that high
ET is linked to reduced hatchling quality and post-hatch broiler production, and an
increased susceptibility to metabolic diseases. According to Zhai et al (2011), the in ovo
injection of 120 μL of different carbohydrate sources or saline that were stored at cool
temperatures before being injected into embryonated eggs at 18 doi resulted in a lower
ET at 22 h after injection in comparison to dry-punch controls. However, in the current
study, the solution that was injected at the room temperature did not affect ET at any of
the time periods observed (P= 0.169). There were significant differences in the ET
observed at the various time periods examined, but there was no clear pattern for the
changes in the ET between the various time periods. The unclear pattern for the changes
in the ET between various time periods could be linked to changes in the room
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temperature leading to changes to the eggshell temperature. The room temperature was
dramatically decreased by approximately 3 ᵒC from 441 to 453 hoi which may be
responsible for the change in ET during this time period.
4.4.2

HATCH AND POST-HATCH VARIABLES
Percentage egg weight loss from 0 to 21 doi, hatchability, hatchling BW and

female and male percentages, and external pip live, external pip dead, and hatchling
mortalities did not differ between treatments (Tables 4.3 and 4.4). However, the in ovo
injection of 25OHD3 resulted in a lower late embryo mortality as compared to that in the
D3 or diluent-injected treatments (Table 4.4). Chick BW did not differ between
treatments at 7 and 14 d post-hatch (Table 4.5). There were also no significant treatment
differences for BW gain from 0 to 14 d of post-hatch age. However, birds that received
25OHD3 had a lower FI in comparison to birds in the other treatment groups, and
25OHD3 in ovo-injected birds had a lower FCR relative to the birds in the other treatment
groups.
In the current study, the in ovo injection of 2.4 μg of 25OHD3 reduced the late
embryo mortality in comparison to diluent- and D3-injected treatments. The injection of
0.60 to 2 μg of 25OHD3 into a vitamin D-deficient embryo was required to support
embryonic survival (Ameenuddin et al 1983). However, Ameenuddin et al. (1983) did
not show the mechanism that may be involved in this improvement. The maximum
activity of 1 α-hydroxylase, which is required for the conversion of 25OHD 3 to the active
form of vitamin D, was observed at 17 doi (Turner et al., 1987). Also, during the last
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three d of incubation, the main source of nutrients including calcium for embryo growth
is the yolk (Noy and Sklan, 2001), and yolk calcium mobilization is regulated by the
active form of vitamin D (Tuan and Suyama, 1996). Hence, an increase the levels of 1,25(OH)2D3 for supporting embryo growth in response to injection of 25OHD3 could be a
possible reason for reduced embryonic mortality in the 25OHD3-injected treatment.
Supplemental 25OHD3 in broiler or broiler breeder diets has resulted in increased
intestinal villus length during the embryonic and later post-hatch developmental periods
(Chou et al., 2009; Ding et al., 2011). Using dietary 25OHD3 as a partial or complete
replacement for D3 has been shown to increase “walkability” and bone quality, and
overall broiler performance (Yarger et al., 1995; Sun et al., 2013). There are 2 possible
explanations for these effects. First, in comparison to D3, 25OHD3 is more efficiently
stored in target tissues (Burild et al., 2016). Both vitamin D3 sources can be stored in
several tissues such as adipose, liver, and white and red muscle tissues (Burild et al.,
2016). When provided at low levels in the diet (5 μg/ feed), 25OHD3 is largely stored in
the liver. Approximately half the amount in the liver is further stored in adipose and
white and red muscle tissue. However, vitamin D3 is mainly stored in adipose tissue,
whereas only small amounts are stored in the liver and muscle tissues for longer periods
of time. When administrated at 18 doi, differences in the storage efficiencies of the 2
forms of vitamin D3 could be the possible reason for their differential effects on
hatchability and bone quality (Bello et al., 2013; Bello et al., 2014), as well as broiler
performance (Ebrahimi et al., 2016). Neonatal broilers have an impaired ability to
convert D3 to 25OHD3 during the first 10 doa because the serum 25OHD3 remained low
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when D3 was supplemented at 3,000 IU/kg feed (Saunders-Blades and Korver, 2014).
However, 25OHD3 can likely be converted to the active form.
The second reason for the greater effectiveness of 25OHD3 is that 1 α-hydroxylase
converts 25OHD3 to the active form of the hormone, but D3 does not stimulate 1 αhydroxylase. The expression of 1 α-hydroxylase occurs in high amounts in the kidney as
well as the thigh and breast muscles in chickens (Shanmugasundaram and Selvaraj,
2012). 1 α-hydroxylase converts 25OHD3 to active form of vitamin D3 functioning in
muscle development (Boland et al., 1985), intestinal calcium and phosphorus absorption
(Fullmer et al., 1996 ) in the chicken. A greater longer half-life of 25OHD3 could allow
25OHD3 stay for longer period of time to be stored or used by newly-hatch broilers. The
tissue expression of 1 α-hydroxylase was not previously examined in response to in ovo
injection of vitamin D3 sources, but increased 25OHD3 serum concentrations were
observed in embryos that received 25OHD3 rather than commercial diluent alone (Bello
et al., 2013; Chapter 3). Therefore, a lower FCR in broilers that were injected with
25OHD3 may be due to an elevated serum 25OHD3 concentration, which may
subsequently contribute to increased intestinal calcium absorption. In conclusion, the
findings observed in this study showed that ET was different but without a definite
pattern between the time periods examined. Also, the use of either source of vitamin D 3
used did not affect embryonic ET. Nevertheless, subsequent effects of in ovo-injected
25OHD3 were observed on early-post hatch broiler performance. The in ovo injection of
2.4 μg of 25OHD3 reduced FCR from 0 to 14 doa in comparison to diluent and noninjected control groups. This finding suggests that the in ovo injection of 25OHD3 at a
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level of 2.4 μg may increase early post-hatch broiler performance. Further studies are
needed to identify biological and morphological changes that may result in response to
the in ovo injection of vitamin D3 sources that are associated with changes in broiler
performance, and to explore the potential of injecting higher levels of vitamin D3 sources.
4.5
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Table 4.1

Feed composition of the experimental diets from 0 to 14 d of age (doa)

Item
Ingredient (%)

Coccidiostat2
BMD3
Total

Pct
53.23
38.23
2.60
2.23
1.27
0.34
1.00
0.28
0.37
0.15
0.25
0.05
0.05
100

Crude protein (%)
Calcium (%)
Available phosphorus (%)
AME (Kcal/kg)
Digestible Methionine (%)
Digestible Lysine (%)
Digestible Threonine (%)
Digestible TSAA (%)
Sodium (%)
Choline (%)

23
0.96
0.48
3,000
0.51
1.28
0.86
0.95
0.16
0.16

Yellow corn
Soybean meal
Animal fat
Dicalcium phosphate
Limestone
Salt
Choline chloride 60%
Lysine
DL-Methionine
L-threonine
Premix1

Calculated nutrients

1

The broiler premix provided per kilogram of diet: vitamin A (retinyl acetate), 10,000 IU; cholecalciferol,
4,000 IU; vitamin E (DL-α-tocopheryl acetate), 50 IU; vitamin K, 4.0 mg; thiamine mononitrate (B 1), 4.0
mg; riboflavin (B2), 10 mg; pyridoxine HCL (B6), 5.0 mg; vitamin B12 (cobalamin), 0.02 mg; Dpantothenic acid, 15 mg; folic acid, 0.2 mg; niacin, 65 mg;biotin, 1.65 mg; iodine (ethylene diamine
dihydroiodide), 1.65 mg; Mn (MnSO4H2O) , 120 mg;
Cu, 20 mg; Zn, 100 mg, Se, 0.3 mg; Fe (FeSO4.7H2O), 800 mg.
2
Decocx ® (Zoetis, Parsippany, NJ).
3
Bacitracin Methylene Disalicylate (BMD® 110; Zoetis Parsippany, NJ, ): containing 55 mg of BMD®
per kg.
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Table 4.2

Eggshell temperature of Ross 708 embryonated in non-injected, diluentinjected vitamin D3 (D3)-injected, and 25-hydroxylcholecalciferol
(25OHD3)–injected at 435, 441, 453, 459, and 465 h of incubation (hoi).
Eggshell
Temperature oC
38.07
37.94

Treatment
Non-injected
Diluent1
Vitamin D32
25OHD3

38.04

3

37.99

Hour
38.01b
38.15a
37.89c
37.99b
38.02b
0.048

435 hoi
441 hoi
453 hoi
459 hoi
465 hoi
Pooled SEM
P-values

0.169
<0.0001
0.994

Treatment
Hour
Hour*Treatment
a-c

Means within Temperature column and hour category with no common superscript differ significantly
(P ≤ 0.05).
1
Eggs injected with 50 μl commercial diluent at 432 hoi.
2
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at at 432 hoi.
3
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at 432 hoi.
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Table 4.3

Hatch parameters in non-injected, diluent-injected vitamin D3 (D3)injected, and 25-hydroxylcholecalciferol (25OHD3)–injected Ross 708
broilers.
Female

Male

PEWL1

Treatment

Hatchability2

%

Hatchling
BW
g

Non-injected
Diluent3

47.22
47.85

52.78
52.15

12.32
12.91

94.14
90.68

42.86
45.03

D34

52.06

47.94

12.28

91.84

43.99

25OHD35
Pooled SEM
P-value
Covariate egg
weight

47.89
3.308
0.680

52.11
3.338
0.680

13.08
0.466
0.332

93.96
1.474
0.291

43.91
0.875
0.397

-

-

-

-

0.014

1

Percentage of egg weight loss from d 0 to 432 h of incubation (hoi).
Hatchability of injected live embryonated eggs deemed alive via candling immediately prior to in ovo
injection at 432 hoi.
3
Eggs injected with 50 μl commercial diluent at 432 hoi
4
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at 432 hoi.
5
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at 432 hoi.
2
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Table 4.4

Treatment

Effects of non-injected and diluent-injected (50 μL) controls, and eggs
injected with 2.4 μg/ egg of vitamin D3 (D3) and 25hydroxycholecalciferol (25OHD3) in 50 μL of diluent in hatch residue at
502 h of incubation (hoi).
EPD1

EPL2

Late embryo
mortality3

Dead
chicks4

---------------------------------(%)-----------------------Non-injected
Diluent5
D36
25OHD37
P-value
SEM

0.67
0.34
0.70
1.11
0.638
0.563

0.34
1.10
0.34
1.17
0.369
0.472

a,b

4.17ab
6.21a
6.08a
2.04b
0.050
1.000

0.68
1.67
1.04
1.72
0.508
0.674

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
1
External pip live (chick pipped shell and was alive) at 502 hoi.
2
External pip dead (chick pipped shell and was dead) at 502 hoi.
3
Dead embryos that had not externally pipped at 502 hoi.
4
Dead chicks that were found at 502 hoi.
5
Eggs injected with 50 μl commercial diluent at 432 hoi.
6
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 μg at 432 hoi.
7
Eggs injected with 50 μl commercial diluent containing D 3 at 2.4 μg at 432 hoi.
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Table 4.5

Treatment

Broiler performance observations from 0 to 14 d of age (doa) in noninjected, diluent-injected vitamin D3 (D3)-injected, and 25hydroxylcholecalciferol (25OHD3)–injected Ross 708 broilers.
BW-d71

BW-d142

ADG3

BWG4

FI5

FCR6

---------------------------- g -----------------------------

--g/g--

Non-injected

163.6

428.7

27.82

389.5

514.4a

1.32a

Diluent7

163.0

428.6

27.68

387.6

523.2a

1.35a

D38

163.1

427.3

27.63

386.8

518.9a

1.34a

25OHD39
Pooled SEM
P-value

163.9

430.4

27.83

389.6

493.4b

1.27b

1.61
0.969

4.71
0.949

0.086
0.787

5.51
0.943

5.35
0.002

0.016
0.005

a,b

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
1
Mean pen BW at 7 doa.
2
Mean pen BW at 14 doa.
3
Mean average daily BW gain from 0 to 14 doa.
4
BW gain from 0 to 14 doa.
5
Feed intake from 0 to 14 doa.
6
Feed conversion ratio which is gram daily feed intake per gram average daily gain from 0 to 14 doa.
7
Eggs injected with 50 μl commercial diluent at from 0 to 14 doa.
8
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at from 0 to 14 doa.
9
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at from 0 to 14 doa.
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CHAPTER V
EFFECTS OF THE IN OVO INJECTION OF VITAMIN D3 AND 25HYDROXYVITAMIN D3 ON THE PERFORMANCE, CARCASS
CHARACTERISTICS, AND INCIDENCE OF WOODY BREAST
MYOPATHY IN ROSS 708 BROILERS FED COMMERCIAL
OR CALCIUM- AND PHOSPHOROUSRESTRICTED DIETS
5.1

ABSTRACT
Effects of the in ovo injection of vitamin D3 (D3) and 25-hydroxyvitamin D3

(25OHD3) on broiler performance, carcass characteristics, and incidence of woody breast
myopathy (WBM) were investigated. A total of 2,880 live, embryonated Ross 708 broiler
hatching eggs were randomly assigned to one of the following in ovo injection treatments
and were injected, using an Inovoject multi-egg injector, at 18 d of incubation (doi): 1)
diluent (50 μL); diluent (50 μL) containing either 2) 2.4 μg D3; 3) 2.4 μg 25OHD3; or 4)
2.4 μg D3 + 2.4 μg 25OHD3. At hatch, 18 male chicks were randomly placed in each of
48 floor pens. Beginning on d of hatch, in each of 6 replicate pens belonging to each in
ovo injection treatment group, birds were fed either a commercial diet or a diet restricted
in calcium and phosphorous (ReCaP) content by 20% for the starter, grower and finisher
dietary phases. Broiler performance measurements were determined from 0 to 14, 15 to
28, and 29 to 40 d of age (doa). At 41 and 46 doa, birds were also processed for
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determination of WBM, carcass weight, and the absolute and relative (% of carcass
weight) weights of various carcass parts. Compared to birds fed the commercial diet,
birds fed ReCaP diets experienced a reduction in performance from 14 to 40 doa, in
breast meat yield at 14 and 40 doa, and in WBM at 41 and 46 doa. At 14 and 40 doa,
birds that received an in ovo injection of 25OHD3 alone displayed a higher breast meat
yield when compared to birds that were diluent-injected or that received an in ovo
injection of D3 and 25OHD3 combined. The lower WBM score in the ReCaP-fed birds
may be associated with a lower breast weight. Also, the increase in breast meat yield in
response to 25OHD3 alone may be due to an improvement in their immunity or small
intestine morphology, which may result in increased nutrient absorption. These potential
physiological responses require future investigation.
Key words: vitamin D source, in ovo injection, woody breast, broiler
performance, breast meat yield
5.2

INTRODUCTION
The absorption of vitamin D3 (D3), a fat-soluble vitamin, is facilitated by bile salts

in the upper small intestine of chickens (Bar et al., 1980). Vitamin D3 is a multifunctional
pre-hormone which requires 2 hydroxylation steps in order to become the active
hormone, 1, 25-dihydroxyvitamin D3 [1 , 25-(OH)2 D3]. After intestinal absorption, D3 is
delivered to the liver for the first hydroxylation which converts it to 25-hydroxyvitamin
D3 (25OHD3) by 25-hydroxylase. The second hydroxylation takes place in renal
epithelial cells which converts 25OHD3 to 1, 25-(OH)2 D3 via 1 α-hydroxylase (Booth et
al., 1987). Inclusion of dietary D3 and its metabolites are essential for proper growth in
commercial broilers. Vitamin D3 is well-known for its functions in intestinal calcium
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(Ca) and phosphorous (P) absorption (Bar et al., 1980), which is essential for bone (Fritts
and Waldroup, 2003) and muscle formation and their development in broilers (Vignale et
al., 2015). In addition, D3 has strong immunomodulatory activity that promotes broiler
immunity during pathogenic infections (Morris et al., 2014; Chou et al., 2009).
Furthermore, 25OHD3 in combination with D3 has been shown to enhance broiler
performance and bone quality in comparison to D3 alone at the same level of inclusion
(Papešova et al., 2008). It is also well documented that 25OHD3 is more effective than
D3, particularly in birds fed Ca and P-restricted diets (Bar et al., 2003). However, the first
metabolite of D3, 25OHD3, is more effective than D3 due to its higher rate of intestinal
absorption (Bar et al., 1980), and the fact that the first hydroxylation step of D3 is
bypassed. In young embryo the conversion of D3 to 25OHD3 is low due to immaturity of
liver which resulted in no changes in serum 25OHD3 when D3 alone was supplemented in
broiler diets (Saunders-Blades and Korver, 2014).
Woody breast myopathy (WBM) is an abnormality in breast fillets that results in
hard and thick breast meat. The occurrence of WBM is due to lymphocyte and
macrophage infiltration, fibrosis (inflammation or necrosis in connective tissue), and
lipidosis in muscle fibers (Kuttappan et al., 2013; Sihvo et al., 2014). Dietary 25OHD3
has been shown to increase the rate of protein synthesis (Hutton et al., 2014) and reduce
inflammation (Fatemi, 2016) in the breast fillets of broilers. These effects may contribute
to a reduction in WBM incidence in breast fillets. In ovo injection technology has
emerged as a means to accelerate embryonic development as well as confer early
immunity to broiler embryos against pathogenic viral infections such as Marek`s disease
(Williams, 2007). The in ovo injection of various vitamin D3 sources in broilers has
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largely focused on their effects on hatchability and embryonic development (Gonzales et
al., 2013; Bello et al 2013, 2015; Mansour et al., 2017). In ovo injection of vitamin D3
(0.2 μg) into the amnion surrounding the embryo at 12 d of incubation (doi) increased
yolk and embryonic tissue concentrations of Ca and P at 17 doi. In comparison to
uninjected controls, the in ovo injection of 0.6 μg of 25OHD3 increased hatchability and
bone quality in broilers (Bello et al., 2013; Bello et al., 2014). Previously in our
laboratory, the in ovo injection of 2.4 μg of 25OHD3 resulted in an improved broiler
hatch quality (Chapter 3) as well as decreased feed conversion ratio (FCR) from 0 to 14 d
of age (doa; Chapter 4). However, there is a limited information concerning effects of the
in-ovo injection of D3 alone or in combination with 25OHD3 on broiler post-hatch
performance and meat yield. Therefore, the objective of this study was to investigate
effects of the in ovo injection of D3 and 25OHD3 alone or in combination on
performance, breast meat yield, and incidence of WBM in broilers fed commercial or Ca
and P-restricted diets.
5.3
5.3.1

MATERIAL AND METHODS
EXPERIMENT DESIGN AND BROILER PERFORMANCE
All experimental procedures were approved by the Institutional Animal Care and

Use Committee of Mississippi State University. Thirty eggs were assigned to each of 4
treatment groups on each of 24 incubator tray levels (blocks) in a Jamesway model PS
500 setter unit (Jamesway Incubator Company Inc., Cambridge, Ontario, Canada) set at
37.5 °C dry bulb and 29 °C wet bulb temperatures. Positional effects were prevented by
re-randomizing all treatments between each incubator level. Incubation temperature and
relative humidity were monitored in 4 locations (top right, middle left, middle right, and
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left bottom) within the incubator every 15 min using HOBO ZW Series wireless data
loggers (Onset Computer Corporation, Bourne, MA). At 18 doi, 50 μL solution volumes
of pre-specified treatments were injected using a Zoetis Inovoject m (Zoetis Animal
Health, Research Triangle Park, NC) in ovo injection machine. At 18 doi, eggs were
subjected to one of the following injection treatments: 1) diluent (control; 50 μL of
commercial diluent); 2) D3 (50 μL of commercial diluent containing 2.4 μg D3 ), 3)
25OHD3 (50 μL of commercial diluent containing 2.4 μg 25OHD3), and D3+25OHD3
(50 μL of commercial diluent containing 2.4 μg of D3 and 25OHD3). All in ovo injection
solutions were prepared and injected according to the procedure described in Chapter 4.
At hatch, 18 male broilers were placed at a 0.062 m2/bird stocking density in each of 48
floor pens containing used litter top dressed with fresh wood shavings. All birds received
either a Mississippi State University basal corn-soybean diet formulated to Ross 708
commercial guidelines (Aviagen, 2014), or the same diet with a 20% reduction in Ca and
available P content (ReCaP; Table 5.1). At 14, 28, and 40 doa, mean bird BW was
determined for each pen, and feed intake (FI), and BW gain (BWG) were determined for
the starter, grower and finisher phases, respectively. Feed conversion ratio (g feed/g gain)
for the same time periods was calculated and adjusted for bird mortality.
5.3.2

MEAT YIELD AND PROCESSING
Six birds per treatment (1 bird per treatment replicate group) were randomly

selected for determination of the weights of their pectoralis major (P. major) and
pectoralis minor (P. minor) muscles at 14 and 40 doa. The remaining birds in each pen
were processed at 41 and 46 doa. Prior to slaughter, birds did not have access to feed or
water for at least 12 h. The birds were according to the method described by Wang et al.
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(2018). ). Carcasses were mechanically defeathered, manually eviscerated, and carcass
traits assessed. Whole carcass, and P. major, P. minor, drumsticks, thigh, and wing
weights and yields (percentage of carcass weight) were determined.
5.3.3

WOODY BREAST SCORE
At 41 and 46 doa, the P. major were scored for incidence of WBM according to

the procedures of Tijare et al. (2016). Briefly, breasts with a score of 0 were considered
normal, a score of 1 was considered mild, a score of 2 was considered moderate, and a
score of 3 was considered as a severe incidence of WBM. Breasts were flexible
throughout. Those with mild scores were fillets with hardness mainly in the cranial region
but also flexible. Those fillets with moderate scores possessed hardness throughout but
flexible in mid to caudal region. Finally, those fillets with a severe score were extremely
hard and rigid throughout from cranial region to caudal tip.
5.3.4

STATISTICAL ANALYSIS
The experimental unit was incubator tray for the hatch data and was floor pen for

the performance, meat yield, and woody breast data. The experimental design was a
randomized complete block for both the incubational and rearing periods. Incubator tray
level was the blocking factor, with all in ovo injection treatments randomly represented
on each of 12 levels (blocks). Pen was the blocking factor, with both the dietary and in
ovo injection treatments being randomly represented in each of 6 blocks. The hatch data
were analyzed using a one-way ANOVA to test the effects of the 4 in ovo injection
treatments. Performance, meat yield, and WBM data were analyzed using two-way
ANOVA in a 2 x 4 factorial arrangement of treatments to test for the main and interactive
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effects of the 2 dietary treatments, and the 4 in ovo injection treatments. The following
model was used for analysis of the posthatch data:
Yijk = μ + Bi+ Dj + Ik + (DI)jk + Eijk,

(5.1)

Where μ was the population mean; Bi was the block factor (i = 1 to 2); Di was the
effect of each dietary treatments (j = 1 to 2); Ik was the effect of in ovo injection
treatment (k = 1 to 4); (DI)ij was the interaction of each dietary treatment with in ovo
injection treatment; and Eij was the residual error.
The procedure for linear mixed models (PROC GLIMMIX) of SAS 9.4© (SAS
Institute, 2013) was used for all the above data analysis. Differences were considered
significant at P≤ 0.05. Differences among mean WBM scores were also analyzed using
the procedure for linear mixed models (PROC GLIMMIX) of SAS 9.4© (SAS Institute,
2013). Differences among means were deemed significant at P≤0.05.
5.4
5.4.1

RESULTS
HATCH AND POST-HATCH PERFORMANCE
No significant treatment differences were observed for the hatchability and hatch

residue data, but there was a notable trend that approached significance (P=0.077)
concerning the effects of treatment on the hatchability of fertile eggs. The in ovo injection
of 25OHD3 alone tended to increase the hatchability of fertile eggs in comparison to the
D3 and diluent-injected treatments. There were no significant main effects due to in ovo
injection treatment and no diet x in ovo injection treatment interactions for any of the
observed performance variables throughout the rearing period (Table 5.3). Furthermore,
broiler performance did not differ between commercial and ReCap treatments from 0 to
14 doa. However, in comparison to birds in the ReCaP treatment, those fed commercial
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diets had a higher BW, BWG, average daily gain (ADG), FI, and average daily FI
(ADFI) and lower FCR from 15 to 28 doa. Also, a similar pattern among the
performance measurements was observed from 29 to 40 doa. The exception to this was
FCR for the ReCap and commercial fed birds from 29 to 40 doa (Table 5.3). However,
total FCR and total mortality were lower between 0 to 40 doa for birds fed commercial
diets as compared to those fed ReCaP diets (Table 5.3).
5.4.2

MEAT YIELD AND PROCESSING
No significant interaction was observed between diet and in ovo injection

treatment for the breast meat yield and processing measurements (Tables 5. 4 and 5.5). At
14 doa, in ovo injection of 25OHD3 alone resulted in higher P. major weights in
comparison to all other treatments, and the diluent-injected treatment resulted in lower P.
major weights compared to the D3 and D3 + 25OHD3 treatments. Also, total breast meat
yield was greater for birds that received 25OHD3 alone in comparison to those that were
injected with diluent or D3 + 25OHD3 (Table 5.4). At 40 doa, P. major and total breast
meat yield was greater for birds that received 25OHD3 alone in comparison to those that
were injected with diluent or D3 + 25OHD3 (Table 5.4). At 41 doa, birds fed commercial
diets had higher carcass weight, P. major, P. minor, and wing weights relative to carcass
weight in comparison to those birds fed ReCap diets (Table 5.5). In comparison to the
commercial diet, the ReCap diet resulted in lower carcass and wing weights relative to
carcass weight at 46 doa (Table 5.5).
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5.4.3

WOODY BREAST MYOPATHY SCORE
No significant interaction was observed between diet and in ovo injection

treatment for WBM at both 41 and 46 doa (Table 5.6). At 41 doa, birds fed a commercial
diet had higher percentage of mid and moderate WBM scores in comparison to those fed
ReCap diets (Table 5.6). The feeding of commercial diets resulted in more 1 and 2 scores
for WBM, and lower numbers of 0 scores for WBM than in the birds fed ReCap diets.
Additionally, birds that received 25OHD3 alone had lower WBM scores of 3 in
comparison to the D3 and the D3 + 25OHD3 treatments. At 46 doa, overall WBM scores
were greater for birds fed commercial diets in comparison to those fed ReCap diets.
Furthermore, the commercial diet resulted in lower scores of 0 and higher scores of 2
than did the ReCap diet.
5.5

DISCUSSION
An antibiotic growth promoter was not used in the diets, but a coccidiostat

(Decocx ®, Zoetis, Parsippany, NJ) was included in both commercial and ReCaP diets in
order to reduce the chance of a coccidiosis infection. Also, phytase was not included in
the broiler diets. This was due to earlier observations showing greater effects of various
vitamin D3 sources on the performance of pigs fed diets lacking supplemental phytase
(O'Doherty et al., 2010). However, the effects of diets deficient in Ca and P, without
supplemental phytase when broilers supplemented with vitamin D3 sources have not been
previously reported. The influence of vitamin D on embryonic development is well
understood. Furthermore, it is also well documented that vitamin D3 sources have a
greater effect on broiler performance when Ca and P are restricted in the commercial diet
(Bar et al., 2003).
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The in ovo injection of vitamin D3 at 12 doi increased Ca and P serum levels in
broiler embryos (Mansour et al., 2017). Additionally, the amniotic in ovo injection of
25OHD3 at 18 doi decreased Ca content in the yolk sac (Bello et al., 2015). These results
indicate that the in ovo injection of the 2 vitamin D3 sources may have the potential to
increase the rate of absorption of Ca and P in broiler embryos, which could be beneficial
for birds fed diets reducing the requirement for Ca and P. However, the results of the
current study indicate that the carryover effect of vitamin D3 sources in broiler embryo
was not sufficient to overcome the negative effects on broiler performance and breast
meat yield in response to 20% dietary reduction in Ca and aP. In comparison to D3,
25OHD3 is more efficient in increasing Ca and P absorption (Bar et al., 1980). Also,
25OHD3 has a longer half-life, which is approximately 14 d (Jones et al., 2015). This is in
contrast to D3 which has a half-life of 15 h (Mawer et al., 1969). Additionally, at the
same level of activity in both broilers (Vignale et al., 2015; Yarger et al., 1995) and
laying hens (Käppeli et al., 2011), dietary 25OHD3 significantly increases circulating
25OHD3 concentrations in comparison to D3. These data indicate that 25OHD3 stays in
the blood for a longer period of time. A longer half-life of 25OHD3 can be beneficial in
the newly hatched chick due to impaired absorption of D3 (Saunders-Blades and Korver,
2014). During the first two weeks of life, the absorption of D3 by the chick is low due to
the immaturity of the digestive tract and low activity of enzymes involved in lipid
absorption (Noy and Sklan, 1995). The delay in access feed in 24-h of post-hatch can
result in decreased in finisher performance at 42 doa (Gonzales et al., 2003, 2008ab).
However, the longer half-life of 25OHD3 may be used to promote broiler production
selected for high grown rate in the very early phase of life.
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In the current study, broiler performance did not significantly differ among in ovo
injection treatments throughout the rearing period. However, the in ovo injection of
25OHD3 at a 2.4 μg dose increased P. major weight over that in birds injected with either
D3 or diluent alone. This improvement in meat yield in the response to the in ovo
injection of 25OHD3 alone is likely due to the longer half-life and a higher rate of
25OHD3 absorption relative to D3. Furthermore, it may be linked to differences in the
duration and levels of storage of the 2 vitamin D3 sources in the tissues of the birds. It is
well documented that 25OHD3 at low levels of inclusion (5 μg) is mainly stored in white
and red muscle more than in adipose tissue. However, although D3 at the same level of
inclusion is mostly stored in adipose tissue with only small amounts stored in the liver or
muscle tissues (Burild et al., 2016), the greater amount of 25OHD3 stored in muscle
tissue may be another reason for the increased P. major yield in birds belonging to the
25OHD3-injected treatments in comparison to those in the D3-injected treatments.
Additionally, the in ovo injection of both vitamin D3 sources proved to be more effective
in terms of increased breast meat yield during the first 2 wk of post-hatch life, but after 2
wk, this effectiveness was more quickly ameliorated in the D3-injected broilers in
comparison to the diluent-injected broilers.
These current results showed that a 20% reduction of dietary Ca and available P
resulted in a decrease in breast meat yield in 2 and 6 wk-old broilers. Effects of different
levels of dietary Ca or P on the breast meat yield of broilers have not been reported todate. However, increased leg meat yield has been previously observed in 41 doa broilers
when the percentage of Ca in the diet increased from 0.95 to 1.05 % (Xing et al., 2019).
Effects of a severe reduction in dietary Ca and P content on broiler performance and bone
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quality have likewise been previously reported, but there is limited information about this
restriction on meat yield. Delezie et al. (2015) reported that a 20% reduction in the Ca
and available P content of corn-soybean meal diets in the absence of phytase reduced BW
and ADFI from 13 to 39 doa, with no effect on FCR. Additionally, similar results were
reported for BWG and FCR from 1 to 41 doa in broilers fed Ca and P- restricted diets
(Ribeiro et al., 2018). In previous studies, the inclusion of dietary phytase allowed the
negative effects of lower dietary levels of Ca and P on broiler performance to be
overcome. It is well documented that supplemental dietary phytase can improve the
performance (Delezie et al 2015; Ribeiro et al., 2018) of broilers fed Ca and P restricted
diets. This improvement in response to dietary phytase could be due to a higher
availability of phosphorous and Ca leading to a reduction of phytate and anti-nutritional
factors, and an increased digestibility of amino acids (Manobhavan et al., 2016). It is
because of these documented effects in response to phytase, that phytase was not
included in the diets of the current study. Nevertheless, a decline in broiler performance
and meat yield is not only linked to other components of the diet such as phytase, but
may also be due to the important functions of Ca, including its role in muscle synthesis
and nutrient absorption.
Both dietary D3 and 25OHD3 have been shown to increase the rate of absorption
of Ca and P in the jejunum (Bar et al., 1980). However, posthatch increases in Ca and P
levels in response to various vitamin D sources administrated by in ovo injection have not
been previously investigated. Nevertheless, previous studies have reported the effects of
the in ovo injection of D3, 25OHD3, 1α-hydroxy vitamin D3, and1 , 25-(OH)2 D3 in
broiler embryos during the incubation period (Bello et al., 2013; Mansour et al., 2017).
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Intracellular Ca promotes the release of hepatocyte growth factor from the extra cellular
matrix, leading to an increase in the number of satellite cells (Allen et al., 1995). Muscle
fiber formation is completed at hatch (Smith, 1963) and subsequent muscle growth is
facilitated by myoblast or satellite cell activity (Mauro, 1961). An increase in the number
of satellite cells is associated with an increase in protein synthesis and muscle fiber
growth through hypertrophy (Moss and LeBlond, 1971). In addition to muscle formation,
dietary Ca can also improve the small intestine morphology of broilers (Xing et al.,
2019). An increase in villus height and a decrease in crypt depth were observed in
response to increased dietary Ca levels which subsequently led to increased BWG,
decreased FCR, and leg meat yield. A 20% reduction in the Ca and available P levels in
broiler diets resulted in a decline in small intestine morphology of broilers at 14 and 40
doa (Chapter 6). These data indicate that a decline in small intestine morphology and
satellite cell numbers could be the reasons for the lower meat yield in ReCaP-fed birds
when compared to those fed commercial diets.
The increased incidence of WBM is a recent major concern in the poultry
industry. It is well documented that the rate of protein synthesis is reduced and that the
fat content is increased in the breast fillets of broilers exhibiting WBM (Kuttappan et al.,
2013; Trocino et al., 2015). Furthermore, RNA sequencing results in WBM breast fillets
has revealed that there is a greater expression of genes involved in oxidative stress, and
that there are higher levels of intracellular Ca as well as an increase in the inflammatory
response in fast-growing broilers (Mutryn et al., 2015). In comparison to D3, in ovo
injection of 25OHD3 alone tended to decrease the inflammatory response in broilers
(Chapter 6). Thus, lower proportions of severe WBM scores in response to the in ovo
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injection of 25OHD3 could be also due to a reduced inflammatory response. An increase
in the amount of Ca in the sarcoplasmic reticulum in skeletal muscle can stimulate
enzymatic activity in association with protein denaturation (Sandercock and Mitchell,
2004; Whitehead et al., 2006). Thus, one of the possible reasons for the increased
incidence of WBM in the broilers fed the commercial diets may be due to increased
intracellular Ca levels, thereby causing the occurrence of WBM to be higher than that of
broilers fed ReCaP diets.
In conclusion, the in ovo injection of 2 vitamin D3 sources on breast meat yield,
incidence of WBM, and the overall performance of broilers fed diets restricted in Ca and
available P was investigated. Our findings revealed that the in ovo injection of those
vitamin D3 sources did not affect broiler performance, meat yield, or quality when Ca and
P were restricted in the diet. Furthermore, in comparison to D3, the in ovo injection of
25OHD3 increased breast meat yield and deceased the WBM scores of the broilers in this
study. The changes in these observed factors may be due to a greater storage efficiency of
25OHD3 in muscle tissue, and an improvement in small intestine morphology. Severe
reductions in dietary Ca and available P resulted in a decline in overall performance and
breast meat yield, and reduced incidence of WBM. The disadvantages caused by the
ReCaP diet could be due to a reduction in Ca and P uptake, which is essential for growth
and muscle development. This could also be the reason for a decrease in intracellular Ca
in association with lower WBM scores. Further study is required to determine the effects
of the in ovo injection of various vitamin D3 sources on the small intestine morphology
and inflammatory response of broiler chickens.

94

5.6

ACKNOWLEDGEMENT
This study was supported by USDA-ARS. Special thanks to Dr. Bradley Turner

and Dr. April Levy for their invaluable assistance.

95

Table 5.1

Feed composition of the experimental diets from 0 to 41 d of age (doa)
Ca and available
phosphorus restricted
(ReCap) diet
Starter (0-14 doa)
Commercial
diet

Item
Ingredient (%)
Yellow corn
Soybean meal
Animal fat
Dicalcium phosphate
Limestone
Salt
Choline chloride 60%
Lysine
DL-Methionine
L-threonine
Premix1
Coccidiostat2
Cellulose
Total
Calculated nutrients
Crude protein (%)
Calcium (%)
Available phosphorus (%)
AME (Kcal/kg)
Digestible Methionine (%)
Digestible Lysine (%)
Digestible Threonine (%)
Digestible TSAA (%)
Sodium (%)
Choline (%)

Pct
53.23
38.23
2.60
2.23
1.27
0.34
1.00
0.28
0.37
0.15
0.25
0.05
0
100

Pct
53.23
38.23
2.60
1.71
1.01
0.34
1.00
0.28
0.37
0.15
0.25

23
0.96
0.48
3,000
0.51
1.28
0.86
0.95
0.16
0.16

23
0.768
0.384
3,000
0.51
1.28
0.86
0.95
0.16
0.16
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0.05
0.78
100

Table 5.1 (continued)
Grower (15-28 doa)
Item
Ingredient (%)
Yellow corn
Soybean meal
Animal fat
Dicalcium phosphate
Limestone
Salt
Choline chloride 60%
Lysine
DL-Methionine
L-threonine
Premix
Coccidiostat
Cellulose
Total
Calculated nutrients
Crude protein (%)
Calcium (%)
Available phosphorus (%)
AME (Kcal/kg)
Digestible Methionine (%)
Digestible Lysine (%)
Digestible Threonine (%)
Digestible TSAA (%)
Sodium (%)
Choline (%)

Pct
57.13
34.80
3.50
2.00
1.17
0.34
0.10
0.21
0.32
0.16
0.25
0.05
0
100

Pct
57.13
34.80
3.50
1.52
0.94
0.34
0.10
0.21
0.32
0.16
0.25
0.05
0.71
100

21.5
0.87
0.435
3,100
0.47
1.15
0.77
0.87
0.16
0.16

21.5
0.696
0.348
3,100
0.47
1.15
0.77
0.87
0.16
0.16
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Table (5.1) continued
Finisher (29-45 doa)
Item
Ingredient (%)
Yellow corn
Soybean meal
Animal fat
Dicalcium phosphate
Limestone
Salt
Choline chloride 60%
Lysine
DL-Methionine
L-threonine
Premix

Pct
54.23
38.23
2.50
2.23
1.27
0.34
0.10
0.28
0.37
0.15
0.25

Pct
54.23
38.23
2.50
1.71
1.01
0.34
0.10
0.28
0.37
0.15
0.25

0.05
Coccidiostat
0.05
0
Cellulose
0.78
100
100
Total
Calculated nutrients
19.5
19.5
Crude protein (%)
0.78
0.624
Calcium (%)
0.39
0.312
Available phosphorus (%)
3,200
3,200
AME (Kcal/kg)
0.43
0.43
Digestible Methionine (%)
1.02
1.02
Digestible Lysine (%)
0.68
0.68
Digestible Threonine (%)
0.8
0.8
Digestible TSAA (%)
0.16
0.16
Sodium (%)
0.16
0.16
Choline (%)
1
The broiler premix provided per kilogram of diet: vitamin A (retinyl acetate),
10,000 IU; cholecalciferol, 4,000 IU; vitamin E (DL-α-tocopheryl acetate), 50
IU; vitamin K, 4.0 mg; thiamine mononitrate (B1), 4.0 mg; riboflavin (B2), 10
mg; pyridoxine HCL (B6), 5.0 mg; vitamin B12 (cobalamin), 0.02 mg; Dpantothenic acid, 15 mg; folic acid, 0.2 mg; niacin, 65 mg;biotin, 1.65 mg;
iodine (ethylene diamine dihydroiodide), 1.65 mg; Mn (MnSO4H2O) , 120 mg;
Cu, 20 mg; Zn, 100 mg, Se, 0.3 mg; Fe (FeSO4.7H2O), 800 mg.
2

Decocx ® (Zoetis, Parsippany, NJ).
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Table 5.2

Effects diluent-injected (50 μL) control, and eggs injected 2.4 μg/ egg of
vitamin D3 (D3) and 25-hydroxycholecalciferol (25OHD3; 50 μL) in birds
fed commercial diet or Ca and available P restricted diet on hatchability of
fertile egg (Hatchability), and hatch residue at 21 d of incubation (doi)
Hatchability
(%)

Live
pipped
(%)

Diluent1

92.0

1.04

D32

92.4

25OHD33

95.4

Treatment

Dead
pipped (%)

Late mortality
(%)

Dead
(%)

1.19

4.85

0.74

0.78

2.13

3.55

1.11

0.45

1.36

2.45

0.30

0.92
0.610
0.527

3.84
0.960
0.140

0.17
0.335
0.119

In ovo injection

D3+25OHD34
94.0
1.48
Pooled SEM
0.077
P-value

0.88
0.408
0.729

1

Eggs injected with 50 μl commercial diluent at d 18 of incubation.

2

Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at d 18 of incubation.

Eggs injected with50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at d 18 of incubation.
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg/egg at d 18 of
incubation.
3
4
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Table 5.3

Effects diluent-injected (50 μL) control, and eggs injected with 2.4 μg of vitamin D3 (D3) and 25hydroxycholecalciferol (25OHD3; 50 μL) in birds fed commercial diet or Ca and available P restricted diets on Ross
708 broiler BW, BW gain (BWG), average daily gain (ADG), feed intake (FI), average daily feed intake (ADFI),
FCR, and total mortality throughout the 40 d of age (doa) rearing period.
BW
(g)

Treatment

BWG
(g)

ADG
(g)

FI
(g)

ADFI
(g)

FCR
(g/g)

Starter (0 to 14 doa)
In ovo injection
Diluent1
D32

427.6
440.7

386.8
400.3

27.63
28.59

445.8
443.6

31.81
31.68

1.151
1.109

25OHD33

434.8

393.7

28.12

449.6

32.12

1.142

D3+25OHD34

429.6

389.3

27.81

441.6

31.57

1.138

SEM

7.55

9.25

0.661

8.55

0.611

0.0211

Commercial
ReCaP5
SEM

430.8
435.6
6.17

Diet

In ovo
Diet
In ovo x Diet

389.9
27.85
442.3 31.59 1.136
395.2
28.23
447.8 31.99 1.134
8.16
0.583
7.54 0.407 0.0186
------------------------------P-value----------------------------0.444 0.445
0.446
0.784 0.783 0.195
0.447 0.400
0.401
0.340 0.338 0.881
0.631 0.738
0.737
0.066 0.066 0.196
BW
BWG
ADG
FI
ADFI FCR
(g)
(g)
(g)
(g)
(g)
(g/g)
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Table 5.3 (continued)
Grower (15 to 28 doa)
In ovo injection
Diluent
D3

1,387
1,364

959
922

68.51
65.88

1404
1359

100.3
97.1

1.481
1.489

25OHD3

1,393

959

68.49

1395

99.6

1.475

D3+25OHD3

1,384

954

68.11

1387

99.1

1.470

SEM

27.9

23.9

1.711

25.9

1.85

0.0334

Commercial

1,502a

1071a

76.53a

1466a 104.7a

1.370a

ReCaP

1,262b

826b

58.97b

1307b

1.588b

Diet

SEM
In ovo
Diet
In ovo x Diet

24.6

93.4b

21.1
1.509
22.8
1.63 0.0296
------------------------------P-value----------------------------0.709 0.323
0.319
0.304 0.304 0.937
0.001 0.001
0.001
0.001 0.001 0.001
0.738 0.736
0.731
0.157 0.157 0.741
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Table 5.3 (continued)
BW
(g)

BWG
(g)

ADG
(g)

FI
(g)

ADFI
(g)

FCR
(g/g)

Finisher (29 to 40 doa)
In ovo injection
Diluent

Total6
Total
FCR Mortality
(g/g)
(%)
(0 to 40 doa)

D3

2,348
2,337

961
974

80.10
81.15

1792
1862

149.3
155.2

1.888
1.915

1.648
1.667

3.2
5.1

25OHD3

2,370

978

81.47

1768

147.4

1.827

1.495

4.2

D3+25OHD3

2,334

951

79.26

1790

149.1

1.889

1.585

6.0

SEM

39.7

39.6

3.30

54.6

4.55

0.0925

0.0380

1.53

Commercial

2,558a

1056a

87.98a

1950a 162.5a

1.867

1.554b

2.8b

ReCaP

2,138b

876b

73.01b

1657b 138.0b

1.893

1.633a

6.5a

34.9
2.91
48.2
4.01 0.0617
0.0335
------------------------------P-value---------------------------------------0.888
0.888
0.296 0.296 0.773
0.491
0.001
0.001
0.001 0.001 0.675
0.003
0.982
0.982
0.150 0.150 0.446
0.094

1.08

Diet

SEM
In ovo
Diet
In ovo x Diet

35.0
0.771
0.001
0.914

a,b

Treatment means within the same column within effect with no common superscripts are significantly different (P < 0.05).
Eggs injected with 50 μl commercial diluent at d 18 of incubation.
2
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at d 18 of incubation.
1

3

Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at d 18 of incubation.

4

Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg/egg at d 18 of incubation.

5

A diet restricted Ca and available P by 20% throughout the rearing period.

6

Accumulative FCR from 0 to 40 d of age.
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0.612
0.021
0.361

Table 5.4

Effects diluent-injected (50 μL) control, and eggs injected with 2.4 μg of
vitamin D3 (D3) and 25-hydroxycholecalciferol (25OHD3; 50 μL) in birds
fed commercial or Ca and available P restricted diets on Pectoralis major
(P. major) and minor (P. minor), and breast meat yield (Breast) at 14 and
40 d of age (doa).
P-major
(%)

P-minor
(%)
14 doa

Breas
t (%)

P-major
(%)

P-minor
(%)
40 doa

Breast
(%)

11.7c
12.7b
13.6a

2.5
2.6
2.8

14.3c
15.3ab
16.3a

20.1b
21.3ab
23.5a

3.7
3.9
4.4

23.8b
25.2ab
27.9a

4

12.6b

2.4

15.0bc

19.6b

3.8

23.5b

SEM

0.30

0.18

0.40

0.96

0.18

1.03

Commercial
ReCaP5
SEM

12.4
2.6
15.03
21.9
3.9
25.8
12.8
2.6
15.40
20.4
4.0
24.4
0.22
0.13
0.31
0.77
0.15
0.83
------------------------------P-value----------------------------0.614
0.107
0.001
0.003
0.047
0.028
0.150
0.773
0.318
0.151
0.396
0.233
0.947
0.430
0.865
0.565
0.926
0.573

Treatment
In ovo injection
Diluent1
D32
25OHD33
D3+25OHD3

Diet

In ovo
Diet
In ovo x Diet
a-c

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
1
Eggs injected with 50 μl commercial diluent at d 18 of incubation.
2
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at d 18 of incubation.
3
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at d 18 of incubation.
4
Eggs injected with 50 μl commercial diluent containing D 3 at 2.4 and 25OHD3 at 2.4 μg/egg at d 18 of
incubation.
5
A diet restricted Ca and available P by 20% throughout the rearing period.
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Table 5.5

Effects diluent-injected (50 μL) control, and eggs injected with 2.4 μg of vitamin D3 (D3) and 25hydroxycholecalciferol (25OHD3; 50 μL) in birds fed commercial or Ca and available P restricted diets on carcass
weight and weights of pectoralis major (P. major) and minor (P. minor) , breast meat yield (Breast), wing,
drumsticks, thighs, fat pad relative to carcass weight at 41 and 46 d of age (doa).

Treatment
In ovo injection
Diluent
D3
25OHD3
D3+25OHD3
SEM
Diet
Commercial
ReCaP
SEM
In ovo
Diet
In ovo x Diet

Carcass P-minor
(g)
(%)

P-major
(%)

Breast
(%)

Wings
(%)
41 doa

Drumsticks
(%)

Thighs
(%)

Fat
(%)

6.0
6.1
6.0
6.0
0.10

35.2
35.6
36.1
36.0
0.52

10.9
10.9
11.0
11.0
0.13

12.6
12.5
12.5
12.4
0.16

1,758
1,749
1,725
1,749
19.0

29.2
29.5
30.1
30.0
0.46

15.7
15.7
15.9
15.5
0.21

0.68
0.64
0.66
0.68
0.024

1,894a
1,597b
15.2

30.4a
6.2a
36.2
11.2a
12.3
15.6
b
b
b
29.0
5.9
34.9
10.7
12.6
15.8
0.50
0.07
0.35
0.14
0.12
0.14
------------------------------P-value----------------------------0.511
0.979
0.620
0.887
0.879
0.603
0.074
0.204
0.006
0.004
0.070
0.001
0.688
0.872
0.803
0.323
0.952
0.800
46 doa

0.67
0.65
0.018

0.647
0.001
0.268
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0.629
0.389
0.368

Table 5.5 (continued)
In ovo injection
Diluent
D3
25OHD3
D3+25OHD3
SEM
Diet
Commercial
ReCaP
SEM

2,055
2,048
2,073
2,073
36.1

32.2
29.2
30.9
28.5
1.9

15.5
15.5
15.6
15.3
0.25

1.27
1.31
1.34
1.23
0.095

2,223a
1902b
27.2

1.29
1.28
0.070

In ovo
Diet
In ovo x Diet

0.946
0.001
0.327

29.5
6.1
35.5
10.9a
12.0
15.5
b
30.9
6.0
36.9
10.4
11.8
15.5
1.5
0.09
1.6
0.13
0.14
0.18
------------------------------P-value----------------------------0.508
0.815
0.505
0.420
0.325
0.787
0.509
0.603
0.531
0.307
0.946
0.020
0.559
0.832
0.570
0.775
0.541
0.271

a-c

6.0
6.1
6.1
5.9
0.11

38.2
35.2
36.9
34.4
2.0

10.8
10.5
10.9
10.6
0.17

12.0
11.7
12.1
11.7
0.18

0.828
0.891
0.756

Treatment means within the same column within effect with no common superscripts are significantly different (P < 0.05).

Eggs injected with 50 μl commercial diluent at d 18 of incubation.
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at d 18 of incubation.
3
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at d 18 of incubation.
4
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg/egg at d 18 of incubation.
5
A diet restricted Ca and available P by 20% throughout the rearing period.
1
2
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Table 5.6

Effects diluent-injected (50 μL) control, and eggs injected with 2.4 μg of
vitamin D3 (D3) and 25-hydroxycholecalciferol (25OHD3; 50 μL) in birds
fed commercial or Ca and available P restricted diets on incidence of
woody breast at d41 and 46.

Treatment

Score 0
(%)

Score 1 (%)

Score 2 (%)

Score 3 (%)

42 doa
In ovo injection
Diluent1
D32
25OHD33
D3+25OHD34
SEM
Diet
Commercial
ReCaP
SEM
In ovo
Diet
In ovo x Diet
In ovo injection
Diluent
D3
25OHD3
D3+25OHD3
SEM
Diet
Commercial
ReCaP
SEM

In ovo
Diet
In ovo x Diet

41.8
41.0
41.8
36.7
5.0

37.6
42.3
48.5
41.0
5.1

19.7
10.4
9.6
15.8
3.7

0.9ab
6.3a
0.1b
6.4a
2.0

18.6b
57.5a
19.0a
4.9
a
b
62.0
27.3
8.8b
1.9
3.0
3.1
2.3
1.8
----------------------------P-value------------------------------0.870
0.495
0.197
0.042
0.193
0.001
0.001
0.024
0.903
0.509
0.153
0.379
46oa
41.8
48.8
49.0
36.8
5.8

25.6
18.6
19.1
30.5
5.6

18.3
14.6
21.6
24.2
4.4

14.3
18.0
10.3
8.4
4.0

31.6b
24.5
27.5a
16.4
a
56.6
22.5
11.9b
9.0
3.5
3.4
2.7
3.0
------------------------------P-value------------------------------0.380
0.383
0.439
0.352
0.756
0.120
0.001
0.004
0.440
0.629
0.151
0.579

a,b

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
1
Eggs injected with 50 μl commercial diluent at d 18 of incubation.
2
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at d 18 of incubation.
3
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at d 18 of incubation.
4
Eggs injected with 50 μl commercial diluent containing D 3 at 2.4 and 25OHD3 at 2.4 μg/egg at d 18 of
incubation.
5
A diet restricted Ca and available P by 20% throughout the rearing period.
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CHAPTER VI
EFFECTS OF THE IN OVO INJECTION OF VITAMIN D3 AND 25HYDROXYVITAMIN D3 ON IMMUNITY AND SMALL
INTESTINE MORPHOLOGY IN BROILERS FED
COMMERCIAL OR CALCIUM- AND
PHOSPHOROUS-RESTRICTED
DIETS
6.1

ABSTRACT
Effects of the in ovo injection of vitamin D3 (D3) and 25-hydroxyvitamin D3

(25OHD3) on broiler chicken immunity and small intestine morphology were
investigated. At 18 d of incubation (doi), a total of 2,880 live embryonated Ross 708
broiler hatching eggs were in ovo-injected with a 50 μL solution of one of the following
treatments using an Inovoject multi-egg injector: 1) diluent (control); diluent containing
either 2) 2.4 μg D3; 3) 2.4 μg 25OHD3; or 4) 2.4 μg D3 + 2.4 μg 25OHD3. At hatch, 18
male broilers were randomly placed in each of 48 floor pens and were fed either a
commercial diet or a diet restricted by 20% in calcium and available phosphorus (ReCaP)
content for the starter, grower and finisher dietary phases. At the d of age (doa) indicated
below, blood and organ samples were collected from 1 bird from each of 6 replicate pens
within each of the 8 treatment groups. Serum IgG and IgM were determined at 14 doa
and α-1-acid glycoprotein was determined at 40 doa. Bursa, liver, spleen, duodenum,
jejunum, and ileum weights were recorded at 7, 14, and 40 doa and histology of the small
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intestine was evaluated at 14 and 40 doa. Blood and organ samples were taken on the
same doa and from the same bird. Serum IgG levels were higher in 25OHD3- than in
diluent- or D3 in ovo-injected birds. At 14 doa, a higher jejunal villus length to crypt
depth ratio (RVC) was observed in birds that were in ovo-injected with 25OHD3 alone as
compared to all other in ovo injection treatments, and a 25OHD3 in ovo injection resulted
in a shallower crypt depth (CD) in comparison to the diluent or D3 treatments. At 40 doa,
villus length (VL) increased in the ileum and CD decreased in the jejunum in commercial
diet-fed birds compared to ReCaP diet-fed birds. In conclusion, the in ovo injection of
25OHD3 alone increased antibody production capacity and improved small intestine
morphology in Ross 708 broilers. However, a ReCaP diet was observed to be detrimental
to their small intestine morphology.
Keywords: In ovo injection, 25-hydroxyvitamin D3, small intestine morphology,
immunity, broilers
6.2

INTRODUCTION
The in ovo injection of broiler hatching eggs is widely used in the poultry

industry. In comparison to the traditional method of broiler vaccination, in ovo injection
is less stressful, and is faster and provides uniform delivery of vaccines or nutrients to
broiler embryos (Williams, 2007). Rapid development of the small intestine begins at 17
d of incubation (doi) and includes an approximately 1.43 fold increase in relative
intestinal weight, and development of villi in length and shape (Uni et al., 2003).
Furthermore, at that time, the expression and activity of brush-border enzymes and
transporters prepare the embryo for exogenous feed ingestion (Uni et al., 2003). An
earlier increase in small intestine development has a positive long-term effect on broiler
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performance (Uni et al., 1999). The in ovo injection of mannan oligosaccharides
increases villus length (VL) and villus area (Cheled-Shoval et al., 2011). Improvements
in small intestine morphology are associated with increased in growth performance
characteristics such as BW and feed conversion ratio (FCR) under commercial
conditions (Yang et al., 2007a,b) as well as during a coccidiosis challenge (Dalloul et al.,
2005). In addition, in ovo injection of different nutrients and injected materials such as
CpG oligodeoxynucleotides, vitamins C and E, and plant extracts have the potential to
enhance immunity (Gore and Qureshi, 1997; Dalloul et al., 2005; Saki and Salary, 2015;
El-Senousey et al. 2018).
Vitamin D3 (D3) is a fat-soluble vitamin and its absorption in the upper region of
the small intestine is facilitated by bile salts. After intestinal absorption, D3 is transported
to the liver where it is converted by 25-hydroxylase to the second metabolite of D3, 25hydroxyvitamin D3 (25OHD3). Subsequently in renal cells, 25OHD3 is converted by 1αhydroxylase to the active form of D3, 1,25-dihydroxyvitamin D3 (1α,25-(OH)2-D3;
Henry, 1980). Vitamin D is crucial for proper embryo development (Narbaitz, 1987), and
is involved in calcium (Ca) and phosphorous absorption (Bar et al, 1980), immunity
(Adams and Hewison, 2008) and intestinal development in chickens (Chou et al., 2009).
When included at the same dietary level, 25OHD3 is approximately twice as active as D3
in promoting Ca absorption (Myrtle and Norman, 1971), and has a higher retention in
chicks compared to D3 (93% and 80% respectively; Bar et al., 1980). Inclusion of
25OHD3 in broiler breeder diets increased VL in the duodenum of broiler embryos at 19
doi and during the first 2 d of posthatch age (doa; Ding et al, 2011). Additionally,
supplemental dietary 25OHD3 at 2,760 IU/kg increased VL and decreased crypt depth
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(CD) in broiler chickens (Chou et al., 2009). An increase in VL is linked to increased
nutrient absorption (Onderci et al., 2006) and decreased CD is associated with less
frequent epithelial cell turnover, leading to a lower energy requirement in the gut (Yang
et al., 2008). Maternal 25OHD3 has also been shown to increase the innate immunity of
chicks relative to D3 (Saunders-Blades and Korve, 2015). Additionally, dietary
supplementation of 25OHD3 has been shown to increase humoral immunity in early
posthatch broiler chickens (Chou et al., 2009). Rodriguez-Lecompte et al. (2016) reported
that the immunomodulatory function of vitamin D is associated with the levels of Ca and
phosphorous in the diet. Birds fed D3 down regulated the expression of a gene (TLR4)
linked to innate immunity, and both vitamin D3 sources increased the expression of genes
linked to T-cell activity (CATH1, CATHB1, Th1, and Th2).
It was hypothesized that the vitamin D3 sources utilized in this study would
positively influence the antibody production and small intestine morphology of the
broilers, especially in those fed Ca and available phosphorous (aP)-restricted diets. In
addition, effects of the in ovo injection of D3 and 25OHD3 on the small intestine
morphology and antibody production of broilers have not been previously investigated.
Therefore, the objective of this study was to determine the effects of the in ovo injection
of D3 and 25OHD3 on small intestine morphology, and non-specific immune indicators of
broilers fed either commercial diets or diets in which Ca and aP were restricted by 20%.
6.3
6.3.1

MATERIAL AND METHODS
EXPERIMENTAL DESIGN AND TREATMENTS
All experimental procedures were approved by the Institutional Animal Care and

Use Committee of Mississippi State University. Fertile broiler eggs laid by 35 wk-old
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Ross 708 breeder hen were obtained from a commercial source and stored for 24 h. Prior
to set, eggs were selected as described by Sokale et al. (2016) and subsequently, a total of
2,880 eggs were set and incubated in a Jamesway model PS 500 setter unit (Jamesway
Incubator Company Inc., Cambridge, Ontario, Canada) under standard conditions (37.5º
C and 29.4º C dry and wet bulb temperatures, respectively). Thirty eggs were assigned to
each of 4 pre-assigned treatment groups on each of 24 incubator tray levels (blocks).
Treatment groups on each tray were randomly placed to avoid positional effects and
monitoring of incubational condition were as described in Chapter 3 and 4. In ovo
injection treatments were prepared according to the procedures in Chapter 3 and 4 and
were injected into the amniotic sac at 18 doi using a Zoetis Inovoject M (Zoetis Animal
Health, Research Triangle Park, NC) in ovo injection machine. In ovo injection
treatments were: 1) diluent (control; 50 μL of commercial diluent); 2) D3 (50 μL of
commercial diluent containing 2.4 μg D3), 3) 25OHD3 (50 μL of commercial diluent
containing 2.4 μg 25OHD3), and D3 + 25OHD3 (50 μL of commercial diluent containing
2.4 μg D3 and 2.4 μg 25OHD3). For the posthatch period, 18 male chicks were placed in
each of 48 floor pens. Bird housing and husbandry during the posthatch period were as
described in Chapter 4. Commercial diets were formulated according to Ross 708
guidelines (Aviagen, 2014). There were 2 dietary treatments: 1) commercial diet; 2) the
commercial diet restricted in Ca and aP content (ReCaP diet) for the starter (Ca=0.76,
aP=0.384), grower (Ca=0.696, aP=0.348) and finisher (Ca=0.624, aP=0.312) dietary
phases. Diets used in Chapter 6 were identical to those used in Chapter 5 presented in
Table 5.1. Eight treatment groups (4 in ovo injection x 2 dietary treatments) were
randomly represented in each of 6 replicate blocks of pens in the grow out facility.
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6.3.2

BLOOD SAMPLING AND IMMUNOLOGICAL ASSESSMENT
One bird from each of the 48 floor pens were randomly selected and individually

weighed and euthanized for organ sampling at each of 0, 7, 14, and 40 doa. At 0 doa,
weights of the liver, spleen, bursa and small intestine (SI, terminus of gizzard to cecal
ducts) without digesta were obtained. At 7, 14, and 40 doa, individual weights of the
liver, spleen, bursa and duodenum, jejunum and ileum were obtained. All weights were
subsequently expressed as percentages of BW. From the same birds that were selected for
sampling of organs, blood samples were collected at 7, 14 and 40 doa, and plasma was
subsequently extracted for immunological assay. Plasma IgG concentration was
determined by ELISA for samples collected at 7 and 14 doa according to the
manufacturer’s protocol (MyBioSource, San Diego, CA). Duplicate 100 μl volumes of
standard and experimental samples were loaded into specific ELISA plate wells
precoated with capture antibody, and were then incubated at 37℃ for 90 min. Plates were
washed 2 times with wash solution (50 mM Tris-buffered saline, 0.14 M NaCl, 0.05%
Tween 20, pH 8.0) and 100 μl of biotinylated chicken IgG antibody was added to each
well, and plates were incubated at 37℃ for 60 min. Plates were washed 3 times with
wash solution and 100 μl of enzyme-conjugate liquid was added to each well in order to
initiate a Tetramethylbenzidine substrate color reaction. Reactant was thoroughly washed
out by Phosphate-buffered saline or tris-buffered saline. Plates were incubated at 37℃ for
30 min and they were washed 5 times with wash solution. A 100 μl volume of color
reagent was added to each well in order to produce a blue color in each sample. Samples
were then incubated in a dark incubator at 37℃ for 30 min. Finally, the color of each
sample was changed from blue to yellow under the action of a 100 μl volume of stop
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solution. Plasma IgM concentration was determined by ELISA at 14 doa according to the
procedure of Perez-Carbajal et al, (2010) and plasma α-1-acid glycoprotien (AGP) was
determined by ELISA at 40 doa according to the procedure of Kaab et al. (2018). Optical
density (OD) at 450 nm (OD450) for IgG, IgM and AGP was measured with a
SpectraMax M5 Microplate Reader (Molecular Devices, San Jose, CA).
6.3.3

SMALL INTESTINE MORPHOLOGY
Each intestine sample collected was from one bird in each of 48 floor pens at 14

and 40 doa, a 2 cm sample from the middle region of the duodenum, jejunum, and ileum
was excised and fixed in 10% formalin. Later, intestinal samples were gradually
dehydrated and embedded in paraffin as described by Wang et al. (2015). The slides used
for histomorphological analysis were prepared according to Wang et al. (2015). Slides
were examined using a light microscope at 40X magnification (Micromaster, Fisher
Scientific, Pittsburgh, PA) according to the method described by Fasina et al. (2010).
Microscopic images were measured using ImageJ software (Wayne Rasband, NIMH,
Bethesda, MD) to measure VL, villus width (VW) and CD from 3 randomly-selected villi
samples within the duodenum, jejunum, and ileum.
Measurements from 3 different locations within each of the 3 intestinal regions
for a particular bird were included on each slide. Mean values within each of the 3
intestinal regions for each bird were subjected to statistical analysis. Villus height was
considered as the distance from the tip to the base of the lamina propria and VW was
measured between the top third and bottom third of the villus. Crypt depth was the length
from the base of the villus to the mucosa layer. The ratio of VL to CD (RVC) was
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calculated by dividing VL by CD. Villus surface area was calculated for all sections
using the formula presented below by Nain et al. (2012).
Villus surface area (VSA) = 2π × (average VW/2) × VL; where average VW is
the average of 3 measurements per bird (2 VW measurements from the 3 sample sections
examined on each slide).
6.3.4

STATISTICAL ANALYSIS
The experimental unit was floor pen, and the experimental design was a

randomized complete block. A group of pens was the blocking factor with all treatments
randomly represented in each of 6 blocks. All data at each individual time period were
analyzed as a two-way analysis of variance with 2 dietary treatments and 4 in ovo
injection treatments, using the procedure for linear mixed models (PROC GLIMMIX) of
SAS 9.4© (SAS Institute, 2013). Differences were considered significant at P≤ 0.05. The
following model was used for analysis of the data:
Yijk = μ + Bi+ Dj + Ik + (DI)jk + Eijk,

(6.1)

Where μ was the population mean; Bi was the block factor (i = 1 to 2); Dj was the
effect of each dietary treatment (j = 1 to 2); Ik was the effect of in ovo injection treatment
(k = 4); (DI)ij was the interaction of each dietary treatment with in ovo injection
treatment; and Eij was the residual error.
6.4
6.4.1

RESULTS
BODY AND ORGAN WEIGHTS
No significant differences due to in ovo injection treatment were observed for BW

nor any relative organ weights at 0 doa (Table 1). No significant interaction was observed
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between diet and in ovo injection treatment for BW and the relative organ weights
examined at 7, 14, and 40 doa. Furthermore, At 7 and 14 doa, there were no significant
main effects due to in ovo or dietary treatment for any of the variables examined.
However, at 14 doa, liver weight relative to BW tended to be lower (P=0.055) in the
25OHD3 treatment in comparison to all other treatments (Table 6.1). There was no
significant main effect due to in ovo treatment for any of the variables examined at 40
doa. However, BW was lower and relative duodenum weight was greater in birds fed
ReCaP diets in comparison to those fed commercial diets (Table 6.1).
6.4.2

IMMUNITY
No significant interactions were observed between diet and in ovo treatment for

any of the immunological measurements determined at their specified time periods
(Table 6.2). There was no significant main effect due to diet for the concentration of IgG
at 7 and 14 doa, IgM at 14 doa, and AGP at 14 doa. There was also no significant main
effect due to in ovo injection treatment for the concentrations of IgG at 7 doa, and AGP at
40 doa. At 14 doa, birds that received 25OHD3 alone had higher serum IgG
concentrations as compared to those that were injected with diluent or D3 alone (Table
6.2). Injection of D3 + 25OHD3 also resulted in serum IgG concentration that were higher
than those in birds injected with D3 alone. Furthermore, at 14 doa, birds that received the
combination of 25OHD3 and D3 had higher serum IgM levels in comparison to those that
received diluent or D3 alone, and those that received 25OHD3 alone had higher IgM
concentrations than those that were in ovo-injected with only diluent (Table 6.2).
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6.4.3

SMALL INTESTINE MORPHOLOGY
No significant interactions were observed between diet and in ovo injection

treatments at any time period for any of the histomorphological measurements (Tables
6.3 and 6.4). Due to the large number of variables examined only the significant main
effects due to in ovo injection and dietary treatment will be discussed. At 14 doa, VL was
higher in the ileum in birds that were injected with 25OHD3 alone as compared to those
that received only diluent and, duodenal CD was shallower in birds injected with
25OHD3 alone in comparison to all other treatments. Additionally, a lower jejunal CD
was observed in birds that received 25OHD3 alone in comparison to those that received
diluent or D3 alone, and was lower in the D3 + 25OHD3 group in comparison to the D3
alone group (Table 6.3). Greater duodenal, jejunal, and ileal RVC were observed in birds
that received 25OHD3 alone in comparison to all other treatments. In comparison to the
diluent-injected group, ileal VSA was decreased in response to the in ovo injection of
25OHD3 alone, and VW in the jejunum was lower in birds that received D3 and 25OHD3
together than if they were received separately. At 14 doa, VL in the duodenum was
decreased in birds fed ReCaP diets as compared to those fed commercial diets, and
jejunal CD was higher in birds fed ReCaP diets in comparison to those fed commercial
diets (Table 6.3).
At 40 doa, VL in the duodenum was greater in birds injected with 25OHD3 alone
in comparison to those that were injected with diluent or D3 alone (Table 6.4). However,
ileal VL increased in response to the injection of 25OHD3 alone when compared to the
D3 alone or 25OHD3 + D3 treatments. Furthermore, VL in the D3 treatment was lower
than that in the diluent control group. Crypt depth in the duodenum and in the ileum was
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shallower in birds that received 25OHD3 alone or in combination with D3 in comparison
to the D3 alone or diluent treatment groups, but CD in the duodenum and jejunum was
only lower in the 25OHD3 treatment in comparison to the D3 alone and diluent treatment
groups (Table 6.4). In the duodenum and jejunum, higher RVC were observed in birds
injected with 25OHD3 alone in comparison to those injected with diluent or D3 alone.
Also, 25OHD3 alone resulted in a higher RVC in the duodenum in comparison to all other
treatments (Table 6.4). At 40 doa, birds fed ReCaP diets had a lower duodenal RVC and
ileal VW, but conversely had a deeper jejunal CD in comparison to those fed commercial
diets (Table 6.4).
6.5

DISCUSSION
Development of the small intestine in response to vitamin D3 occurs mainly

through their effects on the morphology of the small intestine (Chou et al., 2009; Ding et
al., 2011). Inclusion of 25OHD3 in breeder diets resulted in increased VL in broiler
embryos at 19 doi as well as in broilers at 2 doa (Ding et al., 2011). In addition to its
early post-hatch effects, dietary supplementation of 25OHD3 at 2,670 IU/kg has been
shown to increase duodenal and jejunal VL and decrease jejunal CD in 28 and 35 doa
broilers (Chou et al., 2009). Effects of the in ovo injection of various sources of vitamin
D3 including D3, 25OHD3, 1- α hydroxyvitamin D3, and 1α,25-(OH)2-D3 on chick quality,
bone quality, and performance of broilers have been previously reported (Bello et al.,
2014; Abbasi et al., 2017; Mansour et al., 2017). Nevertheless, their effects on the
histomorphology of the small intestine of the embryo or post-hatch broiler have not been
previously reported. However, findings in the current study reveal that the in ovo
injection of 2.4 μg of 25OHD3 improved the small intestine morphology of broilers in
119

comparison to diluent or D3 alone. The mechanism of this change is not clear and further
research is needed to determine the molecular and cellular effects of in ovo injection of
the vitamin D3 sources on small intestine development. One of the possible mechanisms
could involve intestinal calcium-binding protein (CaBP). In mammals, CaBP, such as the
9-kilodalton calcium-binding protein is an indicator of enterocyte maturation (Delvin et
al., 1996). The synthesis of CaBP increased in both villus and crypts cells in response to
active form of vitamin D3 in mammals (Smith et al., 1985). These data indicate that an
increased the level of the active form of vitamin D3 in the small intestine tissue may be
associated with development of villus and crypt cells. In mammals, 1-α hydroxylase,
which converts 25OHD3 to 1α,25-(OH)2-D3, has been identified in dendritic cells,
macrophages (Overbergh et al., 2000; Veldman et al., 2000), B-cells (Chen et al., 2007),
T-cells (Veldman et al., 2000), and duodenal sections of the small intestine (Gawlik et al.,
2015). Additionally, in contrast to dietary D3, dietary 25OHD3 increased the activity of 1α hydroxylase in the chicken (Shanmugasundaram and Selvaraj, 2012). This means that
the increased 1-α hydroxylase in immune or intestine cells may lead to an increase in
levels of 1α,25-(OH)2-D3 leading to increased intestinal epithelium proliferation or
differentiation small intestine and immune cells. This suggests that immune and intestinal
cells may display a greater response to this secondary metabolite of vitamin D 3. In
comparison to D3, the half-life of 25OHD3 is longer (Jones et al., 2015) and it is absorbed
at a higher rate (Bar et al., 1980). As compared to D3, 25OHD3 is mainly stored in the
muscle and liver tissue when supplemented at the low levels of inclusion (Burild et al.,
2016). Saunders-Blades and Korver. (2014) reported that during first 10 d of post-hatch,
serum 25OHD3 did not change in broilers fed D3 at 3,000 IU/kg feed, indicating an
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impaired conversion of D3 to 25OHD3 in early-post hatch broilers. However, 25OHD3
can remain in liver and muscle stores for a longer period of time than D3. It can then be
converted to the active form of vitamin D3 during times when dietary supply of vitamin D
is low, or when there is low conversion of dietary vitamin D3 to 25OHD3, for example in
young birds. Previous findings in our laboratory revealed that breast meat yield increased
(Chapter 5) and FCR decreased (Chapter 4) in response to the in ovo injection of 2.4 μg
of 25OHD3. An increase in RVC is associated with increased in broiler performance as
well as breast meat yield (Wang et al., 2019). Therefore, enhancement in breast meat
yield and growth performance observed in response to the in ovo injection of 25OHD3
could be due to an enhancement of the small intestine morphology and immunity of the
birds.
At least 2 wk are required for lymphocytes to be fully developed in post-hatch
chickens (Bar-Shira and Friedman, 2006). Additionally, various vitamin D3 sources affect
humoral immunity. In the current study, it was shown that in comparison to the injection
of diluent or D3 alone, the in ovo injection of 25OHD3 resulted in increased IgG and IgM
levels at 14 doa when compared to that those injected with diluent or D 3 alone. Abbasi et
al. (2017) also showed that an increase in antibody titers against Newcastle Disease was
observed in hatchlings in response to a 0.5 ml in ovo injection of a combination of
25OHD3 at 0.4 μg and vitamin K at 6 μg. Thus, increased Ig levels of early-hatch broilers
within the first 2 wk of life can be beneficial for the enhancement of their immunity.
These results indicate that the in ovo administration of 2.4 μg of 25OHD3 might be a
suitable candidate for boosting the humoral immunity of early posthatch broilers. In
addition to humoral immunity, the inflammatory response of the broilers was monitored
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by measuring AGP at 40 doa. In the chicken, it has been proposed in several reports that
AGP can be used to monitor increased inflammation (Lee et al., 2010; Asasi et al., 2013).
However, the AGP concentration of the birds in current study were not significantly
affected by in ovo injection or dietary treatment, indicating that a general systemic
inflammatory response in the birds was not significantly affected by either treatment.
In this study, a 20% reduction in dietary Ca and aP resulted in a decline in
duodenal VL at 14 doa, but negative effects were observed in both the duodenum and
ileum at 40 doa. A reduction in dietary aP exerts a greater effect on broiler gut
morphology than a reduction in dietary Ca. A diet containing 0.6 % of Ca and 0.3 % of
aP had no negative effects on RVC in comparison to recommended levels of Ca and aP
(0.9 % of Ca and 45 % of aP) in broilers. However, a 30% reduction in aP with a 0.9 %
of Ca resulted in a lower RVC in the duodenum and ileum (Paiva et al., 2014). The
inclusion of supplemental dietary phytase at 1,000 FTU/kg was sufficient to overcome
the negative effects of reduction in aP on small intestine morphology and broiler
performance (Paiva et al., 2014). In addition to this, an increase in dietary Ca levels from
0.9 to 1.05% did not to affect small intestine morphology in broilers at different ages
(Xing et al., 2019). An increase in intestine weight relative to BW is associated with a
decline in small intestine morphology (Chou et al., 2009; Wu et al., 2013; Wu et al.,
2016), and performance (Wu et al., 2016). In the current study, relative duodenal and
jejunal weights increased at 41 doa and relative jejunal weight tended to increase at 41
doa in birds fed ReCaP rather than commercial diets. Therefore, the decline in small
intestine morphology in response to a 20% reduction in Ca and aP may have been
partially linked to an increase in intestine weight.
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In conclusion, the influence of the in ovo injection of various vitamin D3 sources
on small intestine morphology and immunity of Ross 708 broilers fed commercial and
ReCaP diets were investigated. These results showed that the ReCaP diet adversely
affected intestinal morphology and growth, but that it did not influence effects of the
injection of these vitamin D3 sources on their immunity and small intestine morphology.
Regardless of dietary treatment, the small intestine morphology and non-specific immune
indicators of the birds were improved in response to the in ovo injection of 25OHD3
alone, but these effects were not observed when D3 was injected alone. Further research is
required to determine the effects of the in ovo injection of the vitamin D3 sources on the
molecular mechanisms of intestinal development and immunity in broilers.
6.6
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Table 6.1

Mean BW, relative weight of the whole small intestine (SI), liver, spleen,
bursa, duodenum, jejunum, and ileum at 0, 7, 14, 40 d of age (doa) in
birds in ovo-injected with commercial diluent (50 μL); diluent containing
either 2.4 μg of vitamin D3 (D3), 2.4 μg of 25-hydroxycholecalciferol
(25OHD3; 50 μL), or the combination of 2.4 μg D3 + 2.4 μg 25OHD3 in
birds fed commercial diets or diets restricted in calcium and available
phosphorus by 20%
BW
(g)

SI1
(%)

Liver
(%)
0 doa

Spleen
(%)

Bursa
(%)

Diluent2

41.3

2.88

1.02

0.017

0.087

D33

41.0

3.38

0.99

0.015

0.143

25OHD34
D3+25O
HD35

41.8

2.82

0.95

0.023

0.041

40.6

2.99

0.98

0.016

0.093

0.78
0.759
BW
(g)

0.191
0.177
Duodenum
(%)

0.036
0.588
Jejunum
(%)
7 doa

0.0029
0.158
Ileum
(%)

0.0528
0.599
Liver
(%)

Splee
n (%)

Bursa
(%)

158.8
156.8

1.63
1.77

2.83
2.54

2.46
2.62

3.12
3.18

0.076
0.077

0.36
0.17

147.8

2.16

2.81

2.62

3.15

0.084

0.26

157.4

1.52

2.75

2.29

3.08

0.087

0.17

5.77

0.181

0.300

0.273

0.155

0.007
3

0.112

Commerc
ial

153.5

1.88

2.74

2.62

3.08

0.077

0.16

ReCaP6

156.9

1.67

2.73

2.45

3.18

0.32

5.022

0.175

0.252

0.252

0.130

0.085
0.006
9

Treatment
In ovo injection

SEM
P-value
Treatment
In ovo injection
Diluent
D3
25OHD3
D3+25O
HD3
SEM
Diet

SEM
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0.078

Table 6.1 (continued)
Treatment

In ovo
Diet
In ovo x Diet
Treatment
In ovo
injection
Diluen
t

BW
(g)

Duodenu
m (%)

Jejunum
(%)

Ileum
(%)

Liver
(%)

Spleen
(%)

Bursa
(%)

-----------------------------P-value---------------------------------0.413
0.072
0.845
0.539
0.952
0.634
0.566
0.506
0.230
0.966
0.510
0.437
0.226
0.142
0.177
0.132
0.742
0.881
0.451
0.887
0.530
BW
Duodenu Jejunum
Ileum
Liver
Spleen
Bursa
(g)
m (%)
(%)
(%)
(%)
(%)
(%)
14 doa

452

1.85

1.87

1.58

2.68

0.106

0.493

D3
25OH
D3
D3+25
OHD3

449

1.15

1.76

1.53

2.93

0.169

0.178

465

1.10

1.62

1.42

2.53

0.139

0.210

445

1.27

1.61

1.63

2.75

0.069

0.153

SEM

12.7

0.509

0.143

0.144

0.139

0.0800

0.0415

454

1.46

1.63

1.53

2.73

0.149

0.188

450
11.4

1.23
0.360

1.80
0.101

1.55
0.102

2.72
0.098

0.092
0.0566

0.161
0.0293

Diet
Comm
ercial
ReCaP
SEM
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Table 6.1 (continued)
Treatment

In ovo
Diet
In ovo x Diet
Treatment
In ovo
injection
Diluen
t

BW (g)

Duodenum
(%)

Jejunum
(%)

Ileum
(%)

Liver
(%)

Spleen
(%)

Bursa
(%)

-----------------------------P-value---------------------------------0.563
0.439
0.241
0.514
0.055 0.634 0.493
0.731
0.524
0.087
0.891
0.875 0.318 0.370
0.285
0.280
0.399
0.463
0.061 0.327 0.481
Duodenum Jejunum Ileum
Liver
Splee Bursa
BW (g)
(%)
(%)
(%)
(%)
n (%)
(%)
40 doa

2408

0.497

1.03

0.738

2.26

0.100

0.118

2261

0.564

1.04

0.818

2.14

0.091

0.145

2402

0.532

0.96

0.755

2.14

0.090

0.138

2254

0.510

1.02

0.657

2.50

0.112

0.119

94.7

0.0500

0.088

0.0549

0.176

0.011
1

0.0170

Comm
ercial

2573a

0.476b

0.97

0.718

2.30

0.096

0.125

ReCaP

2089b

0.575a

1.06

0.766

2.22

0.136

69.3

0.0378

0.067

0.0587

0.133

0.101
0.008
3

D3
25OH
D3
D3+25
OHD3
SEM
Diet

SEM
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0.0009

Table 6.1 (continued
Treatment

In ovo
Diet
In ovo x
Diet

BW
(g)

Duodenum
(%)

Jejunum
(%)

Ileum
(%)

Liver
(%)

Bursa
(%)

Spleen (%)

-----------------------------P-value---------------------------------0.228
0.575
0.838
0.350 0.260
0.290
0.342
0.204
0.415 0.566
0.537
0.422
0.001
0.013
0.114

0.819

0.635

0.389

0.518

0.475

0.379

1

The weight of and gastrointestinal tract from the bottom of proventriculus to the end of the ceca.

2

Eggs injected with 50 μl commercial diluent at d 18 of incubation.

3

Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation.

Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg at d 18 of incubation.
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of
incubation.
6
A diet restricted Ca and available P by 20% throughout the
rearing period.
4
5
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Table 6.2

Mean plasma IgG at 7 and 14 d of age (doa), IgM at 14 doa, and alpha-1acid glycoprotein (AGP) at 40 doa concentration in birds in ovo-injected
with commercial diluent (50 μL); diluent containing either 2.4 μg of
vitamin D3 (D3), 2.4 μg of 25-hydroxycholecalciferol (25OHD3; 50 μL),
or the combination of 2.4 μg D3 + 2.4 μg 25OHD3 in birds fed
commercial diets or diets restricted in calcium and available phosphorus
by 20%

Treatment

IgG7doa1

IgG14doa2

IgM-14doa3 AGP-40doa 4

μM
In ovo injection
Diluent
D3
25OHD3
D3+25OHD3
SEM
Diet
Commercial
ReCaP
SEM

6.52bc
6.43c
6.63a
6.58ab
0.020

2.39
2.26
2.34
2.34
0.032

2.37c
2.42bc
2.48ab
2.57a
0.045

2.92
2.93
2.72
2.86
0.008

2.32
2.35
0.028

6.58
2.42
2.86
6.50
2.50
2.82
0.015
0.038
0.006
-----------------P-value----------------0.302
0.079
In ovo
0.013
0.005
0.570
0.090
0.080
0.580
Diet
0.302
0.984
0.974
0.129
In ovo x Diet
a,b
Treatment means within the same column within effect with no common superscripts
are significantly different (P < 0.05).
1

Plasma IgG concentrations at 7 d doa.
Plasma IgG concentrations at 14 doa.
3
Plasma IgM concentrations at 14 doa.
4
Plasma AGP concentrations at 40 doa.
5
Eggs injected with 50 μl commercial diluent at d 18 of incubation.
6
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation.
7
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/ at d 18 of incubation.
8
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of
incubation.
9
A diet restricted Ca and available P by 20% through the rearing period.
2
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Table 6.3

Small intestine morphology at 14 d of age in birds in ovo-injected with commercial diluent (50 μL); diluent
containing either 2.4 μg of vitamin D3 (D3), 2.4 μg of 25-hydroxycholecalciferol (25OHD3; 50 μL), or the
combination of 2.4 μg D3 + 2.4 μg 25OHD3 in birds fed commercial diets or diets restricted in calcium and
available phosphorus by 20%
---------------Duodenum-----------------

Treatment

Villus
length

Villus
width

Crypt
depth

μm
In ovo injection
Diluent

RVC1

VSA
2

Lengt
h/Dep
th

mm2

------------------Jejunum----------------Villus
length

Villus
width

Crypt
depth

μm

RVC

VSA

Length/
Depth

mm2

-------------------Ileum---------------------Villu
s
lengt
h

Villus
width

Crypt
depth

μm

RVC

VSA

Length/
Depth

mm2

994

89.4

136a

7.7b

0.28

848

89.3ab

116b

7.4b

0.34

336b

83.1

90

4.0b

0.40a

D3

999

93.8

137a

7.4b

0.29

922

98.9a

137a

7.0b

0.34

391ab

87.1

107

3.8b

0.35ab

25OHD3

1088

82.8

89b

12.2a

0.24

902

93.0a

88c

10.0a

0.33

480a

81.2

77

6.4a

0.27b

D3+25OHD3

983

83.2

122a

8.2b

0.27

780

73.3b

107cb

7.5b

0.30

428ab

75.4

90

4.8b

0.30ab

SEM

51.2

9.83

9.2

0.71

0.283

45.8

6.26

6.9

0.87

0.245

46.7

12.3

11.2

0.52

0.039

Commercial

1065a

93.3

124

9.5

0.28

849

85.7

104b

8.6

0.32

415

85.8

88

5.0

0.34

a

Diet
ReCaP
SEM

b

81.4

114

9.0

0.27

877

91.5

120

32.3

8.66

8.9

0.49

0.018

34.3

4.66

4.9

967

129

7.7

0.33

403

77.5

94

4.6

0.31

0.61

0.018

34.2

9.17

7.72

0.45

0.033

Table 6.3 (continued)
---------------Duodenum----------------Treatment

Villus
length

Villus
width

Crypt
depth

RVC1
Lengt
h/Dep
th

μm

VSA
2

------------------Jejunum----------------Villus
length

mm2

Villus
width

Crypt
depth

μm

RVC

VSA

Length/
Depth

mm2

-------------------Ileum---------------------Villu
s
lengt
h

Villus
width

Crypt
depth

μm

RVC

VSA

Length/
Depth

mm2

--------------------------------------------------------------------P-value-----------------------------------------------------------------------In ovo

0.092

0.549

Diet

0.005

In ovo x Diet

0.606

0.001
0.311

0.195

0.168

0.062

0.001
0.129

0.644

0.192

0.598

0.942

0.190

0.543

0.021

0.001
0.150

0.068

0.845

0.001

0.555

0.050
0.380

0.176

0.351

a,b

0.864

0.778

0.020
0.746

0.595

0.390

0.362

0.067
0.455

0.001
0.376

0.039
0.409

0.326

0.570

0.178

0.531

Treatment means within the same column within effect with no common superscripts are significantly different (P < 0.05).
Ratio of villus length to crypt depth.
2
Villus surface area (VSA) calculated with average villus length and width = 2π × (width/2) × length.
3
Eggs injected with 50 μl commercial diluent at d 18 of incubation.
4
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation.
5
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg at d 18 of incubation.
6
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of incubation.
7
A diet restricted Ca and available P by 20% throughout the rearing period.
1
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Table 6.4

Treatmen
t

Small intestine morphology at 40 d of age in birds in ovo-injected with commercial diluent (50 μL);
diluent containing either 2.4 μg of vitamin D3 (D3), 2.4 μg of 25-hydroxycholecalciferol (25OHD3; 50
μL), or the combination of 2.4 μg D3 + 2.4 μg 25OHD3 in birds fed commercial diets or diets restricted
in calcium and available phosphorus by 20%
-----------------------Duodenum-----------------Vill
Crypt
us
Villus
RVC1 VSA2
length widt
depth
h
Length
/Depth

μm

----------------------Jejunum--------------------Villu Villu
VS
s
s
Crypt
RVC
lengt widt depth
A
h
h

mm2

Leng
th/De
pth

μm

--------------------------Ileum--------------------------

Villus
length

mm

Villu
s
width

Crypt
depth

μm

2

In ovo
injection
Diluent

RVC

VSA

Len
gth/
Dep
th

mm2

5.9b
b

1182

101

a

124

b

9.9

0.27

975

111

a

123

b

8.2

0.36

ab

565

80.9

a

0.43b

97

c

D3
25OHD3

1200b

113

126a

9.7b

0.30

1388a

106

96b

15.1a

0.24

903

107

119a

7.7b

0.38

458c

86.1

95a

4.9c

0.57a

110

91b

11.3a

0.35

658a

88.2

72b

9.6a

0.43ab

9.5ab

0.37

538bc

80.1

76b

7.5b

0.47b

100
5

D3+25O
HD3

1253a

112a
11.5b

98
b

104a
0.25

918

106

b

b
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Table 6.4 (continued)
SEM

0.03
68.5

10.3

6.1

0.71

72.9

9.9

7.8

0.91

0.031

34.3

7.21

6.1

0.83

0.040

4
Diet
Comme
rcial
ReCaP

1290

106

109

12.4a

0.26

957

111

100b

10.0

0.37

599a

1222

103

120

10.7b

0.27

944

106

118a

8.4

0.36

501b

91.4a

89

7.1

0.47

80

6.9

0.48

5.9

0.42

0.027

76.3
b

SEM

4.1
47.9

7.2

0.02
0.52

60.6

8.1

6.5

0.77

0.026

24.9

5.24

4
--------------------------------------------------------------------P-value-----------------------------------------------------------------------0.474 0.006 0.001 0.276 0.590 0.983 0.011
0.833 0.003 0.834 0.007 0.001 0.031
0.020

In ovo

0.023

Diet

0.166

0.681

0.063

0.032

0.734

0.834

0.560

0.019

0.074

0.490

0.017

0.049

0.115

0.827

0.701

In ovo x Diet

0.606

0.773

0.608

0.672

0.361

0.939

0.541

0.983

0.103

0.117

0.698

0.949

0.820

0.585

0.830

a,b

Treatment means within the same column within effect with no common superscripts are significantly different
(P < 0.05).
1
Ratio of villus length to
crypt depth.
2
Villus surface area (VSA) calculated with average villus length and width = 2π × (width/2) × length.
3
Eggs injected with 50 μl commercial diluent at d 18 of incubation.
4
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation.
5
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg at d 18 of incubation.
6
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of incubation.
7
A diet restricted Ca and available P by 20% throughout the
rearing period.
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CHAPTER VII
EFFECTS OF THE IN OVO INJECTION OF VITAMIN D3 AND 25HYDROXYVITAMIN D3 ON THE PERFORMANCE AND
CARCASS CHARACTERISTICS OF ROSS 708
BROILERS CHALLENGED
WITH COCCIDIOSIS
7.1

ABSTRACT
The effects of the in ovo administration of vitamin D3 (D3) and its metabolite, 25-

hydroxyvitamin D3 (25OHD3), on broiler performance and breast meat yield after a
coccidiosis challenge were investigated. On each of 20 incubator tray levels, 50 live
embryonated Ross 708 broiler hatching eggs were randomly assigned to one of the
following 5 in ovo injection treatments at 18 d of incubation (doi): 1) non-injected; 2)
diluent; diluent containing either 3) 2.4 μg D3, 4) 2.4 μg 25OHD3, or 5) 2.4 μg D3 + 2.4
μg 25OHD3. A 50 μL solution volume was injected into each egg using an Inovoject
multi-egg injector. Hatch residue was analyzed, and hatchability of live embryonated
eggs and hatchling BW were determined. Four male chicks were randomly assigned to
each of 80 battery cages split over each of 2 rooms. Birds belonging to in ovo injected
treatments were challenged with a 20x live coccidial vaccine at 14 d of age (doa).
Therefore, in each room, 8 replicate cages were randomly allocated to each of 4 in ovo
injection treatments. One bird from each of 4 replicate cages was randomly selected for
coccidiosis lesion scoring before and 2 wk after challenge (14 and 28 doa, respectively).
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Mean BW, BW gain (BWG), and feed intake, as well as feed conversion ratio (FCR)
were determined for all birds from 0 to 14, 15 to 28, and 29 to 41 doa. At 42 doa,
approximately 3 birds from each replicate cage were processed for determination of
carcass weight, and the absolute and relative (% of carcass weight) weights of their
carcass parts. Across challenge treatment, birds belonging to the 25OHD3 alone treatment
group experienced an increase in BWG between 29 to 41 doa when compared to the D 3or diluent-injected birds. Furthermore, at processing, pectoralis major percentage
(P=0.059) tended to increase in birds belonging to the 25OHD3 alone treatment in
comparison to birds in the D3- or diluent-injected treatments. These results indicate that
regardless of challenge treatment, 2.4 μg of 25OHD3 exhibited a potential to increase the
BWG and breast meat yield of birds relative to those that only received an injection of
commercial diluent.
Key words: vitamin D source, in ovo injection, coccidiosis, broiler performance,
breast meat yield
7.2

INTRODUCTION
Coccidiosis is the major parasitic disease affecting poultry and results in severe

economic loss due to severe reductions in feed utilization and BW gain (Ritzi et al.,
2014). Increased oxidative stress has been reported in birds infected by coccidiosis
(Georgieva et al., 2006) which can lead to a reduction in the fat-soluble vitamin status,
including that of vitamin D in mammals (Lee, 2018) and poultry (Morris et al., 2015).
Vitamin D3 is mainly absorbed via diffusion into enterocytes residing in the duodenum
and upper jejunum (Borel, 2003). Vitamin D3 absorption is facilitated by the formation of
aggregates called micelles, along with other lipophilic food components. These are then
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transported to the liver as portomicrons (Elaroussi et al. 1994; Cooke and Haddad, 1989).
Vitamin D3 must undergo two sequential hydroxylation steps to become active. The first
hydroxylation occurs through 25-hydroxylase activity in liver microsomes and
mitochondria. This first hydroxylation produces 25-hydroxycholecalciferol (25OHD3).
Later, 25OHD3 is hydroxylated to 1,25-dihydroxyvitamin D3 (1,25(OH)2 D3) by 1αhydroxylase in the kidney (Henry, 1980).
Vitamin D3 sources are capable of accelerating calcium (Ca) absorption through
increased calbindin activity. Calbindin is involved in intestinal intracellular Ca transport
and its expression occurs in the intestine and kidney. Calbindin activity in chickens is
regulated by 1,25(OH)2 D3 (Hall and Norman 1990; Ferrari et al, 1992). In comparison to
vitamin D3 at the same level of inclusion, dietary 25OHD3 provided at a dosage of 69
μg/kg increased the expression of calbindin after 6 h (Hsiao et al., 2018). Although the
enzyme 1 α-hydroxylase is mainly expressed in renal cells, it is also expressed in muscle
cells and macrophages (Shanmugasundaram and Selvaraj, 2012), and its activity causes
the inhibition of Eimeria tenella replication (Morris and Selvaraj, 2014). It is well
documented that dietary 25OHD3 reduces the pro-inflammatory response (IL-1β) and
increases anti-inflammatory (IL-10) cytokine levels, leading to increases in the BW gain
of layers during a coccidiosis infection (Morris et al., 2014). These results indicate that
vitamin D3 sources have the potential to reduce the negative effects caused by a
coccidiosis infection. The dietary effects of various forms of vitamin D3 on broiler
performance during a coccidiosis infection are well understood. However, the influence
of the in ovo injection of various vitamin D3 sources on these effects before hatch have
to-date not been investigated. Therefore, the objective of this study was to determine the
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effects of the in ovo administration of D3 and its metabolite, 25OHD3, on broiler
performance and breast meat yield after a coccidiosis challenge.
7.3

MATERIAL AND METHODS

7.3.1

EXPERIMENT DESIGN AND EGG INCUBATION

This study was conducted according to a protocol approved by the Institutional
Animal Care and Use Committee of Mississippi State University. Fifty eggs were
assigned to each of 5 pre-assigned treatment groups (trays) on each of 20 incubator tray
levels (replicate blocks) in a Chick Master Incubator (Chick Master Incubator Company,
Medina, Ohio) set at 37.5 °C dry bulb and 29 °C wet bulb temperatures. The same
incubator served as both a setter and hatcher unit. Positional effects were removed by rerandomizing all treatments between each incubator level. Incubator air temperature and
relative humidity were recorded every 15 min using HOBO ZW Series wireless data
loggers (Onset Computer Corporation, Bourne, MA) during the 21 d of incubation (doi)
period. At 18 doi, 50 μL solution volumes of pre-specified treatments were injected into
eggs using a Zoetis Inovoject m (Zoetis Animal Health, Research Triangle Park, NC) in
ovo injection machine. The in ovo injection treatments were: 1) non-injected; 2) diluent
(control; 50 μL of commercial diluent); 3) D3 (50 μL of commercial diluent containing
2.4 μg D3); 4) 25OHD3 (50 μL of commercial diluent containing 2.4 μg 25OHD3); and 5)
D3+25OHD3 (50 μL of commercial diluent containing 2.4 μg of D3 and 25OHD3). All in
ovo injection solutions were prepared and injected according to the procedure of Chapter
3.
After injection, eggs were transferred to hatching baskets that were arranged in the
hatcher unit to coincide with the arrangement of the trays for each respective treatment
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replicate in the setter unit. At hatch, all chicks belonging to a replicate basket in each
treatment group were weighed and counted to determine hatchling BW and the
hatchability of injected live embryonated eggs. Also, hatch residue was analyzed as
described by Sokale et al. (2016). All chicks were feather-sexed to select for male
broilers in their pre-specified treatment, and then male chicks from each replicate basket
were pooled within their respective treatment group. Four male chicks were randomly
selected from each pooled treatment group, and were weighed and placed in each of 8
replicate isolated wire-floored battery cages in each of 2 separate rooms of a lightcontrolled research facility (320 total birds). All birds received ad libitum water and a
Mississippi State University basal corn-soybean diet formulated to meet Ross 708
commercial guidelines (Aviagen, 2014) throughout the 41 d of age (doa) period. The diet
composition was identical to the diets presented in Chapter 4 (Table 4.1).
7.3.2

GROWTH PERFORMANCE
All birds were fed a starter diet from 0 to 14 doa, a grower diet from 15 to 28 doa,

and a finisher diet from 29 to 41 doa. The BW, BW gain, average daily gain (ADG), feed
intake (FI), and average daily FI (ADFI) of the birds were determined in each dietary
phase. Percentage mortality and feed conversion ratio (FCR; g feed/g gain) adjusted for
bird mortality, were calculated for the same time periods.
7.3.3

CHALLENGE AND LESION SCORE
At 14 doa, the chicks that belonged to the diluent, D3, 25OHD3, and D3 +

25OHD3 treatment groups were challenged by oral gavage with a 20× dose of a
commercial coccidial vaccine containing live oocysts of Eimeria acervulina, E. maxima,
E. mivati, and E. tenella (Coccivac-B52, Intervet Inc. Omaha, NE), that was diluted in 1
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mL of distilled water. Coccidial lesions in the duodenum, jejunum, ileum, and ceca were
determined at 14 and 28 doa, as described by Johnson and Reid (1970). A score of 0 were
considered normal (no lesion), a score of 1 was considered mild, a score of 2 was
considered moderate, and a score of 3 was considered as a severe lesion of an Emeria
infection. The fecal sample from each of 8 replicate cages in each room that belonged to
the diluent, D3, 25OHD3, and D3 + 25OHD3 treatment groups were collected for oocyst
count analysis at 7 and 14 d post coccidiosis challenge (21 and 28 doa, respectively). The
sporulated oocysts were counted in each 1.0 ml of solution using the hemocytometer
method described by Holdsworth et al. (2004). Fecal samples from 4 replicate cages were
also randomly collected at 21 and 28 doa from the non-injected and unchallenged
treatment group for oocyst count analysis for comparative purpose in order to confirm
success of the coccidiosis challenge.
7.3.4

PROCESSING
The birds that remained in each pen (approximately 47 birds/treatment) were

processed at 42 doa according to the method described by Wang et al. (2018). Weights of
the whole carcass, pectoralis (P) major and P. minor muscles, and drumsticks, thigh, and
wing parts were determined. Parts yields were calculated as percentages of carcass
weight.
7.3.5

STATISTICAL ANALYSIS

The experimental design was a randomized complete block for both the hatch and
rearing periods. Incubator level in the setter and hatcher served as the unit of treatment
replication for the hatch data, and battery cage as the unit of treatment replication for the
performance, meat yield, and coccidiosis lesion scoring data. Room was the blocking
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factor for the grow out phase of the experiment. All data was analyzed by one-way
ANOVA. The non-injected control group was not subjected to a coccidiosis challenge at
14 doa, as were the 4 in ovo-injected treatment groups. Therefore, there were 5 in ovo
injection treatments for the incubation and grow out periods from 0 to 14 doa, but there
were only 4 in ovo injection treatments for the grow out period from 15 to 42 doa. All
data was analyzed using the procedure for linear mixed models (PROC GLIMMIX) of
SAS 9.4© (SAS Institute, 2013). Differences were considered significant at P< 0.05. The
following model was used for analysis of the incubation and posthatch data:
Yij = μ + Bi+ Tj + Eij,

(7.1)

Where μ was the population mean; Bi was the block factor (i = 1 or 2); Tj was the
effect of each in ovo injection treatments (j = number of treatments); and Eij was the
residual error.
7.4

RESULTS
No significant treatment differences were observed for the hatch and broiler

performance measurements from 0 to 28 doa and 0 to 41 doa (Tables 7.1 and 7.2).
Furthermore, in coccidiosis-challenged birds, in ovo treatment had no significant effect
on broiler performance between 15 and 28 doa. However, coccidiosis-challenged birds
injected with 2.4 μg of 25OHD3 had a higher BWG and ADG between 29 to 41 doa in
comparison to those injected with diluent or D3 alone (Table 7.2).
No coccidiosis lesions were observed in any intestinal section before challenge at 14
doa. Furthermore, at 28 doa, there were no significant treatment differences for E.
acervulina and maxima lesion scores in the duodenum, jejunum, and ileum intestinal
sections (Table 7.3). No coccidia oocysts were observed in the fecal samples taken from
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the non-injected and unchallenged birds at 21 and 28 doa. Conversely, in challenged
birds, fecal oocyst counts ranged from 93 to 121 per g of feces at 21 doa and from 59 to
81 per g of feces at 28 doa, depending on in ovo injection treatment (Fig 7.1).
Nevertheless, there were no significant in ovo injection treatment differences for the
intestinal coccidia counts at both 7 and 14 d post coccidiosis challenge (Fig 7.1).
Carcass weight and the relative weights of the P. major and P. minor muscles, as well
as the process parts of birds challenged with coccidiosis, were not significantly affected
by in ovo injection treatment. However, the effects of in ovo injection treatment
approached significance for carcass weight (P=0.058) and relative P. major muscle
weight (P=0.059). Coccidiosis-challenged birds that received 25OHD3 alone tended to
have a higher carcass weight in comparison to those that were injected with diluent or D 3
alone. Additionally, in ovo injection of 25OHD3 alone tended to increase relative P.
major muscle weight when compared to the injection of diluent or D3 alone (Table 7.4).
7.5

DISCUSSION
The objective of this study was to determine effects of the in ovo injection of 2

vitamin D3 sources on hatching and grow out broiler performance through 14 doa, as well
as their effects on the grow out performance, meat yield, and incidence of coccidiosis
lesions in coccidiosis-challenged birds from 15 to 42 doa. Fat absorption in the small
intestine is reduced during a coccidiosis infection (Adams et al., 1996). In addition, liver
functionality is reduced in response to severe Emeria infection (Ali, 1997). Vitamin D3 a
fat-soluble vitamin whose absorption is facilitated by the formation of micelles and the
presence of bile salts (Garrett and Young, 1975). Vitamin D3 is predominantly converted
to 25OHD3 in the hepatic cells (Booth et al., 1985), with lower rates of conversion
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occurring in the intestine, kidney (Norman, 1987), and skin (Hansdottir et al., 2008), in
response to 25-hydroxlase. This information indicates that vitamin D requirements may
increase during a coccidiosis infection (Morris et al., 2015). Coccidiosis is a parasitic
disease, mainly affecting the intestinal tract of many species, including chickens.
Subclinical coccidiosis results in decreases in BW and feed intake, and increases in the
FCR of broiler chickens (Amerah and Ravindran, 2015). Coccidiosis has been also shown
to inhibit small intestine morphological development (Sharma et al., 2015), cellular
immunity, and inflammatory responses (Morris et al., 2015) in chickens. A decline in
small intestine morphological development in response to a coccidiosis infection is
associated with impaired broiler performance (Wang et al., 2019). In addition to this, a
lower BWG due to a coccidiosis infection has been linked to an increase in the
inflammatory response of broilers (Morris et al., 2015). In agreement with the results of
this study, a coccidiosis challenge has been shown to result in impaired broiler
performance (Wang et al., 2019; Amerah and Ravindran, 2015).
Comparison of the fecal oocyst counts between the unchallenged and challenged
birds showed that under the housing conditions in this study, fecal oocysts were only
observed in those birds that received a coccidiosis vaccine challenge, and that overall
counts across injection treatment were reduced between 21 and 28 doa, indicating a lack
of oocyst cycling. These current results reflect those of Shanmugasundaram et al. (2019),
who likewise observed similar fecal oocyst count in Turkey that had received on oral
coccidiosis vaccine and were housed in suspended cages. Conversely, Sokale et al.
(2016) observed that the fecal oocyst shedding continued when birds were house in floor
pens containing used litter.
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Shanmugasundaram et al. (2019) further reported that 25OHD3 at110 μg/kg feed
reduced fecal oocyst counts 5 d after a coccidial vaccine challenge in turkeys. The
occurrence of fewer oocysts in the feces is associated with a decrease in coccidiosis
lesion scores and improved broiler performance (Ritzi et al., 2014). Nevertheless, vitamin
D3 sources in ovo injected treatments did not affect oocyst shedding at 7 or 14 d post
challenge. The differing results between the current and previous studies could be due the
different methods of 25OHD3 administration (in ovo injection vs dietary
supplementation), differences in the levels of administered of 25OHD3 (5 μg vs 110 μg),
and differences in the species of bird (broilers vs turkey) used. Among the various
vitamin D3 sources, 25OHD3 has been reported to be the more potent form for chickens,
because it has a longer half-life (approximately 15 d) in comparison to the other forms of
vitamin D3 (Mawer et al., 1969; Jones et al., 2014). It is also less toxic in comparison to
1,25(OH)2 D3 (Pesti and Shivaprasad, 2010), and does not require liver hydroxylation. In
comparison to D3, 25OHD3 is more efficiently absorbed due to its greater polarity (Bar et
al., 1980), and at the same level of inclusion, 25OHD3 increased performance (Yarger et
al., 1995), protein synthesis, and breast muscle yield (Vignale et al., 2015) in broilers.
Furthermore, dietary 25OHD3 increased the BWG of broilers challenged with coccidiosis
(Morris et al., 2015; Leyva-Jimenez et al., 2019). In addition, when compared to the in
ovo injection of D3 or diluent alone, the in ovo injection of 2.4 of μg of 25OHD3 has been
shown to increase the breast meat yield (Chapter 5), and improve the small intestine
morphology and immunity (Chapter 6) of Ross 708 broilers. In the current study, the in
ovo injection of 25OHD3 resulted in an increase in the BWG and ADG of Ross 708
broilers when compared to the injection of diluent alone. Therefore, increased
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performance of the Ross 708 broilers in response to the in ovo injection of 25OHD3 may
be due to its moderation of the negative effects caused by coccidiosis.
In addition to its effects on performance, a reduction in breast meat yield of
coccidiosis- challenged birds was observed in this study. Wang et al. (2019) reported that
reductions in the breast meat yield of coccidiosis-challenged broilers can be linked to
decreases in their intestinal villus height to crypt depth ratios (RVC). Also, increased
RVC is associated with increased nutrient absorption such as glucose (Awad et al., 2008).
The small intestine morphological findings observed in the companion study in Chapter
6, in which the same birds were used, revealed that the in ovo injection of 25OHD3
increased the villus height to crypt depth ratios of the birds when compared to the in ovo
injection of diluent or D3 alone. In addition to small intestine morphology, a reduction in
meat yield caused by coccidiosis can be due to morphological changes in breast muscle
fillets. A subclinical Eimeria infection has been observed to result in a decrease in muscle
fiber cross-sectional area (Chodová et al., 2018) and an increase in plasma levels of 3methyl histidine, which is associated with muscle breakdown (Fetterer and Allen, 2001).
Dietary 25OHD3 increased muscle fiber cross-sectional area (Hutton et al., 2014), which
can subsequently result in an increase in breast meat yield (Vignale et al., 2015) in
broilers. In chickens, 1α-hydroxylase and 24-hydroxylase are both expressed in high
amounts (Shanmugasundaram and Selvaraj, 2012), with 1α-hydroxylase converting
25OHD3 to the active hormone, 1,25(OH)2 D3. Subsequently, 1,25(OH)2 D3 is converted
to the inactive form of vitamin D, 24,25-dihydroxyvitamin D3, by 24-hydroxylase (Jones
et al., 2012). The expression of 1α-hydroxylase was shown to remain constant, whereas
the expression of 24-hydroxylase was reduced in chicken breast muscle during an
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inflammatory response (Jones et al., 2012). These results indicated that 25OHD 3 has a
greater impact on breast meat yield in comparison to the in ovo injection of D3 alone.
Thus, the improvement in small intestine morphology might have been a partial reason
for the increase in the BWG and breast meat yield of the broilers that received 25OHD3
alone during a coccidiosis challenge. However, further research is required determine the
expression of 1α-hydroxylase and 24-hydroxylase during a coccidiosis challenge in birds
received in ovo-injected vitamin D3 sources.
In conclusion, the impact of the in ovo injection of 2.4 μg of D3 and 25OHD3 on
broiler performance and meat yield of Ross 708 broilers before and after a coccidiosis
challenge was investigated. Our findings revealed that a coccidiosis challenge resulted in
a decline in broiler performance and to some extend a decrease in breast meat yield.
Nevertheless, regardless of challenge treatment, 2.4 μg of 25OHD3 exhibited a potential
to increase the BWG and breast meat yield of birds relative to those that only received an
injection of commercial diluent. The increase in breast meat yield and performance of
Ross 708 broilers in response to the in ovo injection of 2.4 μg of 25OHD3 may be due to
its longer-half life, the greater expression of 1α-hydroxylase than 24-hydroxylase in
breast meat tissue, and improvements in their immunity and small intestine morphology
during a coccidiosis challenge. Further research is required to determine the effect of in
ovo injection of vitamin D3 sources on immunity, small intestine morphology and gene
expression of broilers during a coccidiosis challenge.
7.6
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Table 7.1

Effects of 50 μL volume treatment (non-injected; diluent-injected; injected
with 2.4 μg of vitamin D3 (D3) or 25-hydroxycholecalciferol (25OHD3);
and 2.4 μL of D3 and 25OHD3) on hatchability of injected live,
embryonated Ross 708 eggs, and hatch residue at 21 d of incubation (doi)

In ovo
injection
Treatment

Egg
weight
(g)

Egg
loss1
(%)

Hatchling
BW (g)

Hatchability
(%)

Live
pipped
(%)

Dead
pipped
(%)

Non-injected2

60.8

6.7

42.9

96.3

1.7

0

Diluent3

60.9

6.4

43.2

92.3

1.3

0

D34

61.1

6.3

43.5

97.3

0

0

25OHD35

61.4

6.4

43.2

94.9

1.8

0.6

D3+25OHD36
Pooled SEM
P-value

61.8
0.30
0.171

7.0
0.26
0.243

43.0
0.27
0.427

95.5
1.75
0.304

1.9
0.73
0.340

0
0.29
0.445

1

percentage of egg loss from 0 to 12 d of incubation.

2

Eggs that were not injected with no solution.

3

Eggs injected with 50 μl commercial diluent at d 18 of incubation.

4

Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation.

Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg at d 18 of incubation.
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of
incubation.
5
6
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Table 7.2

Effects of 50 μL volume treatment (non-injected; diluent-injected; injected
with 2.4 μg of vitamin D3 (D3) or 25-hydroxycholecalciferol (25OHD3); and
2.4 μL of D3 and 25OHD3) on Ross 708 broiler performance through 41 d of
age (doa)

In ovo injection
Treatment

BW
(g)

BWG1
(g)

ADG1
(g)
Starter (0 to 14 doa)
27.5

FI1
(g)

ADFI1
(g)

FCR1
(g/g)

496

35.4

1.29

Non-injected2

427

385

Diluent3

410

368

26.3

485

34.6

1.34

D34

405

363

25.9

488

34.8

1.35

25OHD35

421

378

27.0

497

35.5

1.32

D3+25OHD36
Pooled SEM
P-value

419
9.5
0.508
BW
(g)

376
14.2
0.489
BWG
(g)

36.6
1.08
0.330
ADFI
(g)

1.37
0.042
0.288
FCR
(g/g)

Diluent

1,390

980

116

1.67

D3

1,398

993

70.9

1,746

125

1.79

25OHD3

1,469

1048

74.8

1,702

122

1.63

D3+25OHD3
Pooled SEM
P-value

1,434
31.5
0.282
BW
(g)

1014
28.1
0.353

72.5
2.00
0.353

BWG (g)

ADG (g)

1,750
67.2
0.513
FI
(g)

125
4.8
0.512
ADFI
(g)

1.74
0.081
0.518
FCR
(g/g)

122
127

1.93
1.91

b

26.9
513
1.01
15.2
0.490
0.332
ADG
FI
(g)
(g)
Grower (15 to 28 doa)
70.0
1,623

Finisher (29 to 41 doa)
117b
2,870
b
119
2,954

D3

2,925
2,943

1523
1544b

25OHD3

3,096

1665a

128a

3,032

128

1.83

3,054
80.4
0.098
BW
(g)

ab

ab

3,041
115.2
0.578
FI
(g)

129
3.7
0.578
ADFI
(g)

1.88
0.091
0.730
FCR
(g/g)

Diluent

D3+25OHD3
Pooled SEM
P-value

1620
51.2
0.030
BWG
(g)

125
3.9
0.030
ADG
(g)
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Table 7.2 (continued)

Diluent

2,925

2881

0 to 41 doa
70.3

D3

2,943

2900

70.7

5,188

227

1.76

25OHD3

3,096

3053

74.5

5,232

233

1.68

D3+25OHD3
Pooled SEM
P-value

3,054
80.4
0.098

3011
83.0
0.100

73.4
1.43
0.100

5,304
145.5
0.431

234
5.0
0.578

1.74
0.063
0.741

a-b

4,977

226

1.70

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
1
BW gain (BWG), average daily gain (ADG), feed intake (FI), average daily feed intake (ADFI), and feed
conversion ratio (FCR).
2
Eggs that were not injected with any solution and also were not challenged with coccidiosis at 14 d of age.
3
Eggs injected with 50 μl commercial diluent at d 18 of incubation and also were challenged with a
coccidiosis at 14 doa.
4
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation and also
were challenged with coccidiosis at 14 doa.
5
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg at d 18 of incubation and also
were challenged with coccidiosis at 14 doa.
6
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of
incubation and also were challenged with coccidiosis at 14 doa.
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Table 7.3

Table 7.3 Effects of 50 μL volume treatment (non-injected; diluentinjected; injected with 2.4 μg of vitamin D 3 (D3) or 25hydroxycholecalciferol (25OHD3); and 2.4 μL of D3 and 25OHD3 on
Ross 708 broiler coccidiosis lesion scores at 28 d of age (doa)
Duodenum
Acervulina/ Mivati

In ovo
injection
Treatment

Score Score Score
0
1
2

1

Maxima2

Score
3

Score
0

Score
1

Score
2

Score 3

Diluent7

25.0

50.0

25.0

0.0

100.0

0.0

0.0

0.0

D38

37.5

50.0

0.0

25.0

75.0

12.5

12.5

0.0

25OHD39

37.5

25.0

37.5

0.0

87.5

12.5

0.0

0.0

D3+25OHD310 50.0
16.84
Pooled SEM
0.777
P-value

37.5

12.5

0.0

100.0

0.0

0.0

0.0

12.73
0.594

6.25
0.408

-

18.12 19.84
0.729 0.287

11.28
0.085

14.73
0.288
Jejunum

Diluent

Acervulina/ Mivati3
Score Score Score Score
0
1
2
3
75.0
12.5 12.5
0.0

Score
0
12.5

Maxima4
Score Score
1
2
50.0
37.5

D3

75.0

12.5

12.5

0.0

25.0

25.0

50.0

0.0

25OHD3

75.0

12.5

12.5

0.0

37.5

25.0

37.5

0.0

D3+25OHD3
Pooled SEM
P-value

75.0
23.32
1.000

25.0
0.0
18.87 15.50
0.882 0.807

0.0
-

37.5
18.87
0.666
Ileum

25.0
16.67
0.644

37.5
25.17
0.953

0.0
-

Diluent
D3

Acervulina/ Mivati3
Score Score Score Score
0
1
2
3
100
0.0
0.0
0.0
100
0.0
0.0
0.0

Score
0
12.5
25.0

Maxima5
Score Score
1
2
50.0
37.5
25.0
50.0

Score 3
0.0

Score 3
0.0
0.0

25OHD3

100

0.0

0.0

0.0

37.5

25.0

37.5

0.0

D3+25OHD3
Pooled SEM

100
-

0.0
-

0.0
-

0.0
-

37.5
16.45

25.0
23.57

37.5
26.52

0.0
-
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Table 7.3 (continued)
P-value

-

-

-

-

1

0.666

0.289

0.408

-

Eimeria acervulina/ mivati lesion score in the duodenum
Eimeria maxima lesion score in the duodenum
3
Eimeria acervulina lesion score in the jejunum
4
Eimeria maxima lesion score in the jejunum
5
Eimeria maxima lesion score in the ileum
6
Eimeria acervulina lesion score in the jejunum
7
Eggs injected with 50 μl commercial diluent at d 18 of incubation and also were challenged with
coccidiosis at 14 d of age.
8
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg/egg at d 18 of incubation
and also were challenged with coccidiosis at 14 d of age.
9
Eggs injected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg/egg at d 18 of incubation and
also were challenged with coccidiosis at 14 d of age.
10
Eggs injected with 50 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg/egg at d 18 of
incubation and also were challenged with coccidiosis at 14 d of age.
2
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Table 7.4

In ovo
injection
Treatment

Effects of 50 μL volume treatment (non-injected; diluent-injected; injected
with 2.4 μg of vitamin D3 (D3) or 25-hydroxycholecalciferol (25OHD3);
and 2.4 μL D3 and 25OHD3) on Ross 708 broiler carcass weight and
weights of pectoralis major (P-major) and minor (P-minor) muscle,
breast, wing, drumsticks, thighs, and fat pad parts relative to carcass weight
at 42 d of age (doa)
Carcas
s (kg)

Pmajor
(%)

Pminor
(%)

Breast
(%)

Wings
(%)

Drumstick
s (%)

Thigh
s (%)

Fat
(%)

Diluent1

2,062

28.2

5.72

33.9

10.7

13.5

17.4

1.54

D32

2,072

28.1

5.78

33.9

10.5

13.4

17.4

1.61

25OHD33
D3+25OHD3

2,168

30.0

5.85

35.9

10.6

13.4

17.3

1.55

2,153

29.2

5.64

34.8

10.3

13.1

16.7

1.58

48.0

2.87

0.130

0.89

0.19

0.25

0.36

0.058

0.059

0.540

0.085

0.563

0.632

0.434

4

Pooled SEM
P-value

0.08
3
0.93
7

Eggs injected with 50 μl commercial diluent at d 18 of incubation and also were challenged with
coccidiosis at 14 doa.
2
Eggs injected with 50 μl commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation and also
were challenged with coccidiosis at 14 doa.
3
Eggsinjected with 50 μl commercial diluent containing 25OHD3 at 2.4 μg at d 18 of incubation and also
were challenged with coccidiosis at 14 doa.
4
Eggs injected with 9550 μl commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of
incubation and also were challenged with coccidiosis at 14 doa.
1
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140

Diluent
D3

120

Fecal oocyst count (\g)

25OHD3
D3 + 25OHD3

100
80
60
40
20
0

21

28

d of age
Figure 7.1

Effects of 50 μL volume treatment (non-injected; diluent-injected; injected
with 2.4 μg of vitamin D3 (D3) or 25-hydroxycholecalciferol (25OHD3);
and 2.4 μL of D3 and 25OHD3 on Ross 708 broiler fecal oocyst counts at 7
and 14 post coccidiosis challenge [21 and 28 d of age (doa)]. P values: 21
doa, P= 0.153; 28 doa, P=0.235.
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CHAPTER VIII
REDUCTION IN INFLAMMATORY REACTION AND IMPROVEMENT IN SMALL
INTESTINE MORPHOLOGY OF ROSS 708 BROILERS IN RESPONSE TO THE IN
OVO INJECTION OF VARIOUS SOURCES OF VITAMIN D3 WHEN SUBJECTED
TO A COCCIDIOSIS CHALLENGE
8.1

ABSTRACT
The effects of the in ovo administration of D3 (D3) and 25-hydroxyvitamin D3

(25OHD3) on the small intestine morphology and inflammatory response in Ross 708
broilers subjected to a coccidiosis challenge were investigated. Live embryonated Ross
708 broiler hatching eggs were randomly assigned to one of the following 5 in ovo
injection treatments at 18 d of incubation (doi): 1) non-injected; 2) diluent; diluent
containing either 3) 2.4 μg D3; 4) 2.4 μg 25OHD3; or 5) 2.4 μg D3 + 2.4 μg 25OHD3. A
50 μL solution volume was injected into each egg using an Inovoject multi-egg injector.
At hatch, 4 male chicks were randomly assigned to each of 40 battery cages in each of 2
rooms. Only in ovo-injected treatments were challenged with a 20x live coccidial vaccine
dosage at 14 d of age (doa). Therefore, after 14 doa, 8 replicate cages were allocated to
only the diluent, D3, 25OHD3, and D3 + 25OHD3 treatment groups in each of the 2 rooms.
At 14 and 28 doa, one bird from each of 4 replicate cages in each in ovo injection
treatment group was randomly selected and its blood drawn for determination of plasma
IL-1β and nitric oxide levels. From the same birds, 2 cm of the middle section of the
duodenum, jejunum, and ileum were excised for histomorphological analysis, which
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included measurements of villus length, crypt depth, villus length to crypt depth ratio
(RVC), and villus surface area. At 28 doa, nitric oxide plasma levels were significantly
(P=0.028) decreased in the 25OHD3 alone-injected birds in comparison to the diluent or
D3-injected birds. At 14 doa, in ovo injection of 25OHD3 alone resulted in a higher
duodenal RVC in comparison to all other treatments. At 28 doa, th e in ovo injection of
25OHD3 alone resulted in a greater duodenal RVC in comparison to the diluent and D3
alone, and the D3 + 25OHD3 combination treatments. These results indicate that the in
ovo injection of 2.4 μg of 25OHD3 has the potential to improve the small intestine
morphology and inflammatory response of broilers during a coccidiosis challenge.
Keywords: In ovo injection, 25-hydroxyvitamin D3, small intestine morphology,
inflammatory response, and coccidiosis
8.2

INTRODUCTION
Coccidiosis is a parasitic infection that is considered as one of the main diseases

affecting the performance of poultry reared under intensive production systems.
Williams. (1999) estimated that total economic losses in the United Kingdom due to
coccidiosis is approximately 6.4 million GBP annually, and is the result of anticoccidial
drugs for the chicken. Chapman et al. (2009) assumed that these losses according to the

10-fold-larger poultry industry in the United States were about $127 million annually in
2009. Coccidiosis increases feed conversion ratio (FCR) and reduces feed intake and BW
gain (BWG) due to deteriorative impacts on the small intestine and immunity of chickens
(Sharma et al., 2015; Nabian et al., 2018). Birds testing positive for coccidiosis exhibit
massive infiltration of heterophils and mononuclear cells as well as severe damage to
intestinal villi. Morphological declines in the small intestine are due to
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pathomorphological alterations caused by coccidiosis. An increase in villus height is
associated with increased nutrient absorption (Onderci et al., 2006) and a deeper crypt is
the result of increased enterocyte epithelial cell turnover, which leads to increased gut
energy requirements (Yang et al., 2008). It has been shown that intestinal villus height to
the crypt depth ratio decreases during a coccidiosis infection (Wang et al., 2015).
Vitamin D3 and its metabolite, 25-hydroxyvitamin D3 (25OHD3), have been shown to
affect small intestine morphology, humoral immunity, and inflammatory responses in
broiler chickens (Chou et al., 2009; Morris et al., 2014, 2015). Vitamin D3 and 25OHD3
are multifunctional nutrients involved in calcium and phosphorus absorption (Bar et al.,
1980), bone metabolism and mineralization (Fritts and Waldroup, 2003), muscle
development (Vignale et al., 2015), immunity (Chou et al., 2009; Morris et al., 2014,
2015; Morris and Shanmugasundaram, 2014) and small intestine morphology (Chou et
al., 2009; Ding et al., 2011). In comparison to D3, 25OHD3 has been shown to be a more
effective promoter of the performance and immunity of broiler chickens during a
coccidiosis infection (Morris et al., 2014; Morris and Selvaraj, 2014). The BWG of
infected birds was increased in 25OHD3-fed birds relative to D3-fed birds, and the proinflammatory response decreased and anti-inflammatory response increased in infected
birds fed 25OHD3 in comparison to birds fed D3 at the same level of inclusion.
In ovo vaccination has been widely used in the broiler industry to promote the
immunity of broiler embryos and hatchlings (Williams, 2007). In addition, the in ovo
injection of various nutrients has been shown to increase antibody titer against Newcastle
disease (Abbasi et al., 2017), antioxidant capacity (El-Senousey et al., 2018; Zhang et al.,
2019), and villus to crypt depth ratio (Peebles et al., 2018) of broilers. Effects of the in
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ovo injection of the coccidiosis vaccine or vitamin D sources on broiler performance have
also been previously reported. In ovo injection of a 10X dose of the coccidiosis vaccine
has been shown to increase oocyst shedding (Sokale et al., 2016), and to decrease the
performance of 14 d of age (doa: Sokale et al., 2017) and 35 doa (Sokale et al., 2018)
posthatch broilers. Conversely, the in ovo injection of 25OHD3 has been shown to
increase the bone quality of male broilers (Bello et al, 2014). Additionally, preliminary
work in our laboratory suggests that increases in breast muscle yield (Chapter 5), and
humoral immune function and small intestine morphology (Chapter 6), may occur in
response to amniotic administration of 2.4 μg of 25OHD3 at 18 d of incubation (doi). The
impact of the in ovo injection of any nutrient or vaccine on the small intestine
morphology and immunity of chickens subjected to a coccidiosis challenge has not been
previously reported. Therefore, the objective of this study was to determine the effects of
the in ovo administration of D3 and 25OHD3 on the small intestine morphology and
inflammatory response of broilers when challenged by coccidiosis.
8.3
8.3.1

MATERIAL AND METHODS
EXPERIMENTAL AND INCUBATION CONDITIONS
A ll experimental procedures were approved by the Institutional Animal Care and

Use Committee of Mississippi State University. Fertile broiler hatching eggs laid by Ross
708 breeder hens at 35 wk of age were obtained from a commercial source and stored for
24 h. A total of 1,000 eggs were set and incubated in a Chick Master Incubator (Chick
Master Incubator Company, Medina, Ohio) under standard conditions (37.5 ◦C and 29.4◦C
dry and wet bulb temperatures, respectively). Fifty eggs were allocated to each of 5 preassigned treatment groups on each of 20 incubator tray levels (blocks). In ovo injection
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treatments were prepared according to procedures presented by Chapter 3. Treatment
solutions were injected into the amniotic sac of corresponding eggs at 18 doi using a
Zoetis Inovoject m (Zoetis, Parsippany, NJ) in ovo injection machine. Eggs were
subjected to one of the following injection treatments: 1) non-injected; 2) diluent
(control; 50 μL of commercial diluent); 3) D3 (50 μL of commercial diluent containing
2.4 μg D3); 4) 25OHD3 (50 μL of commercial diluent containing 2.4 μg 25OHD3); and 5)
D3 + 25OHD3 (50 μL of commercial diluent containing 2.4 μg D 3 and 2.4 μg 25OHD3).
At hatch, 4 male broilers were randomly placed in each of 8 replicate isolated wirefloored battery cages belonging to each treatment group in each of 2 separate rooms of a
light-controlled research facility (320 total birds). Environmental temperature and light
settings were maintained as specified by Ross 708 recommendations (Aviagen, 2014).
Chicks had ad libitum access to feed and fresh water. Mississippi State University basal
corn-soybean diets formulated to Ross 708 commercial guidelines (Aviagen, 2014) were
fed as crumbles from 0 to 14 doa and then as pellets from 15 to 41 doa. The diet
composition was identical to the diets presented in Chapter 4 (Table 4.1).
8.3.2

COCCIDIOSIS CHALLENGE AND SAMPLING
At 14 doa, birds in the 8 replicate battery cages belonging to only the diluent, D3,

25OHD3, and D3 + 25OHD3 treatments in each room were orally challenged with a 20X
coccidiosis vaccine (Coccivac-B52, Intervet Inc. Omaha, NE) containing Eimeria
acervulina, maxima, mivati, and tenella oocysts suspended in 1 mL of distilled water to
induce a coccidial infection. The chicks in the uninjected treatment group were left
unchallenged. At 14 and 28 doa, one bird from each of 4 replicate cages in each treatment
group in each room (40 total birds) was weighed and then sampled as described below.
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8.3.3

IMMUNOLOGICAL ASSESSMENT
Blood samples were collected from each sampled bird at the times specified and

from the number of birds as previously described. Plasma was subsequently extracted and
IL-1β concentrations were determined by ELISA according to the manufacturer’s
protocol [Chicken interleukin 1 beta (IL-1β); MyBioSource, San Diego, CA]. Duplicate
tubes, each containing a 100 μl volume of either IL-1β standard or plasma samples, were
loaded to IL-1β monoclonal antibody precoated ELISA plates. Plates were incubated at
37℃ for 90 min with capture antibody. Plates were washed 2 times with wash solution
(50 mM Tris-buffered saline, 0.14 M NaCl, 0.05% Tween 20, pH 8.0) and 100 μl of
biotinylated chicken IL-1β antibody was added to each cell and plates were incubated at
37℃ for 60 min. Plates were washed 3 times with wash solution and 100 μl of avidinperoxidase conjugates was added to each well in order to use Tetramethylbenzidine
substrate for coloring after reactant thoroughly washed out by Phosphate-buffered saline
or tris-buffered saline . Plates were incubated at 37℃ for 30 min and were subsequently
washed 5 times with wash solution. A 100 μl of color reagent was added to each well in
order to cause a blue color in samples and they were then incubated in a dark incubator at
37℃ for 30 min. Finally, samples turned to a yellow color under the action of 100 μl of a
stop solution. Plasma nitric oxide (NO) concentration was determined according to
Bowen et al. (2007). Optical density (OD) at 450 nm (OD450) for IL-1β and NO was
measured with a SpectraMax M5 Microplate Reader (Molecular Devices, California,
USA).
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8.3.4

SMALL INTESTINE MORPHOLOGY

Intestine samples were collected from each sampled bird at the times specified and
from the number of birds as previously described. Tissue samples (2 cm) were obtained
from the midpoint of the duodenum, jejunum, and ileum and fixed in 10% formalin for
subsequent morphological examination. Later, intestinal samples were gradually
dehydrated and embedded in paraffin for slide preparation. The slides used for
histomorphological analysis were prepared according to the procedures of Wang et al.
(2015). Histomorphological analysis was performed using a light microscope at 40X
magnification (Micromaster, Fisher Scientific, Pittsburgh, PA) and following the method
described by Fasina et al. (2010). Microscopic images were measured using ImageJ
software (Wayne Rasband, NIMH, Bethesda, MD). Duodenum, jejunum, and ileum villus
length (VL), crypt depth (CD), villus length to crypt depth ratio (RVC), and villus
surface area (VSA) were measured as described by Nain et al. (2012).
Each slide contained all intestinal sections for each bird. On each slide, measurements
were made at 3 different locations within each intestinal section, and the mean values
across the 3 different locations were used for statistical analysis. Villus height was
considered as the distance from the tip to the base of the lamina propria, villus width
(VW) was measured between the top third and bottom third of the villus, and CD was
measured from the base of the villus to the top of the mucosal layer. The RVC was
calculated by dividing VL by CD. Villus surface area (VSA) for all intestinal sections
was calculated following the formula presented below by Nain et al. (2012).
VSA = 2π × (average VW/2) × VL;
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where average VW is the average of 6 measurements per bird (2 VW measurements
from the three sample sections examined on each slide).
8.3.5

STATISTICAL ANALYSIS

The experimental design was a randomized complete block and experimental unit
was the wire-floored battery cage for all immunological and small intestine morphology
data. Room was the blocking factor with all treatments randomly represented in each of
the 2 blocks. All data were analyzed by one-way ANOVA. The non-injected control
group was not challenged with coccidiosis at 14 doa, whereas the 4 in ovo-injected
treatment groups were subjected to a coccidiosis challenge. Therefore, there were 5 in
ovo injection treatments in the pre-challenge period from 0 to 14 doa, and there were only
4 in ovo injection treatments for the post-challenge period from 15 to 42 doa. All data
was analyzed using the procedure for linear mixed models (PROC GLIMMI) of SAS
9.4© (SAS Institute, 2013). Differences were considered significant at P< 0.05. The
following model was used for analysis of the data:
Yij = μ + Bi + T j + Eij,

(8.1)

Where μ was the population mean; Bi was the block factor (i = 1 to 2); Tj was the
effect of in ovo injection treatment (j = 1 to 4 or 5); Eij was the residual error.
8.4
8.4.1

RESULTS
CARCASS CHARACTERISTICS
No significant treatment differences were observed for bird BW, the lengths of

the duodenum, jejunum, and ileum, and the relative weights of the organs at 14 doa.
However, at 14 doa, ceca length was longer for birds in the D3 + 25OHD3 treatment
group in comparison to all other treatment groups, was longer in the 25OHD3 group in
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comparison to the D3, diluent, and non-injected groups, was longer in the D3 treatment
group compared to both control groups, and was longer in the diluent-injected compared
to the non-injected control group (Table 8.1). Also, birds that received 25OHD3 alone
tended (P=0.055) to have a higher relative spleen weight as compared to those belonging
to the non-injected and D3 + 25OHD3-injected treatments. At 28 d or 2 wk postchallenge, no significant treatment differences were observed for bird BW, the lengths of
the duodenum, jejunum, and ileum, and the relative weight of the intestinal sections as
well as the spleen and liver (Table 8.1). Additionally, birds injected with D3 or 25OHD3
alone had longer ceca as compared to those that received diluent alone, with the D3 +
25OHD3 group being intermediate at 28 doa. Furthermore, the in ovo injection of
25OHD3, D3, or D3 + 25OHD3 increased relative bursa weight in the challenged birds at
28 doa in comparison to the diluent-injected controls (Table 8.1).
8.4.2

INFLAMMATORY RESPONSE
No treatment differences were observed for IL-1β concentrations among

treatments before and after coccidiosis infection (Table 8. 2). However, the in ovo
injection of 25OHD3 alone decreased plasma NO concentrations in comparison to all
other challenge treatments at 28 doa.
8.4.3

SMALL INTESTINE MORPHOLOGY
At 14 doa, in ovo injection of 25OHD3 alone resulted in a higher duodenal and

ileal RVC as compared to all other treatments, and birds injected with D3 + 25OHD3 had
a higher RVC as compared to those belonging to the non-injected treatment group. Also,
a greater jejunal RVC was observed in birds injected with 25OHD3 alone in comparison
to those belonging to the non-injected and D3 alone treatments (Table 8.3). The in ovo
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injection of 25OHD3 alone tended (P=0.056) to decrease CD in the jejunum comparison
to the D3-injected treatment group (Table 3). At 28 doa, duodenal VL and RVC
increased in birds injected with 25OHD3 alone when compared to all other challenge
treatment groups (Table 8.4). At the same day, the in ovo injection of 25OHD3 alone also
increased ileal RVC in comparison to D3- or diluent-injected treatments, and birds
injected with D3 +25OHD3 had a higher RVC in comparison to those that received D3
alone. Birds that received 25OHD3 alone tended (P=0.056) to have a higher VL when
compared to those injected with diluent or D3 alone, and D3 alone tended (P=0.054) to
increase ileal CD in comparison to all other challenge treatments at 28 doa (Table 8.4).
8.5

DISCUSSION
The objectives of this study were to investigate the impacts of the in ovo injection of

2 vitamin D sources on small intestine morphology and the inflammatory response of
broilers during a coccidiosis challenge. Coccidiosis is economically the most important
disease affecting the performance of poultry reared under intensive production systems
(Jones et al., 2019). In poultry, most coccidiosis species belong to the
genus Eimeria and infect various sites in the intestine (Price, 2012). The infectious
process is quick (4 to7 days) and is identified by parasite replication in host cells with
extensive damage to the intestinal mucosa (Chapman et al., 2005). Poultry coccidia are
generally host-specific, and the different species are localized in specific parts of the
intestine (Price, 2012). In poultry, coccidiosis increases villus atrophy, crypt
hyperplasia (Morris et al., 2004) and leukocyte infiltration (Gadde et al., 2011). In
addition, coccidiosis degrades small intestine morphology by decreasing VL (Kim et al.,
2017), RVC (Morris et al., 2004; Kim et al., 2017), and increasing CD (Wang et al.,
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2014). An increase in VL is associated with increased intestinal absorptive surface area,
leading to increased nutrient absorption (Onderci et al., 2006). Furthermore, an increase
in intestinal epithelial cell turnover is associated with an increased rate of cell
proliferation and migration, leading to a greater CD (Boshuizen et al., 2003) and
increased gut energy requirement (Wang et al., 2018). Before a coccidiosis challenge, the
in ovo injection of 2.4 μg of 25OHD3 resulted in a higher RVC in all intestinal sections
and a shallower CD in the duodenum and ileum when compared with all the other
treatments employed. After challenge, the effectiveness of the 25OHD3 treatment
remained constant in comparison to the other in ovo treatments. Previous studies have
demonstrated that in comparison to D3 at the same level dietary inclusion, 25OHD3
increased VL and decreased CD when used in broiler diets (Chou et al., 2009).
Additionally, VL increased in embryos and newly-hatched broiler chicks in response to
supplemental 25OHD3 in maternal diets (Ding et al., 2011). Furthermore, improvements
in small intestine morphology have also been reported in response to the in ovo injection
of 2.4 μg of 25OHD3 (Chapter 6). The greater response to 25OHD3 may be due to an
increase in the intestinal expression of 1α-hydroxylase and vitamin D3 receptors (VDR;
Panda et al., 2001). The enzyme, 1α-hydroxylase, converts 25OHD3 to the active form of
vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2 D3). Increased circulating levels of
1,25(OH)2 D3 alone or in combination with increased VDR expression leading to an
increase in breast meat yield (Vignale et al., 2015), improvements in intestinal
development (Shinki et al., 1985), and a reduction in inflammatory response (Shojadoost
et al., 2015) in chickens. It is also worth mentioning that the expression of 1αhydroxylase remained constant in breast and kidney, but the amount of 24-hydroxylase
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was reduced during systemic inflammation (Shanmugasundaram and Selvaraj, 2012).
The 24-hydroxylase converts 25OHD3 to 24, 25-dihydroxyvitamin D3 which is being 500
to 1000 times less active as compared to 1,25(OH)2 D3 (Rosol et al., 2000). Therefore, an
increased the level of 24-hydroxylase can result in lower levels of the active form of
vitamin D3. Coccidiosis has been shown to cause systemic inflammation in broiler
chickens (Morris et al., 2014). These data indicates that the rate of conversion of 25OHD3
to the active form via1α-hydroxylase in breast and kidney tissues may not be reduced
during systemic inflammation in response to diseases such as coccidiosis. Therefore, the
improvement in small intestine morphology in response to 25OHD3 alone during a
coccidiosis infection might have been due to adequate expression of 1α-hydroxylase and
a subsequent reduction in inflammatory response. However, further research is required
to identify the intestinal expression of 1α-hydroxylase and 24- hydroxylase in response to
in ovo injection of vitamin D3 sources during a coccidiosis infection.
In the current study, the in ovo injection of 25OHD3 alone reduced NO production
during a coccidiosis challenge. Nitric oxide is an important indicator of an inflammatory
response, and is produced by the oxidation of L-arginine by the action of NO synthase
(MacMicking et al., 1997). Increased level of inducible NO synthase is considered to be
of primary importance in immune and inflammatory responses (MacMicking et al.,
1997). The gene expression of cytokines such as IL-1β, IL-12, interferon-γ, or tumor
necrosis factor increases the production of NO (Stuehr and Marletta, 1989). In addition,
serum concentrations of NO increase during an Eimeria infections in chickens (Lillehoj
and Li, 2004). In comparison to dietary vitamin D3 at the same level of inclusion, dietary
25OHD3 reduced pro-inflammatory and increased anti-inflammatory gene activity during
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a coccidiosis infection (Morris and Selvaraj, 2014). In addition, 25OHD3 has an
immunoregulatory effect on T-cells during a coccidiosis infection. Dietary 25OHD3
increases the number of CD4+CD25+ regulatory T (T-reg) cells in mucosal regions, such
as the cecal tonsils, of Eimeria-infected chickens in comparison to uninfected chickens
(Morris et al., 2015) leading to reduced inflammation. These results indicate that
25OHD3 has the potential to reduce inflmmation caused by a coccidiosis infection. A
decrease in inflammation has also been shown to be associated with an increase in the
BWG of the broilers challenged with coccidiosis (Morris et al., 2014). Broilers
challenged with a 20X coccidiosis vaccine dose (Coccivac-B52) had lower BWG, breast
meat yield, and RVC in comparison to unchallenged birds (Wang et al., 2019). An
increase in RVC is associated with increased the rate of nutrient absorption (Dailey,
2014). Thus, an improvement in the immunity and small intestine morphology of broilers
can increase breast meat yield and broiler performance. Furthermore, it was also observed
in a companion study that birds injected with 2.4 μg of 25OHD3 experienced a greater
BWG through 41 doa and an increase in relative pectoralis major weight at 42 doa in
comparison to birds that received an in ovo injection of D3 or diluent alone (Chapter 7).
Thus, the enhancement of small intestine morphology and inflammatory response in 2.4
μg of 25OHD3-injected birds might have been the basis for an increase in the breast meat
yield and performance of the broilers challenged with coccidiosis.
In conclusion, the objectives of this study were to determine the small intestine
morphology and inflammatory reaction of broilers in response to the in ovo injection of 2
vitamin D3 sources before and after a coccidiosis challenge. In comparison to birds that
received in ovo diluent and D3-injections, NO production decreased and RVC increased
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in birds that received an in ovo injection of 2.4 μg of 25OHD3 during a coccidiosis
infection. The current finding showed that coccidiosis has declined the small intestine
morphology and reduced inflammatory response of broilers. Therefore, these results
indicate that the in ovo injection of 2.4 μg of 25OHD3 may have a potential to reduce
inflammation and enhance small intestine morphology of broilers in response to a
coccidiosis infection. These benefits may have been due to the increased expression of
genes that contribute to improved immunity and intestinal development. Further research
is required to determine the regulatory effects of various vitamin D3 sources on the
immunity and intestinal development of broilers during a coccidiosis infection.
8.6
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Table 8.1

In ovo
injection
Treatment
Non-injected1

Diluent2
D33
25OHD34
D3+25OHD3
5

Pooled SEM
P-value
Diluent
D3
25OHD3
D3+25OHD3
Pooled SEM
P-value

Effects of non-injected eggs, diluent-injected (50 μL), and eggs injected 2.4 μg of vitamin D3 (D3), 25hydroxycholecalciferol (25OHD3; 50 μL), and 2.4 μg D3 and 25OHD3 μg (50 μL) on lengths of small intestine
sections, and weights of liver, spleen bursa, duodenum, jejunum, ceca, and ileum at 14 and 28 d of age (doa).
BW
(g)

Duodenum
length
(cm)

Jejunum
length
(cm)

Ileum
length
(cm)

Ceca
length
(cm)

Duodenum
weight
(%)

Jejunum
weight
(%)

Ileum
weight
(%)

Ceca
weight
(%)

Spleen
(%)

Bursa
(%)

Liver
(%)

424
433
399
416

20.3
20.0
20.7
19.9

39.8
39.0
38.7
43.9

37.9
37.2
35.9
42.4

16.5e
20.5d
24.5c
28.5b

14 doa
1.28
1.00
1.19
1.14

1.68
1.38
1.64
1.86

1.87
1.59
1.76
2.02

0.49
0.68
0.66
0.62

0.08
0.09
0.08
0.10

0.19
0.21
0.22
0.23

2.47
2.38
2.47
2.29

414

19.9

38.2

37.7

32.5a

0.96

1.74

1.77

0.53

0.07

0.19

2.59

19.6
0.62
8

0.71

1.85

1.99

0.19

0.101

0.209

0.177

0.078

0.009

0.018

0.37

0.889

0.109

0.073

0.001

0.071

0.344

0.418

0.196

0.055

0.334

0.164

1.64
1.65
1.67
1.68
0.128

1.53
1.56
1.48
1.35
0.140

0.62
0.67
0.61
0.62
0.082

0.09
0.10
0.11
0.11
0.014

0.16b
0.20a
0.21a
0.21a
0.014

2.44
2.36
2.52
2.54
0.139

0.983

0.456

0.865

0.191

0.049

0.538

1455
1417
1547
1487
66.3
0.34
4

27.3
24.7
28.8
27.6
2.51

59.7
65.7
67.4
64.6
3.66

63.1
57.3
67.6
62.8
5.62

13.9
16.1a
15.4a
14.8ab
0.663

28 doa
0.83
0.79
0.78
0.77
0.053

0.436

0.270

0.361

0.016

0.657

b

a-e

Treatment means within the same column within effect with no common superscripts are significantly different (P <
0.05).
1
Eggs that were not injected with any solution and also were challenged with coccidial vaccine at 14 doa.
2
Eggs injected 50 μl commercial diluent at d 18 of incubation and also were challenged with coccidial vaccine at 14 doa.
3
Eggs injected 50 μl commercial diluent containing vitamin 2.4 μg of D3 at d 18 of incubation and also were challenged with coccidial vaccine at 14
doa.
4
Eggs injected 50 μl commercial diluent containing 2.4 μg of 25OHD3 at d 18 of incubation and also were challenged with coccidial vaccine at 14 doa.
5
Eggs injected 50 μl commercial diluent containing 2.4 μg of D3 and 2.4 μg of 25OHD3 at d 18 of incubation and also were challenged with coccidial
vaccine at 14 doa.
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Table 8.2

Effects of non-injected eggs, diluent-injected, and eggs injected 2.4 μg of
vitamin D3 (D3), 25-hydroxycholecalciferol (25OHD3), and 2.4 μg of D3
and 2.4 μg of 25OHD3 on plasma nitric oxide (NO) and IL-1β
concentration at 14 and 28 d of age (doa).

In ovo injection
Treatment

Non-injected5
Diluent6

NO-d141

NO-d282

IL-1β-d143

IL-1β-d284

----------------------------------------μM-------------------------------13.92
8.50
a
14.36
18.6
8.26
10.39

D37

14.34

18.5a

6.65

10.60

25OHD38

11.08

16.1b

6.87

6.85

15.66
1.711
0.432

a

6.23
0.826
0.220

9.10
2.010
0.541

D3+25OHD39
Pooled SEM
P-value

18.1
0.633
0.028

a-b

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
2
Plasma nitric oxide concentrations at 28 doa.
3
Plasma IL-1β concentrations at 14 doa.
4
Plasma IL-1β concentrations at 28 doa.
5
Eggs that were not injected with any solution and also were challenged with coccidial vaccine at 14 doa.
6
Eggs injected with 50 μl commercial diluent at d 18 of incubation and also were challenged with
coccidial vaccine at 14 doa.
7
Eggs injected with 50 μl commercial diluent containing vitamin 2.4 μg of D 3 at d 18 of incubation and
also were challenged with coccidial vaccine at 14 doa.
8
Eggs injected with 50 μl commercial diluent containing 2.4 μg of 25OHD 3 at d 18 of incubation and also
were challenged with coccidial vaccine at 14 doa.
9
Eggs injected with 50 μl commercial diluent containing 2.4 μg of D 3 and 2.4 μg of 25OHD3 at d 18 of
incubation and also were challenged with coccidial vaccine at 14 doa.

184

Table 8.3

Effects of non-injected eggs, diluent-injected (50 μL), and eggs injected 2.4 μg of vitamin D3 (D3), 25hydroxycholecalciferol (25OHD3; 50 μL), and 2.4 μg of D3 and 25OHD3 (50 μL) on small intestine
morphology at d14

Duodenum
Treatment

Villu
s
lengt
h

Villu
s
width

Cryp
t
dept
h

RVC1

Lengt
------------μm-------h/Dep
th

Jejunum
VSA
2

mm
2

Villu
s
lengt
h

Vill
us
widt
h

Crypt
depth

Ileum
RVC

Lengt
------------μm--------- h/Dep
th

VSA

mm
2

Villu
s
lengt
h

Vill
us
widt
h

Cryp
t
dept
h

RVC

Lengt
------------μm------h/Dep
-th

VSA

mm
2

Noninjected3

889

81

89

10.1b

0.29

558

80

86

6.7b

0.46

171

37

40

4.3c

0.71

Diluent4

863

96

130

8.1b

0.37

647

87

88

7.4ab

0.43
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40

38

4.8bc

0.73

D35

887

84

93

9.7b

0.30

618

90

101

6.3b

0.47

193

39

41

4.6bc

0.70

25OHD36
D3+25OHD

1009

93

71

14.7a

0.29

669

82

78

8.9a

0.39

237

45

36

4.6a

0.62

945

81

103

9.4b

634

90

84

7.6ab

41

35

6.6b

5.2

20.1

0.91

38.7

4.8

5.3

0.57

0.46
0.02
9

191

50.1

0.27
0.02
7

17.4

4.2

2.2

0.36

0.65
0.05
5

3

7

Pooled
SEM
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Table 8.3 (continued)

P-value

0.263

0.14
6

0.07
6

0.001

0.10
2

0.33
6

0.45
5

a-c

0.056

0.029

0.38
9

0.08
7

0.77
1

0.26
0

0.001

0.62
0

Treatment means within the same column within effect with no common superscripts are significantly
different (P < 0.05).
1
Ratio of villus length to crypt depth.
2
Villus surface area (VSA) calculated with average villus length and width = 2π × (width/2) × length.
3
Eggs that were not injected with any solution and also were challenged with coccidial vaccine at 14 d of age.
4
Eggs injected with 50 μl commercial diluent at d 18 of incubation and also were challenged with coccidial vaccine at 14 d of age.
5
Eggs injected with 50 μl commercial diluent containing vitamin 2.4 μg of D3 at d 18 of incubation and also were challenged with coccidial vaccine
at 14 d of age.
6
Eggs injected with 50 μl commercial diluent containing 2.4 μg of 25OHD3 at d 18 of incubation and also were challenged with
coccidial vaccine at 14 d of age.
7
Eggs injected with 50 μl commercial diluent containing 2.4 μg of D3 and 2.4 μg of 25OHD3 at d 18 of incubation and also were challenged with
coccidial vaccine at 14 d of age.
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Table 8.4

Effects of diluent-injected (50 μL), and eggs injected 2.4 μg of vitamin D3 (D3), 25-hydroxycholecalciferol
(25OHD3; 50 μL), and 2.4 μg of D3 and 25OHD3 (50 μL) on small intestine morphology at d28.
Duodenum

Treatment

Villu
s
lengt
h

Villu
s
width

Cryp
t
dept
h

------------μm--------

Jejunum

RVC1

Villu

r
VSA
s
2
lengt
h

Lengt
h/Dep
th

Vill
us
widt
h

Ileum

Crypt
depth

RVC

VSA

Villu
s
lengt
h

Vill
us
widt
h

Cryp
t
dept
h

RVC

VSA

mm2

------------μm--------

Lengt
h/Dep
th

mm2

-----------μm--------

Lengt
h/Dep
th

mm2

Diluent3

918b

110

103

8.5b

0.34

734

92

115

6.6

0.42

229

46

39

5.7bc

0.67

D34

894b

95

106

8.5b

0.33

708

94

106

6.6

0.43

229

42

49

4.6c

0.63

25OHD35

1233a

95

112

12.3a

0.28

889

109

107

8.5

0.39

313

42

39

8.1a

0.47

983b

107

97

9.8b

0.31

729

94

109

6.7

0.43

260

48

38

7.0ab

0.57

60.8

10.9

13.3

0.89

0.03
0

75.2

7.2

10.2

0.84

0.05
2

33.0

5.2

4.4

0.503

0.08
1

D3+25OHD
3

6

Pooled
SEM
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Table 8.4 (continued)

P-value
a-c

0.002

0.524

0.910

0.001

0.26
8

0.31
6

0.32
2

0.930

0.090

0.88
0

0.05
6

0.79
3

0.05
4

0.001

0.09
3

Treatment means within the same column within effect with no common superscripts are significantly different (P < 0.05).

1

Ratio of villus length to crypt depth

2

Villus surface area (VSA) calculated with average villus length and width = 2π ×
(width/2) × length.
2
Eggs injected with 50 μl commercial diluent at d 18 of incubation and also were challenged with coccidial vaccine at 14 d of age.
3
Eggs injected with 50 μl commercial diluent containing vitamin 2.4 μg of D3 at d 18 of incubation and also were challenged with coccidial vaccine
at 14 d of age.
4
Eggs injected with 50 μl commercial diluent containing 2.4 μg of 25OHD3 at d 18 of incubation and also were challenged with
coccidial vaccine at 14 d of age.
5
Eggs injected with 50 μl commercial diluent containing 2.4 μg of D3 and 2.4 μg of 25OHD3 at d 18 of incubation and also were challenged with
coccidial vaccine at 14 d of age.
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CHAPTER IX
SUMMARY
9.1

CURRENT FINDINGS
In the preliminary and main trials, varying dosages of vitamin D3 (D3) and 25-

hydroxycholecalciferol (25OHD3) alone and in combination were injected into the
amnion of developing broiler embryos on 18 d of incubation (doi). The results from the
preliminary study revealed the in ovo injection of 1.2 μg of both D3 and 25OHD3
increased the serum 25OHD3 concentrations of broiler embryos in comparison to noninjected and diluent-injected control groups. In the main study, serum 25OHD3
concentrations of broiler embryos were increased when D3 and 25OHD3 were
administrated at dosages between 0.60 to 4.8 μg alone or in combination. Additionally,
across dosage of injection, the in ovo injection of 25OHD3 alone increased yolk dry
matter percentage in comparison to birds that received an in ovo injection of D3 alone.
However, the combination of D3 and 25OHD3 at a total level of 4.8 μg, resulted in an
increase in relative liver weight and reduced yolk dry matter percentage. In addition to
evaluating their effects on embryogenesis and hatchability, the effects of the two sources
of vitamin D3 on broiler performance through 2 week post-hatch were also tested. The
results revealed that feed conversion ratio was reduced from 0 to 14 d of age (doa) in
birds that received 2.4 μg of 25OHD3 as compared to those that were non-injected, or that
received in ovo injections of diluent or 2.4 μg of D3.
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Positive performance results of early post-hatch broilers in response to the in ovo
injection of 25OHD3 encouraged further investigation into the in ovo injection of the two
vitamin D3 sources on commercial broiler grow out through 42 doa. Therefore, effects of
the in ovo injection of 2.4 μg of D3 and 25OHD3 alone or in combination on performance,
breast meat yield, non-specific immune response, small intestine morphology, and
incidence of woody breast myopathy (WBM), in broilers fed a commercial diet or a diet
restricted calcium and phosphorous by 20% were further explored. The results of that
study revealed that the in ovo injection of those vitamin D3 sources did not affect broiler
performance, meat yield or quality, small intestine morphology, or the immunity of
broilers when calcium and available phosphorous were restricted in their diets.
Furthermore, in comparison to the in ovo injection of diluent or 2.4 μg of D3, the in ovo
injection of 2.4 μg of 25OHD3 increased breast meat yield, deceased the WBM scores,
and improved the small intestine morphology and humoral immunity of the broilers. In
comparison to the regular commercial diet, the ReCaP diet resulted in severe declines in
the performance, meat yield, and small intestine morphology of the broilers. Conversely,
the ReCaP diet resulted in a decrease in WBM scores. The increase in the meat yield of
the birds that received 25OHD3 could be due to improvements in their small intestine
morphology and non-specific immune response. The first metabolite of D3 (25OHD3) is
stored to a greater extent in muscle and liver tissues when fed at lower levels of inclusion
as compared to D3 alone. The 25OHD3 has longer half-life, approximately 2 weeks in
comparison to 15 hours for vitamin D3. It is also worth mentioning that broiler hatchlings
are not able to fully respond to D3 supplementation due to the immaturity of their livers
activity and their low amount of 25-hydroxylase, which can increase their vitamin D3
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requirements. The rate of nutrient absorption is highly associated with morphology of the
small intestine in which an increase in ratio villus height to crypt depth (RVC) is linked
to increased nutrient absorption. Additionally, increased RVC is associated with
increased performance and breast meat yield. Therefore, increased breast meat yield in
response to 2.4 μg of 25OHD3 could have been due to improvement in small intestine
morphology. However, further research is need to identify the molecular or cellular
mechanism might have been involved in this improvement in response to the in ovo
injection vitamin D3 sources.
Coccidiosis is a parasitic infection that is considered as one of the main diseases
affecting the performance of poultry, and results in a world-wide loss of approximately 3
billion USD annually. Dietary 25OHD3 has been previously shown to increase the BW
gain (BWG) and anti-inflammatory response, and to decrease the pro-inflammatory
response, of broilers subjected to a coccidiosis challenge. In a subsequent study, the
effects of the two vitamin D3 sources on the performance, meat yield, small intestine
morphology, and inflammatory response of Ross 708 broilers before and after a
coccidiosis challenge were investigated. The results of that study revealed that the in ovo
injection of 2.4 μg of 25OHD3 increased the BWG of the birds from 29 to 41 doa, and
tended to increase their relative pectoralis major weight in comparison to those birds
injected with 2.4 μg of D3 or diluent alone. A similar treatment effect pattern was
observed for RVC before and 2 weeks after a coccidiosis challenge. Also, plasma nitric
oxide levels were decreased 2 weeks after a coccidiosis challenge in response to 25OHD 3
alone in comparison to all other treatments. Therefore, the improvements observed in
broiler performance and meat yield in response to 2.4 μg of 25OHD 3 during a coccidiosis
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challenge may be due to a decrease in the inflammatory response and a promotion in the
small intestine morphology of the broilers.
9.2

RECOMMENDATION
The overall findings of these studies indicate that the in ovo injection of both D3

and 25OHD3 are capable of increasing circulating 25OHD3 concentrations in broiler
embryos. In addition, the in ovo injection of 2.4 μg of 25OHD3 may be capable of
effectively increasing the breast meat yield and reducing the incidence of WBM as well
as reducing inflammatory reaction, and improving small intestine morphology, of Ross
708 broilers raised through 42 d of age (doa) under normal commercial conditions or
after a coccidiosis challenge. In conclusion, it is suggested that the in ovo injection of
25OHD3 at a 2.4 μg dose may be used to effectively improve the performance, breast
meat yield, immunity, and small intestine morphology of modern commercial broilers
through 42 doa.
9.3

STUDY LIMITATIONS
In Chapter 7 of this dissertation, differences between coccidiosis-infected and un-

infected treatment groups could not be determined due to limited battery cage space in
each of the replicate rooms that would be required to more accurately compare noninjected with coccidiosis-challenge treatment birds. In addition, the results of this
dissertation have shown that the in ovo injection of 2.4 µg of 25OHD3 had a greater
impact on breast meat yield and small intestine morphology in comparison to the in ovo
injection of the 2.4 µg of D3 and 2.4 µg of 25OHD3 combination. There are possible
reasons for these results. These include a potential toxicity of the 4.8 µg dosage of
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vitamin D3 sources, a negative interaction between vitamin D3 and 25OHD3, and a
competitive exclusion between D3 and 25OHD3. However, further research is needed to
test these possible hypotheses. Furthermore, the current research findings reveal that only
the individual in ovo injection of 25OHD3 increased breast meat yield, decreased
inflammatory response, and improved small intestine morphology. However, the possible
mechanism that can be involved in those improvements is not well-understood.
Nevertheless, it may be speculated that one possible mechanism would be increases in the
gene expression of 1α-hydroxylase and the vitamin D receptor (VDR) that subsequently
increases the rate of conversion of 25OHD3 to the active form of vitamin D3 in the small
intestine and breast tissue. However, further research is required to identify the
expression of both 1α-hydroxylase and VDR in response to vitamin D3 sources in the
small intestine and breast muscle tissues. Another potential mechanism would be linked
to the different rates of storage of the vitamin D3 sources tested. When 25OHD3
supplemented at low levels of inclusion, it is mainly stored in the liver and muscle
tissues. However, vitamin D3 is not efficiently stored in either liver or muscle tissue.
These not been previously tested in response to in ovo injection of the two vitamin D3
sources.
The broiler industry has been using in ovo vaccination against Marek's disease
using commercial Marek's disease diluent as a suspension solution. In the current study,
commercial Marek's disease diluent was used as a carrier for vitamin D3 sources tested,
but it did not contain Marek's disease vaccine. Therefore, the impact of the in ovo
injection of the vitamin D3 sources along with the Marek's disease vaccine on broiler
performance, breast meat yield, and small intestine morphology should be examined in
197

order to increase the validity of the current finding for the poultry industry. Another
limitation of this study was the use of a single strain (Ross 708). The in ovo injection of
25OHD3 has displayed different hatchability responses in Ross and Cobb strains.
However, the post-hatch effects of the vitamin D3 sources have not been reported in the
Cobb strain. These results indicate that the post-hatch effects of the in ovo injection of
these vitamin D3 sources requires further investigation.
9.4

IMPLICATION AND FUTURE RESEARCH
Dietary vitamin D3 sources, particularly, 25OHD3, have been used in the poultry

industry to promote broiler and layer production. The NRC recommendation for vitamin
D3 in broiler diets is 250 IU/kg, which was used in the current study. Additionally,
several studies using different strains of broilers have shown that various vitamin D 3
sources increased bone quality, broiler performance and breast meat yield when
supplemented from 2,000 to 5,000 as compared to the NRC recommended level of
vitamin D3. Thus, the comparison of the in ovo injection of vitamin D3 and dietary
vitamin D3 or 25OHD3 between the range of 2,000 to 5,000 IU/ kg feed on performance
and breast meat yield of broiler chickens should be determined. The activity of enzymes
involved in vitamin D metabolism are very low at first week of hatch, but these enzyme
activity is very high from 17 to 20 d of incubation. Additionally, various forms of vitamin
D3 can be stored in tissues such as liver, adipose, and red and white muscle. The
considerable level of 1α hydroxylase found in muscle and liver tissues can convert
25OHD3 to the active form of vitamin D3. Additionally, the expression of 1α-hydroxylase
remained constant in breast and kidney, but the amount of 24-hydroxylase was reduced
during systemic inflammation such as coccidiosis. Under these circumstances, the rate of
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conversion of 25OHD3 to the active form via1α-hydroxylase in breast and kidney tissues
may not be reduced during systemic inflammation in response to diseases such as
coccidiosis. Therefore, in ovo injection of vitamin D3 sources would be beneficial for
embryonic growth and early post hatch broilers. The results of the current dissertation
reveal that the in ovo administration of 2.4 µg of 25OHD3 increased breast meat yield and
early-post-hatch antibody production capacity, reduced inflammatory response, and
improved small intestine morphology when vitamin D3 was supplemented at NRC
recommended level. These current findings revealed that the in ovo administration of
25OHD3 has the potential to also achieve similar results when compared to dietary
supplementation of 25OHD3. However, the effects of dietary and in ovo injection of
25OHD3 on breast meant yield, immunity, small intestine morphology, and performance
of broilers should be compared. Therefore, future research should be focused on the
effects of both dietary and in ovo-administered of 25OHD3 on broiler performance as
well as meat yield and quality. Recent findings in our laboratory have also demonstrated
positive effects of the in ovo injection of vitamin C on broiler performance, meat quality,
and antioxidant capacity in broilers at 42 doa. Additionally, water soluble forms of D 3
and 25OHD3 allowed for the individual and combined in ovo injection of these vitamins
in order to more accurately and efficiently test for their effects on meat yield and quality.
Therefore, future research should employ the use of these water-soluble forms of D3.

199

